0001820872 false --12-31 0001820872 2022-05-27 2022-05-27 0001820872 us-gaap:CommonClassAMember 2022-05-27 2022-05-27 0001820872 gbtg:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOfDollar11.50PerShareMember 2022-05-27 2022-05-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): June 3, 2022 (May 27, 2022)

 

Global Business Travel Group, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware   001-39576   98-0598290
(State or other jurisdiction of
incorporation or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

666 3rd Avenue, 4th Floor

New York, NY 10017
(Address of principal executive offices) (Zip Code)

 

(212) 679-1600
(Registrant’s telephone number, including area code)

 

Not applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which
registered
Class A common stock, par value of $0.0001 per share   GBTG   The New York Stock Exchange
         
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share   GBTG.WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Introductory Note

 

Unless the context otherwise requires, “we,” “us,” “our,” “PubCo” and the “Company” refer to Global Business Travel Group, Inc., a Delaware corporation, and its consolidated subsidiaries following the Closing (as defined below). Unless the context otherwise requires, references to “APSG” refer to Apollo Strategic Growth Capital, a blank check company incorporated as a Cayman Islands exempted company, prior to the Closing, references to “Legacy GBT” refer to GBT JerseyCo Limited, a company limited by shares incorporated under the laws of Jersey, prior to the Closing, and references to “GBT” refer to GBT JerseyCo Limited, a company limited by shares incorporated under the laws of Jersey, following the Closing.

 

On May 25, 2022, APSG held an extraordinary general meeting of its shareholders (the “Shareholder Meeting”), at which the APSG shareholders considered and adopted, among other matters, a proposal to approve the previously announced business combination (the “Business Combination”) pursuant to the terms of the Business Combination Agreement (the “Business Combination Agreement”), by and between APSG and Legacy GBT. Pursuant to the terms and subject to the conditions set forth in the Business Combination Agreement, following the Shareholder Meeting, on May 27, 2022 (the “Closing Date”), the Business Combination was consummated (the “Closing”). Upon the completion of the Business Combination and the other transactions contemplated by the Business Combination Agreement (the “Transactions”), Legacy GBT became a direct subsidiary of APSG, with APSG being re-domesticated as a Delaware corporation and renamed “Global Business Travel Group, Inc.” and conducting its business through GBT in an umbrella partnership-C corporation structure (an “Up-C Structure”).

 

Item 1.01.Entry into a Material Definitive Agreement.

 

Subscription and Distribution Agreements

 

At the Closing, PubCo and GBT entered into a Class B Common Stock Subscription Agreement (the “PubCo Class B Common Stock Subscription Agreement”) and a Subscribed Ordinary Shares Subscription Agreement (the “PubCo Subscribed Ordinary Shares Subscription Agreement”).

 

Pursuant to the PubCo Class B Common Stock Subscription Agreement, PubCo issued and sold to GBT, and GBT subscribed for and purchased from PubCo, a number of shares of PubCo class B common stock, par value $0.0001 per share (the “Class B Common Stock”) equal to the total number of B Ordinary Shares of GBT (the “B Ordinary Shares”) issued in connection with the Business Combination Agreement, and GBT paid to PubCo the amount which equals the product of (a) $0.0001 per share and (b) the aggregate number of shares of Class B Common Stock subscribed for by GBT at the Closing in accordance with the Business Combination Agreement (the “GBT Subscription”).

 

Pursuant to the PubCo Subscribed Ordinary Shares Subscription Agreement, GBT issued and sold to PubCo, and PubCo subscribed for and purchased from GBT, (i) a number of shares of A Ordinary Shares of GBT (the “A Ordinary Shares”) equal to the number of shares of PubCo class A common stock, par value $0.0001 per share (the “Class A Common Stock”) outstanding after giving effect to the transactions contemplated by the Business Combination and the related transactions and (ii) a Z ordinary share of GBT, and PubCo paid GBT the PubCo Subscribed Ordinary Shares Purchase Price (as such term is defined in the Business Combination Agreement).

 

In addition, GBT, Juweel Investors (SPC) Limited (a successor entity of Juweel Investors Limited), a resident of Cayman Islands (“Juweel”), EG Corporate Travel Holdings LLC, a Delaware limited liability company (“Expedia”), American Express Travel Holdings Netherlands Coöperatief U.A., a cooperative organized under the laws of the Netherlands (“Amex HoldCo” and, together with Juweel and Expedia, the “Continuing JerseyCo Owners”) entered into an PubCo Class B Common Stock Distribution Agreement (the “PubCo Class B Common Stock Distribution Agreement”). Pursuant to the PubCo Class B Common Stock Distribution Agreement, following the GBT Subscription, GBT distributed to the Continuing JerseyCo Owners, and each Continuing JerseyCo Owner accepted from GBT, the shares of Class B Common Stock that GBT acquired in connection with the PubCo Class B Common Stock Subscription Agreement, in partial consideration for the redemption and cancellation of the GBT ordinary shares held by the Continuing JerseyCo Owners.

 

2 

 

 

The foregoing descriptions of the PubCo Class B Common Stock Subscription Agreement, the PubCo Subscribed Ordinary Shares Subscription Agreement and the PubCo Class B Common Stock Distribution Agreement do not purport to be complete and is qualified in its entirety by the full text of such agreements, copies of which are attached hereto as Exhibits 10.1, 10.2 and 10.3, respectively, and are incorporated herein by reference.

 

Registration Rights Agreement

 

At the Closing, PubCo, APSG Sponsor, L.P., a Cayman Islands limited partnership (the “Sponsor”), certain members of the APSG board of directors and management (the “Insiders”) and the Continuing JerseyCo Owners entered into an amended and restated registration rights agreement (the “Registration Rights Agreement”), pursuant to which, among other things, PubCo agreed to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of Class A Common Stock and other equity securities of PubCo that are held by the holders party to the Registration Rights Agreement from time to time. Pursuant to the Registration Rights Agreement, PubCo will be required to submit or file with the U.S. Securities and Exchange Commission (the “SEC”), within 30 calendar days after the Closing, a shelf registration statement covering the issuance and the resale of all such registrable securities on a delayed or continuous basis, and to use its commercially reasonable efforts to have such shelf registration statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) 60 calendar days (or 90 calendar days if the SEC notifies PubCo that it will “review” the shelf registration statement) after the filing thereof and (ii) the 10th business day after the date PubCo is notified (orally or in writing, whichever is earlier) by the SEC that the shelf registration statement will not be “reviewed” or will not be subject to further review.

 

When an effective shelf registration statement is on file with the SEC, the Sponsor and the Insiders may collectively demand not more than one underwritten shelf takedown per fiscal quarter and each Continuing JerseyCo Owner may demand not more than one underwritten shelf takedown per fiscal quarter, in each case, subject to certain customary limitations set forth in the Registration Rights Agreement, including the right of the underwriters to limit the number of securities to be included in an underwritten offering and PubCo’s right to delay or withdraw a registration statement under certain circumstances. The holders party to the Registration Rights Agreement are also entitled to certain piggyback registration rights and indemnification rights.

 

The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by the full text of the Registration Rights Agreement, a copy of which is attached hereto as Exhibit 10.4 and is incorporated herein by reference.

 

Exchange Agreement

 

At the Closing, PubCo, GBT and the Continuing JerseyCo Owners entered into an Exchange Agreement (the “Exchange Agreement”), giving the Continuing JerseyCo Owners (or certain permitted transferees thereof) the right, on the terms and subject to the conditions thereof, to exchange their B Ordinary Shares of GBT (with automatic surrender for cancellation of an equal number of shares of Class B Common Stock) for shares of Class A Common Stock on a one-for-one basis, subject to customary adjustments for stock splits, dividends, reclassifications and other similar transactions, or, in certain limited circumstances, at the option of the exchange committee (the “Exchange Committee”) designated in the Exchange Agreement, for cash (based on the dollar volume-weighted average price (the “VWAP”) of Class A Common Stock for the five trading day period ending on the trading day immediately preceding the applicable exchange date).

 

In addition, to preserve the contemplated Up-C Structure, the Exchange Agreement provides that PubCo and GBT will take (or, in some cases, forbear from taking) various actions, as necessary to maintain a one-to-one ratio between the number of issued and outstanding (x) Class A Common Stock (and equivalents) and the A Ordinary Shares and (y) Class B Common Stock and the B Ordinary Shares. For example, if PubCo issues or sells additional shares of Class A Common Stock, PubCo will contribute the net proceeds of such issuance or sale to GBT, and GBT will issue to PubCo an equal number of A Ordinary Shares. Similarly, the Exchange Agreement provides neither PubCo nor GBT may effect any subdivision or combination of any of its equity securities unless the other effects an identical subdivision or combination of the corresponding class of its equity securities. As the Continuing JerseyCo Owners (or certain permitted transferees thereof) exchange B Ordinary Shares (with automatic surrender for cancellation of an equal number of shares of Class B Common Stock) for shares of Class A Common Stock or cash, the number of A Ordinary Shares held by PubCo will be correspondingly increased, and a corresponding number of shares of Class B Common Stock will be cancelled.

 

3 

 

 

PubCo, acting through the Exchange Committee, may limit or restrict such exchanges if the Exchange Committee determines that such limitations or restrictions are necessary to avoid a violation of applicable law or GBT being classified as a “publicly traded partnership” taxable as a corporation for U.S. federal income tax purposes.

 

The foregoing description of the Exchange Agreement does not purport to be complete and is qualified in its entirety by the full text of the Exchange Agreement, a copy of which is attached hereto as Exhibit 10.5 and is incorporated herein by reference.

 

New Shareholders Agreement

 

At the Closing, PubCo, GBT and the Continuing JerseyCo Owners entered into a Shareholders Agreement (the “New Shareholders Agreement”). The New Shareholders Agreement sets forth various restrictions, limitations and other terms concerning the transfer of equity securities of PubCo and GBT by the parties thereto (other than, in most circumstances, the A Ordinary Shares). Among other matters, and subject to certain terms, conditions and exceptions, the New Shareholders Agreement prohibits each Continuing JerseyCo Owner, severally and not jointly, from effecting transfers of such equity securities to certain specified restricted persons, as well as transfers that would violate applicable securities laws or cause GBT to be treated other than as a pass-through entity for U.S. federal income tax purposes.

 

The New Shareholders Agreement specifies the initial composition of the board of directors of PubCo (the “PubCo Board”), effective immediately upon the Closing. PubCo agreed with each Continuing JerseyCo Owner (on a several basis), following the Closing, to take all necessary action within its control to cause the PubCo Board to have 11 directors, consisting of the Chief Executive Officer, two Amex HoldCo nominees, two Juweel nominees, one Expedia nominee, one Sponsor nominee, and, for so long as the director designated by the Sponsor is serving on the PubCo Board, four independent nominees, nominated by the PubCo Board’s nominating and governance committee, and, following the conclusion of the Sponsor designee’s service on the PubCo Board, five such independent nominees. If Amex HoldCo or Juweel ceases to own at least 15% of PubCo’s issued shares, it will thereafter have the right (on a several basis) to nominate only one director, and if any Continuing JerseyCo Owner ceases to own at least 5% of PubCo’s issued shares, it will thereafter have no right to nominate a director, except that Amex HoldCo will continue to have the right (on a several basis) to nominate a director for so long as PubCo is a “controlled entity” under the Bank Holding Company Act of 1956 (the “BHC Act”).

 

The New Shareholders Agreement will also require (subject to certain specified conditions and exceptions including those described below) the approval of each Continuing JerseyCo Owner for PubCo or its subsidiaries to take certain actions, including:

 

Other than in accordance with the PubCo Delaware Certificate or pursuant to an issuer tender offer or share repurchase program that, in each case, was approved by the PubCo Board, the redemption, cancellation or repayment of any equity securities of PubCo or GBT, other than on a pro rata basis from all shareholders;

 

Dividends or distributions, other than on a pro rata basis;

 

Other than in accordance with the PubCo Delaware Certificate, any share exchanges, splits, combinations and similar actions with respect to one or more, but not all, classes or series of PubCo or GBT shares;

 

Amendments to GBT’s organizational documents that relate specifically and solely to rights, priorities and privileges of the B Ordinary Shares or the C ordinary shares of GBT (the “C Ordinary Shares”), as applicable, or have a disproportionate adverse effect on such shares as compared to any other class or series of shares, and do not require a separate class vote of the holders of such shares; or

 

Any agreement or commitment to do any of the foregoing.

 

4 

 

 

In general, the foregoing approval right of a Continuing JerseyCo Owner will terminate if the such Continuing JerseyCo Owner ceases to own at least 10% of the issued Common Stock of PubCo (“Common Stock”); however, an amendment to GBT’s organizational documents of the type described in the fourth bullet in the preceding sentence will require the approval of any Continuing JerseyCo Owner to which such amendment is materially adverse, regardless of such Continuing JerseyCo Owner’s percentage interest of Common Stock. The foregoing approval rights do not apply to actions that PubCo or GBT undertake to effect an exchange pursuant to the Exchange Agreement, actions that they are otherwise authorized to undertake pursuant to the Exchange Agreement.

 

In addition, provided Amex HoldCo. continues to own 25% of PubCo’s issued stock, Amex HoldCo has approval rights with regard to a certain specified internal corporate transactions and other actions or inactions that would result in consolidation of PubCo or GBT with American Express Company and its consolidated subsidiaries (“American Express”) and/or its affiliates or result in PubCo or GBT becoming a “variable interest entity” under Accounting Standard Codification 810 - Consolidation.

 

Each Continuing JerseyCo Owner will appoint PubCo as its attorney-in-fact to, among other things, execute (x) written resolutions in their capacities as holders of B Ordinary Shares and C Ordinary Shares, as applicable, and (y) instruments appointing PubCo as their proxy to vote such shares, in each case on all such matters as to which a vote or written resolution of the holders of such shares is required by law, other than matters that relate specifically and solely to the rights, priorities and privileges of the B Ordinary Shares or the C Ordinary Shares, as applicable, or matters that have a disproportionate adverse effect on the B Ordinary Shares or the C Ordinary Shares, as applicable, as compared to any other class or series.

 

At the Closing, PubCo became a holding company whose principal asset is the A Ordinary Shares. As such, PubCo has no independent means of generating revenue or operating cash flows. GBT is treated as a partnership for U.S. federal income tax purposes and, as such, generally will not be subject to U.S. federal income tax. Instead, taxable income will be allocated to holders of GBT capital stock, including PubCo. Accordingly, PubCo will incur income taxes on its allocable share of any net taxable income of GBT and will also incur taxes and other expenses incidental to its functions as a public company.

 

Pursuant to the New Shareholders Agreement, GBT will make pro rata cash distributions to GBT’s shareholders, including PubCo, in amounts intended to be sufficient to enable PubCo to satisfy its liabilities for taxes, as reasonably determined by the PubCo Board. GBT will be required to make tax distributions pro rata in accordance with ownership of GBT capital stock.

 

In addition to tax expenses, PubCo will incur other expenses incidental to its functions as a public company, which could be significant. The New Shareholders Agreement requires GBT to pay or reimburse (or to cause one or more of its subsidiaries to pay or reimburse) such non-tax expenses (without making corresponding ratable distributions to GBT’s other shareholders). However, GBT’s ability to make such distributions and pay or reimburse such expenses may be subject to various limitations and restrictions, including but not limited to, restrictions in debt documents and the applicable provisions of Jersey law including, but not limited to, the obligation of the GBT Board to declare a 12-month forward-looking cash flow solvency statement in accordance with the Companies (Jersey) Law 1991, prior to the declaration of a distribution. Subsidiaries of GBT are also generally subject to similar or other types of legal limitations on their ability to make distributions that would have the effect of rendering them insolvent.

 

Under the New Shareholders Agreement, for as long as American Express “controls” PubCo under the BHC Act, PubCo must provide prior notice to Amex HoldCo before it and its subsidiaries may engage in certain new activities, investments and acquisitions, subject to exceptions for certain pre-approved new products and services, and Amex HoldCo may veto such new activities, investments and acquisitions if, after cooperating with PubCo for a period of time to reach a mutually agreeable solution, Amex HoldCo reasonably concludes that such new activities, investments and acquisitions would have an adverse effect on Amex HoldCo’s regulatory status under applicable banking laws.

 

The New Shareholders Agreement permits American Express to take, or require PubCo to take (in American Express’s sole discretion), certain actions to terminate its deemed “control” of PubCo under the BHC Act upon the occurrence of any of the “Amex Exit Conditions” specified in the New Shareholders Agreement.

 

5 

 

 

If an Amex Exit Condition occurs, American Express may exercise any of the following remedies to terminate its deemed “control” of PubCo for purposes of the BHC Act:

 

Require PubCo to issue to American Express in exchange for its shares of Class A Common Stock and/or Class B Common Stock, as the case may be, an equal number of shares of PubCo Class A-1 Preferred Stock, par value $0.00001 per share (“Class A-1 Preferred Stock”) and PubCo Class B-1 Preferred Stock, par value $0.00001 per share (“Class B-1 Preferred Stock”), respectively, which are non-voting;

 

Exercise demand registration rights under the Registration Rights Agreement without regard to most restrictions and limitations on the exercise of demand registration rights thereunder; or have no obligation to renew such co-brands or support any future co-brands once the amended and restated trademark license agreement is terminated).

 

Transfer some or all of its shares of PubCo or GBT without regard to most transfer restrictions and limitations that would otherwise apply in connection with a transfer of such shares.

 

If an Amex Exit Condition occurs and American Express is required to or chooses to terminate its deemed “control” of PubCo under the BHC Act, American Express will have the sole right to determine what approach or option to take to achieve a decontrol position, subject to a requirement to use commercially reasonable efforts and consult with PubCo in good faith to minimize costs and maximize tax efficiency for both American Express and PubCo. In addition, if PubCo makes a “PubCo Election” (as defined in the New Shareholders Agreement), Amex HoldCo may, at its option, terminate the amended and restated trademark license agreement between GBT Travel Services UK Limited, a private company with limited liability organized under the laws of the England and Wales (“GBT UK”) (and certain of its affiliates) and American Express, subject to the two-year transition period set forth therein (including termination of the “Payment Provider Obligations” referred to in the amended and restated trademark license agreement and the American Express exclusivity obligations to PubCo and its affiliates and Pubco’s and its affiliates’ other exclusivity obligations to American Express under the operating agreements between GBT UK (and its affiliates, where applicable) and American Express; provided, however, that PubCo’s co-brand obligations with respect to the existing co-brands will continue on their current terms until the existing termination dates of such agreements; provided, further, that PubCo and its affiliates will have no obligation to renew such co-brands or support any future co-brands once the amended and restated trademark license agreement is terminated).

 

The foregoing description of the New Shareholders Agreement does not purport to be complete and is qualified in its entirety by the full text of the New Shareholders Agreement, a copy of which is attached hereto as Exhibit 10.6 and is incorporated herein by reference.

 

Sponsor Side Letter Amendment

 

As previously disclosed, in connection with the Business Combination Agreement, on December 2, 2021, the Sponsor, the Insiders, APSG and Legacy GBT entered into a side letter (the “Sponsor Side Letter”) which, among other things, contain certain restrictions on the transfer by the Sponsor and the Insiders with respect to the Class A Common Stock issued to each of them at the Closing. The Sponsor and the Insiders are not permitted to transfer their Class A Common Stock, subject to certain permitted exceptions, until the earlier to occur of (a) one year following the Closing and (b) the date which the VWAP of Class A Common Stock exceeds $12.00 per share for any 20 trading days within a period of 30 consecutive trading days.

 

In connection with the Closing, APSG, Legacy GBT, Sponsor and certain of its insiders entered into an amendment to the Sponsor Side Letter (the “Sponsor Side Letter Amendment”), to subject an additional approximately 10% of Sponsor’s Class A Common Stock that would have immediately vested at the Closing to a vesting condition that the VWAP of the Company's Class A common stock exceeds $12.50 for any 20 trading days in a period of 30 consecutive trading days within five years of Closing.

 

6 

 

 

After giving effect to the Sponsor Side Letter Amendment, 12,268,186 of the Class A Common Stock issued to Sponsor at the Closing (such shares, which for the avoidance of doubt do not include any shares of Class A Common Stock issued to Sponsor in connection with the PIPE Investment (as defined below) or any Syndicate Shares (as defined in the Proxy Statement/Prospectus), the “Sponsor Shares”) immediately vested without restrictions and 8,077,064 of the Sponsor Shares were deemed unvested subject to certain triggering events to occur within five years following the Closing (the “Sponsor Side Letter Vesting Period”). If, within the Sponsor Side Letter Vesting Period, the VWAP of Class A Common Stock is greater than or equal to $12.50 for any 20 trading days within a period of 30 consecutive trading days, 4,720,098 of the unvested Sponsor Shares will vest. If, within the Sponsor Side Letter Vesting Period, the VWAP of Class A Common Stock is greater than or equal to $15.00 for any 20 trading days within a period of 30 consecutive trading days the remaining 3,356,966 of the unvested Sponsor Shares will vest. To the extent that either of the aforementioned triggering events do not occur within the Sponsor Side Letter Vesting Period, such Sponsor Shares will be forfeited to and terminated by PubCo. For the avoidance of doubt, any Class A Common Stock purchased by the Sponsor in connection with the PIPE Investment will not be subject to the vesting or transfer restrictions described above.

 

The registered holder(s) of the unvested Sponsor Shares continue to be entitled to all of the rights of ownership thereof, including the right to vote and receive dividends and other distributions in respect thereof. The number of shares and the price targets listed above will be equitably adjusted for stock splits, reverse stock splits, dividends (cash or stock), reorganizations, recapitalizations, reclassifications, combinations or other like changes or transactions with respect to the Class A Common Stock occurring after the Closing.

 

The foregoing description of the Sponsor Side Letter Amendment does not purport to be complete and is qualified in its entirety by the full text of the Sponsor Side Letter Amendment, a copy of which is attached hereto as Exhibit 10.7 and is incorporated herein by reference.

 

PubCo 2022 Equity Incentive Plan

 

At the Shareholder Meeting, the APSG shareholders approved the Global Business Travel Group, Inc. 2022 Equity Incentive Plan (the “2022 Plan”). The 2022 Plan was previously approved, subject to shareholder approval, by the APSG board of directors.

 

47,870,291 total shares (the “2022 Plan Reserve”) are available for issuance pursuant to awards granted under the 2022 Plan, which is also the maximum number of shares that may be issued in respect of incentive stock options. The 2022 Plan Reserve will also be increased by the number of shares underlying the portion of an award granted under the PubCo MIP (as defined below) that is cancelled, terminated or forfeited or lapses after the effective date of the 2022 Plan. Shares issued by us in connection with the assumption or substitution of outstanding grants or under certain stockholder approved plans from an acquired company will not reduce the number of shares available for awards under the 2022 Plan. Shares underlying the portion of an award that is forfeited or otherwise terminated for any reason whatsoever, in any case, without the issuance of shares, will be added back to the number of shares available for grant under the 2022 Plan.

 

Under the 2022 Plan, no non-employee director may be paid, issued, or granted in any one calendar year, compensation exceeding $750,000 in the aggregate. Shares issued under the 2022 Plan may, at the election of the PubCo Board, be (i) authorized but previously unissued shares or (ii) shares previously issued and outstanding and reacquired by PubCo.

 

The 2022 Plan is described in greater detail in the proxy statement/prospectus included in APSG’s Registration on Form S-4 (File No. 333-261820) (the “Proxy Statement/Prospectus”) in the section titled “The Equity Incentive Plan Proposal” which information is incorporated herein by refence. That summary and the foregoing description of the 2022 Plan does not purport to be complete and is qualified in its entirety by reference to the text of the 2022 Plan, which is filed as Exhibit 10.8 hereto and incorporated herein by reference.

 

PubCo Employee Stock Purchase Plan

 

At the Shareholder Meeting, the APSG shareholders approved the Global Business Travel Group, Inc. Employee Stock Purchase Plan (the “ESPP”). The ESPP was previously approved, subject to shareholder approval, by the APSG board of directors.

 

7 

 

 

11,068,989 total shares (the “ESPP Cap”) are initially available for purchase under the ESPP. On January 1 of each year during which the ESPP is in effect, commencing on January 1, 2023, the number of shares available for purchase under the ESPP will be automatically increased by the lesser of (x) the ESPP Cap, (y) 1% of the number of shares of all common stock outstanding as of the immediately preceding December 31 (calculated on a fully diluted basis, including derivative securities of PubCo and securities of GBT that may become convertible for equity securities of PubCo), and (z) such lesser number of shares as the PubCo Board may determine, in each case, subject to equitable adjustment to reflect certain corporate events. Shares issued under the ESPP may be shares already outstanding or newly issued or treasury shares. Notwithstanding the foregoing or anything contained in the ESPP to the contrary, not more than 12% of the fully diluted number of shares of all classes of PubCo (including derivative securities of PubCo and securities of GBT that may become convertible into shares of PubCo), measured immediately after the Closing (post-money and post-conversion) may be issued under the portion of the ESPP that is intended to be qualified under Section 423 of the Code, and not more than 12% of the fully diluted number of shares of all classes of PubCo (including derivative securities of PubCo and securities of GBT that may become convertible into shares of PubCo), measured immediately after the Closing (post-money and post-conversion) may be issued under the portion of the ESPP that is not intended to be qualified under Section 423 of the Code.

 

The ESPP is described in greater detail in the Proxy Statement/Prospectus in the section titled “The ESPP Proposal” beginning on page 229. That summary and the foregoing description of the ESPP does not purport to be complete and is qualified in its entirety by reference to the text of the ESPP, which is filed as Exhibit 10.9 hereto and incorporated herein by reference.

 

Commercial Arrangements with American Express

 

In June 2014, in connection with, and as part of, the formation of a joint venture (the “JV”) comprising the Legacy GBT operations established by American Express in June 2014 with a predecessor of Juweel, which represents a group of institutional investors led by an affiliate of Certares Management LLC, GBT US LLC, a wholly-owned subsidiary of Legacy GBT, entered into a trademark license agreement (the “Trademark License Agreement”) with American Express pursuant to which GBT US LLC was granted a license for GBT US, GBT III B.V., a private company with limited liability organized under the laws of the Netherlands (“GBT III B.V.”), all wholly-owned subsidiaries of GBT III B.V. and other permitted sublicensees to license the American Express trademarks used in the American Express Global Business Travel and American Express Meetings & Events brands for business travel, business consulting and meetings and events businesses on an exclusive and worldwide basis.

 

Before the consummation of the Business Combination, on May 27, 2022, the parties amended and restated the Trademark License Agreement (the “A&R Trademark License Agreement”) to grant GBT Travel Services UK Limited (“GBT UK”) a long-term, 11-year license (unless earlier terminated or extended) pursuant to which GBT UK, all wholly owned operating subsidiaries of PubCo and other permitted sublicensees will continue to license the American Express trademarks used in the American Express Global Business Travel brand, transition the American Express Meetings & Events brand to the American Express GBT Meetings & Events brand, and license the American Express trademarks used in the American Express GBT Meetings & Events brand for business travel, meetings and events, business consulting and other services related to business travel (“Business Travel Services”). The A&R Trademark License Agreement also provides PubCo the flexibility to operate non-Business Travel Services businesses under brands that do not use any trademarks owned by American Express, subject to BHC Act permissibility and other requirements.

 

In June 2014, in connection with, and as part of, the formation of the JV, GBT III B.V. entered into a series of commercial arrangements on an arm’s-length basis with affiliates of American Express. These arrangements included, among other things, American Express’ oversight of certain legal compliance functions of GBT’s business, services in support of American Express’ consumer services and consumer travel businesses, including GBT’s support of certain American Express partnerships and the parties’ joint negotiation with travel suppliers, American Express card acceptance by GBT as an American Express card merchant, the strategic relationship between GBT and American Express’ corporate payments/commercial services business, including lead generation, joint client services and product development, and data sharing, the provision of business travel and meetings and events services by GBT to American Express, the provision of corporate payments services by American Express to GBT and participation in the American Express Membership Rewards Program for the provision of bonus points to qualifying GBT clients.

 

8 

 

 

In anticipation of, and effective upon, the consummation of the Business Combination, the parties amended the terms of certain of these commercial arrangements (such agreements, as amended and collectively with the A&R Trademark License Agreement, the “Amended Amex Commercial Agreements”) by providing for the following:

 

GBT UK (including American Express-branded and non-American Express branded businesses of PubCo) continues to be committed to: (i) solely and exclusively offer, promote and market American Express payment product solutions to any current, future or potential client of PubCo; (ii) make available American Express products and services as the default and/or primary payment option when a client or its personnel use or otherwise select a payment method on GBT’s platform; (iii) solely and exclusively make available American Express payments products, including the American Express corporate card, to our own personnel; (iv) not directly or indirectly offer, promote, market or provide any scorecard or travel-related benefit to or through certain American Express competitors, third party travel agency or other third party, in each case as a card member benefit; and/or (v) not permit any consumer travel agency (other than American Express’ Travel and Lifestyle Services division) to use GBT’s travel volume as a means of obtaining any scorecard or travel-related benefit for purposes of providing such travel-related benefit, in each case as a card member benefit (such obligations in (i) through (v), collectively, the “GBT Exclusivity Obligations”). However, GBT may accept payments from other providers and may develop technical integration of products that support payments made via other payment providers.

 

American Express exclusively uses GBT as its business travel and meetings and events provider for so long as the GBT Exclusivity Obligations remain in place.

 

American Express exclusively submits business travel and meetings and events leads to GBT, but will not be foreclosed from receiving leads from any third party.

 

American Express is restricted from entering into any exclusive agreements or otherwise exclusively partnering with specified categories of GBT’s competitors for the development and delivery of Business Travel Services.

 

GBT continues to support certain pre-Closing American Express partnerships, renewals of those relationships, and certain new partnerships, each on mutually acceptable terms.

 

GBT and American Express collaborate on mutually beneficial growth opportunities on mutually beneficial terms, including the expansion of their global lead generation partnership and joint client value proposition and retention.

 

GBT continues to accept the American Express card as an American Express card merchant as long as the license of the American Express trademarks used in our brands is in effect.

 

The foregoing description of the Amended Amex Commercial Agreements does not purport to be complete and is qualified in its entirety by the full text of the Amended Amex Commercial Agreements, copies of which are attached hereto as Exhibits 10.27 through 10.30 and are incorporated herein by reference.

 

Item 2.01.Completion of Acquisition or Disposition of Assets.

 

As described in the Introductory Note above, which is incorporated into this Section 2.01 by reference, on May 25, 2022, APSG held the Shareholder Meeting, at which the APSG shareholders considered and adopted, among other matters, a proposal to approve the Business Combination Agreement and the Transactions. On May 27, 2022, the parties consummated the Business Combination. In connection with the Closing, APSG changed its name from Apollo Strategic Growth Capital to Global Business Travel Group, Inc.

 

Holders of 77,514,764 shares of APSG’s public shares that were sold in the APSG’s initial public offering (the “public shares”) properly exercised their right to have such shares redeemed for a full pro rata portion of the trust account holding the proceeds from APSG’s initial public offering, calculated as of two business days prior to the consummation of the Business Combination, which was approximately $776 million in the aggregate.

 

9 

 

 

Pursuant to subscription agreements entered into in connection with the Business Combination Agreement (collectively, the “PIPE Subscription Agreements”), certain investors (the “PIPE Investors”) subscribed for an aggregate of 32,350,000 newly-issued shares of Class A Common Stock at a purchase price of $10.00 per share for an aggregate purchase price of $323.5 million (the “PIPE Investment”). At the Closing, the Company consummated the PIPE Investment. On the Closing date, one investor did not fund its $12.0 million committed amount under its PIPE Subscription Agreement.

 

After giving effect to the Transactions and the consummation of the PIPE Investment there are currently 56,945,033 shares of Class A Common Stock issued and outstanding, 394,448,481 shares of Class B Common Stock issued and outstanding, 36,535,801 stock options to purchase Class A Common Stock (“Pubco MIP Options”) issued and outstanding and 39,451,134 warrants to purchase Class A Common Stock (“PubCo Warrants”) issued and outstanding.

 

The Class A Common Stock and PubCo warrants commenced trading on The New York Stock Exchange (the “NYSE”) under the symbols “GBTG” and “GBTG.WS,” respectively, on May 31, 2022.

 

As noted above, an aggregate of $776 million was paid from the APSG’s trust account to holders that properly exercised their right to have public shares redeemed, and the remaining balance of approximately $42 million was released to the Company.

 

A description of the treatment of the equity of APSG and Legacy GBT prior to the Business Combination is set forth in the Proxy Statement/Prospectus in the section titled “The Business Combination Proposal – General Description of the Business Combination” on page 144, which is incorporated herein by reference.

 

FORM 10 INFORMATION

 

Item 2.01(f) of Form 8-K states that if the registrant was a shell company, as APSG was immediately before the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, the Company is providing below the information that would be included in a Form 10 if it were to file a Form 10. Please note that the information provided below relates to the combined company after the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires.

 

Forward-Looking Statements

 

Certain statements made in this Current Report on Form 8-K are “forward-looking statements.” Statements regarding the expectations regarding the combined business are “forward-looking statements.” In addition, words such as “estimates,” “projected,” “expects,” “estimated,” “anticipates,” “suggests,” “projects,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “could,” “future,” “propose,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include:

 

The expected benefits of the Business Combination;

 

the projected financial information, anticipated growth rate and market opportunity of PubCo;

 

GBT’s ability to maintain its existing relationships with customers and suppliers and to compete with existing and new competitors in existing and new markets and offerings;

 

10 

 

 

various conflicts of interest that could arise among us, affiliates and investors;

 

our success in retaining or recruiting, or changes required in, our officers, key employees or directors following the Business Combination;

 

our directors and officers potentially having conflicts of interest with our business or in approving the Business Combination, as a result of which they would receive compensation;

 

intense competition and competitive pressures from other companies in the industry in which the combined company will operate;

 

factors relating to the business, operations and financial performance of GBT, including market conditions and global and economic factors beyond GBT’s control;

 

the impact of COVID-19 and related changes in base interest rates and significant market volatility on our business, the travel industry, travel trends and the global economy generally;

 

costs related to the Business Combination;

 

the sufficiency of GBT’s cash, cash equivalents and investments to meet its liquidity needs;

 

the global travel industry;

 

political, social and macroeconomic conditions (including the widespread adoption of teleconference and virtual meeting technologies which could reduce the number of in person business meetings and demand for travel and GBT’s services);

 

the effect of legal, tax and regulatory changes.

 

The forward-looking statements contained in this Current Report on Form 8-K are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in the Proxy Statement/Prospectus. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

Business

 

The business of Legacy GBT prior to the Business Combination is described in the Proxy Statement/Prospectus in the section titled “Business of GBT” beginning on page 263, and that information is incorporated herein by reference.

 

Risk Factors

 

The risk factors related to GBT’s business and operations and the Business Combination are set forth in the Proxy Statement/Prospectus in the section titled “Risk Factors” beginning on page 60, and that information is incorporated herein by reference.

 

11 

 

 

Financial Information

 

Reference is made to (a) the disclosure in the Proxy Statement/Prospectus in the sections titled “Selected Historical Consolidated and Combined Financial Information of GBT” beginning on page 53 and (b) the disclosure in item 9.01 of this Current Report on Form 8-K are incorporated herein by reference.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Reference is made to (a) the disclosure contained in the Proxy Statement/Prospectus in the sections titled “APSG’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” beginning on page 294 and “GBT’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” beginning on page 298 and (b) the information contained in Management Discussion and Analysis of Financial Condition and Results of Operations of Legacy GBT as of and for the three months ended March 31, 2022, are attached hereto as Exhibit 99.2, which are incorporated herein by reference.

 

Quantitative and Qualitative Disclosures about Market Risk

 

Reference is made to the disclosure contained in the Proxy Statement/Prospectus in the sections titled “Qualitative and Quantitative Disclosures about Market Risk” on pages 297 and 320, which is incorporated herein by reference.

 

Properties

 

Reference is made to the disclosure contained in the Proxy Statement/Prospectus in the section titled “Business of GBT – Facilities” on page 291, which is incorporated herein by reference.

 

Security Ownership of Certain Beneficial Owners and Management

 

The following table sets forth information known to the Company regarding the beneficial ownership of PubCo common stock as of the Closing Date by:

 

each person who is the beneficial owner of more than 5% of issued and outstanding shares of Class A Common Stock or Class B Common Stock;

 

each of PubCo’s current named executive officers and directors; and

 

all executive officers and directors of PubCo as a group.

 

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Company stock issuable upon exercise of options and warrants currently exercisable within 60 days are deemed outstanding solely for purposes of calculating the percentage of total voting power of the beneficial owner thereof.

 

The beneficial ownership of PubCo common stock is based on 56,945,033 shares of Class A Common Stock and 394,448,481 shares of Class B Common Stock outstanding as of the Closing Date.

 

Unless otherwise indicated, PubCo believes that each person named in the table below has sole voting and investment power with respect to all shares of PubCo common stock beneficially owned by them.

 

12 

 

 

   PubCo Class A Common Stock
Beneficially Owned
   PubCo Class B Common Stock
Beneficially Owned(1)
   Combined Total
Voting Power
 
Name of Beneficial Owner(2)  Shares   Percent   Shares   Percent   Percent 
Five Percent Holders                         
Juweel(3)            162,388,084    41.2%   36.0%
American Express Company(4)            157,786,199    40.0%   35.0%
Expedia(5)            74,274,198    18.8%   16.5%
APSG Sponsor, L.P.(6)    34,569,384    60.7%           7.7%
Marshall Wace LLP(7)    6,109,059    10.7%           1.4%
Empyrean Capital Overseas Master Fund, Ltd.(8)    4,696,981    8.2%           1.0%
Bank of Montreal(9)    4,144,754    7.3%           0.9%
PubCo Directors and Named Executive Officers                        
Paul Abbott                     
Andrew George Crawley                     
Michael Qualantone(10)    1,535,784    2.7%           0.3%
James P. Bush                     
Gloria Guevara Manzo                     
Eric Hart                     
Raymond Donald Joabar                     
Michael Gregory O'Hara                     
Richard Petrino                     
Mohammed Saif S.S. Al-Sowaidi                     
Itai Wallach                     
Susan Ward                     
Kathleen Winters                     
PubCo Directors and Executive Officers as a Group (20 Individuals)(10)    6,304,425    11.1%           1.4%

 

 

*Less than 1%

 

(1)The Continuing JerseyCo Owners (or certain permitted transferees thereof) have the right, on the terms and subject to the conditions of the Exchange Agreement, to exchange their B Ordinary Shares (with automatic surrender for cancellation of an equal number of shares of Class B Common Stock) for shares of Class A Common Stock on a one-for-one basis, subject to customary adjustments for stock splits, dividends, reclassifications and other similar transactions or, in certain limited circumstances, at the option of the Exchange Committee, for cash (based on the VWAP of the shares of Class A Common Stock for the five trading day period ending on the trading day immediately preceding the applicable exchange date); however, the beneficial ownership table assumes the ownership of the Continuing JerseyCo owners immediately following the Closing without giving effect to any such exchanges.

 

(2)The business address of Itai Wallach is c/o Apollo Strategic Growth Capital, 9 West 57th Street, 43rd Floor New York, NY 10019. The business address of each director and executive officer of PubCo (other than Mr. Wallach) is c/o GBT JerseyCo Limited, 666 3rd Avenue, 4th Floor, New York, NY 10172.

 

(3)Juweel is managed by its board of directors. The business address of Juweel is 350 Madison Avenue, 8th Floor, New York, NY 10017.

 

(4)Consists of securities held of record by American Express Travel Holdings Netherlands Coöperatief U.A., an indirect, wholly-owned subsidiary of American Express. The principal business address of this entity is 200 Vesey Street, New York, NY 10285.

 

(5)Expedia is a direct, wholly-owned subsidiary of Expedia Group, Inc. The business address of such parties is 1111 Expedia Group Way W., Seattle, Washington 98119.

 

(6)Numbers and percentages include 12,224,134 PubCo warrants, which, beginning 30 days following the Closing, may be exercised for 12,224,134 shares of Class A Common Stock. Sponsor is managed by affiliates of Apollo. AP Caps II Holdings GP, LLC (“Holdings GP”) is the general partner of Sponsor. Apollo Principal Holdings III, L.P. (“Principal III”) is the sole member of Holdings GP. Apollo Principal Holdings III GP, Ltd. (“Principal III GP”) serves as the general partner of Principal III. Messrs. Marc Rowan, Scott Kleinman and James Zelter are the directors of Principal III GP and as such may be deemed to have voting and dispositive control of the securities held of record by Sponsor. The address of Sponsor, Holdings GP, Principal III and Principal III GP is c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands. The address of each of Messrs. Rowan, Kleinman and Zelter is 9 West 57th Street, 43rd Floor, New York, New York 10019.

 

(7)Based solely upon the Schedule 13G filed with the SEC on February 14, 2022 by Marshall Wace LLP. The business address of Marshall Wace LLP is George House, 131 Sloane Street, London, SW1X 9AT, UK.

 

(8)Based solely upon the Schedule 13G/A filed with the SEC on May 2, 2022 by Empyrean Capital Overseas Master Fund, Ltd., Empyrean Capital Partners, LP and Amos Meron, each of which shares voting and dispositive power with respect to the reported shares shown above. The business address of such parties is c/o Empyrean Capital Partners, LP, 10250 Constellation Boulevard, Suite 2950, Los Angeles, CA 90067.

 

(9)Based solely upon the Schedule 13G filed with the SEC on February 15, 2022 by Bank of Montreal. The business address of Bank of Montreal is 100 King Street West, 21st Floor, Toronto, M5X 1A1, Ontario, Canada.

 

(10)Shares consist of vested and unvested PubCo MIP Options that are exercisable within 60 days from the date of this Current Report on Form 8-K.

 

13 

 

 

Directors and Executive Officers

 

The Company’s directors and executive officers after the consummation of the Transactions are described in the Proxy Statement/Prospectus in the section titled “Management Following the Business Combination” beginning on page 344, and that information is incorporated herein by reference.

 

Director Independence

 

Information with respect to the independence of the Company’s directors is set forth in the Proxy Statement/Prospectus in the section titled “Management Following the Business Combination – Independence of the PubCo Board” beginning on page 346, and that information is incorporated herein by reference.

 

Committees of the Board of Directors

 

Information with respect to the composition of the committees of the board of directors immediately after the Closing is set forth in the Proxy Statement/Prospectus in the section titled “Management Following the Business Combination – Board Committees” beginning on page 348, and that information is incorporated herein by reference.

 

Executive Compensation

 

A description of the compensation of the named executive officers of Legacy GBT before the consummation of the Business Combination is set forth in the Proxy Statement/Prospectus in the section titled “GBT’s Director and Executive Compensation” beginning on page 334, and that information is incorporated herein by reference.

 

At the Shareholder Meeting, the APSG shareholders approved the 2022 Plan. The description of the 2022 Plan is set forth in the Proxy Statement/Prospectus section entitled “The Equity Incentive Plan Proposal” beginning on page 220, which is incorporated herein by reference. The disclosure set forth under the heading “PubCo Equity Incentive Plan” in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

14 

 

 

At the Shareholder Meeting, the APSG shareholders approved the ESPP. The description of the ESPP is set forth in the Proxy Statement/Prospectus section entitled “The ESPP Proposal” beginning on page 229, which is incorporated herein by reference. The disclosure set forth under the heading “PubCo ESPP” in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Director Compensation

 

A description of the compensation of the directors of Legacy GBT and of APSG before the consummation of the Business Combination is set forth in the Proxy Statement/Prospectus in the sections titled “GBT’s Director and Executive Compensation” on page 334 and “Information About APSG” on page 260, respectively, and that information is incorporated herein by reference.

 

Certain Relationships and Related Party Transactions

 

Certain relationships and related party transactions are described in the Proxy Statement/Prospectus in the section titled “Certain Relationships and Related Party Transactions” beginning on page 356, and that information is incorporated herein by reference.

 

Legal Proceedings

 

Reference is made to the disclosure regarding legal proceedings in the sections of the Proxy Statement/Prospectus titled “Information about APSG – Legal Proceedings” on page 261 and “Information about GBT – Legal Proceedings” on page 292, and that information is incorporated herein by reference.

 

Market Price of and Dividends on the Company’s Common Equity and Related Stockholder Matters

 

As of the Closing Date, there were approximately 18 registered holders of our Class A Common Stock.

 

Our Class A Common Stock and public warrants began trading on NYSE under the ticker symbols “GBTG” and “GBTG.WS,” respectively, on May 31, 2022.

 

We have not paid any cash dividends on shares of our Class A Common Stock to date. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our board of directors may deem relevant. Because PubCo is a holding company and has no direct operations, we will only be able to pay dividends from funds we receive from our subsidiaries. In addition, our ability to pay dividends will be limited by covenants in its existing indebtedness and may be limited by the agreements governing other indebtedness that it or its subsidiaries incur in the future.

 

Recent Sales of Unregistered Securities

 

The disclosure set forth in Item 3.02 of this Current Report on Form 8-K is incorporated herein by reference.

 

Description of Company’s Securities

 

The description of the Company’s securities is contained in the Proxy Statement/Prospectus in the section titled “Description of PubCo Securities” beginning on page 367, and that information is incorporated herein by reference.

 

Immediately following the Closing, the authorized capital stock of the Company included (a) 3,000,000,000 shares of Class A Common Stock, (b) 3,000,000,000 shares of Class B Common Stock, (c) 20,420,250 shares of Class X Common Stock and (d) 6,010,000,000 shares of Preferred Stock.

 

15 

 

 

Indemnification of Officers and Directors

 

PubCo entered into indemnification agreements with each of its directors and executive officers on May 27, 2022 to indemnify such directors and executive officers under the circumstances and to the extent provided for therein, from and against all losses, claims, damages, liabilities, joint or several, expenses (including legal fees and expenses), judgments, fines, penalties, interest, settlements or other amounts arising from any and all threatened, pending or completed claim, demand, action, suit or proceeding, whether civil, criminal, administrative or investigative, and whether formal or informal, and including appeals, in which he or she may be involved, or is threatened to be involved, as a party or otherwise, to the fullest extent permitted under the DGCL.

 

Financial Statements and Exhibits

 

The information set forth under Item 9.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 3.02.Unregistered Sales of Equity Securities.

 

PIPE Investment

 

As disclosed above, in connection with the Transactions and immediately prior to the Closing, a total of 32,350,000 shares of Class A Common Stock were issued for $323,500,000 in cash pursuant to the PIPE Subscription Agreements in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act.

 

Pursuant to the PIPE Subscription Agreements, PubCo is required to submit or file with the SEC, within (i) 30 calendar days after the Closing or (ii) 90 calendar days following PubCo’s most recent fiscal year end if audited financials for the year ended December 31, 2021 are required to be included, a registration statement on Form S-1 or Form S-3, as applicable (“Shelf”), covering the resale of the Class A Common Stock issued pursuant to the PIPE Subscription Agreements and to use its commercially reasonable efforts to have such Shelf declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) 60 calendar days (or 90 calendar days if the SEC notifies PubCo that it will “review” the Shelf) after the filing thereof and (ii) the 10th business day after the date PubCo is notified (orally or in writing, whichever is earlier) by the SEC that the Shelf will not be “reviewed” or will not be subject to further review.

 

Other Subscriptions and Distributions

 

The information set forth in Item 1.01 in the section entitled “Subscriptions and Distributions” and in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference. In connection with the Closing, the Company issued 394,448,481 shares of Class B Common Stock to the Continuing JerseyCo Owners.

 

B Ordinary Share Exchange

 

The information set forth in Item 1.01 in the section entitled “Exchange Agreement” is incorporated herein by reference.

 

Item 3.03.Material Modification to Rights of Security Holders.

 

The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference.

 

Also, as disclosed below in Item 8.01, in accordance with Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), PubCo is the successor issuer to APSG and has succeeded to the attributes of APSG as the registrant. In addition, the shares of our Class A Common Stock, as the successor to APSG, are deemed to be registered under Section 12(b) of the Exchange Act.

 

16 

 

 

The Class A Common Stock and PubCo warrants are listed on the NYSE under the symbols “GBTG” and “GBTG.WS,” respectively.

 

Item 5.01.Changes in Control of Registrant.

 

The disclosure set forth under the Introductory Note and in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Officers and Directors

 

In connection with the consummation of the Business Combination, and in accordance with the terms of the Business Combination Agreement, the executive officers of APSG ceased serving in such capacity, and Sanjay Patel, Scott Kleinman, Jennifer Fleiss, Mitch Garber and James H. Simmons III ceased serving on APSG’s board of directors.

 

Effective as of the consummation of the Business Combination, Paul Abbott, Eric Hart and Kathleen Winters were appointed as Class I directors, James P. Bush, Richard Petrino, Mohammed Saif S.S. Al-Sowaidi and Susan Ward were appointed as Class II directors and Gloria Guevara Manzo, Raymond Donald Joabar, Michael Gregory (Greg) O’Hara and Itai Wallach were appointed as Class III directors, each to serve until the end of their respective terms and until their successors are elected and qualified.

 

Effective as of the consummation of the Business Combination, Paul Abbot was appointed as PubCo’s Chief Executive Officer, Andrew George Crawley was appointed as PubCo’s Chief Commercial Officer, Martine Gerow was appointed as PubCo’s Chief Financial Officer and Christopher Van Vliet was appointed as PubCo’s Chief Accounting Officer.

 

Reference is made to the disclosure in the Proxy Statement/Prospectus in the section entitled “Management Following the Business Combination” beginning on page 344 for biographical information about each of the Company’s directors and executive officers following the Business Combination, which is incorporated herein by reference.

 

Christopher Van Vliet served as the Controller of Legacy GBT since April, 2015, responsible for the controllership and financial reporting activities, including oversight of accounting policies, internal controls, treasury, and corporate accounting transactions. Mr. Van Vliet was appointed Controller of PubCo, which is PubCo’s principal accounting officer, at the Closing. Prior to joining Legacy GBT in 2015, Mr. Van Vliet served as Assistant Controller at Travelport where he led the accounting team through the Travelport IPO in 2014.  He has also held various positions within the SEC Reporting teams at Avis Budget and Cendant Corporation.  Mr. Van Vliet began his career as an auditor at Deloitte in New York City. Mr. Van Vliet received his B.A in accounting and MBA from the State University of New York at Buffalo.

 

A description of the compensation of the named executive officers and directors of Legacy GBT before the consummation of the Business Combination is set forth in the Proxy Statement/Prospectus in the section titled “GBT’s Director and Executive Compensation” beginning on page 334, and that information is incorporated herein by reference.

 

Employment Agreements with Our Named Executive Officers

 

Legacy GBT entered into an employment agreement with Paul Abbott dated June 5, 2020. The employment agreement will remain in effect unless terminated by either party upon 26 weeks’ notice by Mr. Abbott or 52 weeks’ notice by us, or upon an earlier termination due to breach of the agreement by Mr. Abbott.

 

Legacy GBT entered into an employment agreement with Andrew Crawley dated November 26, 2019, in connection with Mr. Crawley’s assumption of the role of Chief Commercial Officer on April 1, 2020. The employment agreement will remain in effect unless terminated by either party upon 26 weeks’ notice, or upon an earlier termination due to breach of the agreement by Mr. Crawley.

 

17 

 

 

Legacy GBT entered into an employment letter with Michael Qualantone, effective April 1, 2019, that provides for at-will employment with GBT US LLC.

 

A description of the employment agreements entered into with our named executive officers is set forth in the Proxy Statement/Prospectus in the section entitled “GBT’s Director and Executive Compensation – Employment Agreements with Our Named Executive Officers” beginning on page 336, and that information is incorporated herein by reference. The foregoing description of the employment agreements is qualified in its entirety by reference to the text of the plans and the form of award agreements thereunder attached hereto as Exhibits 10.10 through 10.12.

 

Severance Protection Agreements and Amendments with Our Named Executive Officers

 

Prior to Closing, Legacy GBT entered into severance protection agreements and amendments with certain of our executive officers, including our named executive officers, that became effective upon the Closing and which provide for certain severance payments and benefits if the executive’s employment is terminated by PubCo or its applicable affiliate without cause or due to the executive’s disability (and not due to death) or if the executive resigns employment for good reason (in either case, a “qualifying termination”).

 

A description of the severance protection agreements and amendments entered into with our named executive officers is set forth in the Proxy Statement/Prospectus in the section entitled “Interests of GBT’s Directors and Executive Officers in the Business Combination – Severance Protection Agreements and Amendments with Executive Officers of GBT” beginning on page 208, and that information is incorporated herein by reference. The foregoing description of the severance protection agreements and amendments is qualified in its entirety by reference to the text of the plans and the form of award agreements thereunder attached hereto as Exhibits 10.13 through 10.15.

 

Executive Long-Term Cash Incentive Plans

 

Legacy GBT has granted long-term cash incentive awards to certain of our executive officers, including our named executive officers, under each of the GBT JerseyCo Limited 2021 Executive Long-Term Cash Incentive Award Plan and the GBT JerseyCo Limited 2020 Executive Long-Term Cash Incentive Award Plan. A description of the long-term cash incentive awards granted to our named executive officers is set forth in the Proxy Statement/Prospectus in the section entitled “Interests of GBT’s Directors and Executive Officers in the Business Combination – GBT JerseyCo Limited 2021 Executive Long-Term Incentive Plan” beginning on page 207 and the section “GBT’s Director and Executive Compensation – GBT JerseyCo Limited 2020 Long-Term Incentive Plan” beginning on page 340, and that information is incorporated herein by reference. The foregoing description of the GBT JerseyCo Limited 2021 Executive Long-Term Cash Incentive Award Plan and the GBT JerseyCo Limited 2020 Executive Long-Term Cash Incentive Award Plan is qualified in its entirety by reference to the text of the plans and the form of award agreements thereunder attached hereto as Exhibits 10.21 through 10.26.

 

Amended & Restated Global Business Travel Group, Inc. Management Incentive Plan

 

Upon the Closing, PubCo adopted the Amended & Restated Global Business Travel Group, Inc. Management Incentive Plan (the “PubCo MIP”) which supersedes the predecessor the Legacy GBT Management Incentive Plan, as amended and restated on December 2, 2021 (the “Legacy GBT MIP”). A description of the Legacy MIP is set forth in the Proxy Statement/Prospectus in the section titled “Interests of GBT’s Directors and Executive Officers in the Business Combination – GBT JerseyCo Limited Amended & Restated Management Incentive Plan” beginning on page 205. Pursuant to the terms of the Legacy GBT MIP, all options granted under the Legacy GBT MIP that were outstanding at the Closing were converted into options to purchase shares of Common Stock of PubCo (“PubCo MIP Options”) and were treated as if they were originally granted under the PubCo MIP. Generally, the vesting and forfeiture terms of the PubCo MIP Options held by executive officers of GBT continue to be the same as provided under the Legacy GBT MIP, as described below.

 

18 

 

 

Under the PubCo MIP, all unexercised PubCo MIP Options, whether vested or unvested, expire on the tenth anniversary of their grant date, unless earlier cancelled, such as in connection with a termination of employment. PubCo MIP Options granted to our executive officers in December 2021 vest one-third annually over a three-year period and all other PubCo MIP Options generally vest annually at the rate of 20% per year, in each case, generally subject to continued service on the applicable vesting date.

 

Upon a termination of employment by PubCo or its affiliates without cause or a resignation for good reason by the participant (in each case, other than in connection with a change in control), the portion of PubCo MIP Options held by our executive officers that was granted in December 2021 and that is then outstanding and was scheduled to vest during the period the participant is entitled to receive severance payments or benefits under any employment or severance agreement with PubCo or its affiliates as a result of a termination by PubCo or its affiliates without cause or a resignation for good reason (the “severance period”) will continue to vest on the applicable vesting date during the severance period. Upon a termination of employment due to death, all outstanding and unvested PubCo MIP Options held by our executive officers that were granted in December 2021 will immediately vest in full. Upon a termination of employment due to retirement or disability, the portion of PubCo MIP Options held by our executive officers that was granted in December 2021 and that is then outstanding and was scheduled to vest on the next anniversary of the grant date immediately following such termination due to disability or retirement will vest in full on such scheduled vesting date.

 

The portion of the PubCo MIP Options held by our executive officers that was granted in December 2021 and that is or becomes vested and exercisable as of or after the date of a termination of employment by PubCo or its affiliates without cause, due to death or disability, resignation for good reason or due to retirement (in each case, other than in connection with a change of control) will remain exercisable until the earlier of (i) the later of the eighteen month anniversary of the Business Combination and the date that is one year after the date of termination of employment (or in the case of a termination without cause or resignation for good reason, one year after the last day of the participant’s severance period (which period may be longer in the event of certain corporate transactions)) and (ii) the tenth anniversary of the applicable grant date, in each case, subject to earlier termination in accordance with the terms of the PubCo MIP and the applicable award agreement; provided, however, that if such termination of employment occurs prior to the six month anniversary of the Business Combination, then no portion of such PubCo MIP Option held by our executive officers will become exercisable (even if vested) before the first date immediately following the six month anniversary of such Business Combination. In the event that the participant incurs (a) a termination of employment by PubCo or its affiliates without cause within 60 days before, or within 18 months after, a change in control of PubCo or its affiliates or (b) a termination of employment as the result of participant’s death or disability or by the participant for good reason, in each case, within 18 months after a change in control of PubCo or its affiliates, then in each such case, the portion of the PubCo MIP Option granted in December 2021 that is then outstanding and unvested will immediately become vested and exercisable (or in the case that a change in control occurs after such eligible termination of employment, will become vested and exercisable upon the occurrence of the change in control) and such PubCo MIP Option will remain exercisable until the earlier of (x) the first anniversary of such termination of employment and (y) the tenth anniversary of the applicable grant date.

 

With respect to all PubCo MIP Options granted to our executive officers prior to December 2021, (i) upon a termination of employment without cause (other than within 12 months after a change in control), the unvested portion of the PubCo MIP Option will continue to vest for six months after such termination (PubCo MIP Options that become so vested remain exercisable for 90 days following the applicable vesting date, but not beyond the tenth anniversary of the applicable grant date), (ii) upon a termination of employment due to death or disability, the unvested portion of the PubCo MIP Option will continue to vest for one year after such termination (PubCo MIP Options that become so vested remain exercisable for one year following the applicable vesting date, but not beyond the tenth anniversary of the applicable grant date) and (iii) upon a termination of employment without cause or for good reason, in each case, within 12 months after a change in control, the PubCo MIP Option will vest in full and remain exercisable until the tenth anniversary of the applicable grant date. Any such PubCo MIP Options that were vested as of such termination of employment will remain exercisable for 90 days following a termination without cause and for 12 months following a termination due to death or disability, but in no event beyond the tenth anniversary of the applicable grant date.

 

“Change in Control” under the PubCo MIP continues to have the same meaning as under the predecessor Legacy GBT MIP. For avoidance of doubt, the Business Combination will not constitute a change in control under the PubCo MIP.

 

19 

 

 

The foregoing description does not purport to be complete and is qualified in its entirety by reference to the PubCo MIP and the form award agreements attached hereto as Exhibits 10.16 through 10.20.

 

PubCo 2022 Equity Incentive Plan

 

The disclosure set forth under the heading “PubCo 2022 Equity Incentive Plan” in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

PubCo ESPP

 

The disclosure set forth under the heading “PubCo ESPP” in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

In connection with the change of APSG’s jurisdiction of incorporation from the Cayman Islands to the State of Delaware by deregistering as an exempted company in the Cayman Islands and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware, immediately prior to the Business Combination, APSG filed the Certificate of Incorporation of PubCo, and the Certificate of Designations for the Class A-1 Preferred Stock and the Certificate of Designations for the Class B-1 Preferred Stock (collectively, the “PubCo Delaware Certificate”) with the secretary of state of the State of Delaware and adopted the Bylaws of PubCo (“PubCo Delaware Bylaws”). The material terms of the PubCo Delaware Certificate and the PubCo Delaware Bylaws are described in the Proxy Statement/Prospectus in the sections entitled “The Amendment Proposal” beginning on page 127, “The Unbundling Precatory Proposals” beginning on page 129, “Comparison of Corporate Governance and Shareholder Rights” beginning on page 364 and “Description of PubCo’s Securities” beginning on page 367, each of which is incorporated by reference herein.

 

The foregoing description of the PubCo Delaware Certificate and the PubCo Delaware Bylaws does not purport to be complete and is qualified in its entirety by the terms and conditions of the PubCo Delaware Certificate and the PubCo Delaware Bylaws, which are attached hereto as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated herein by reference.

 

Item 5.06.Change in Shell Company Status.

 

As a result of the Business Combination, the Company ceased to be a shell company upon the Closing. The material terms of the Business Combination are described in Proxy Statement/Prospectus in the sections titled The Business Combination Proposal” beginning on page 144, and is incorporated herein by reference.

 

Item 9.01.Financial Statements and Exhibits.

 

(a)Financial statements of businesses acquired.

 

The audited consolidated financial statements of Legacy GBT as of December 31, 2021 and 2020 and for each of the years in the three year period ended December 31, 2021, and the related notes and report of independent registered public accounting firm thereto, are set forth in the Proxy Statement/Prospectus beginning on page F-28 and are incorporated herein by reference.

 

The unaudited condensed consolidated financial statements of Legacy GBT as of March 31, 2022 and for the three months ended March 31, 2022 and March 31, 2021, and the related notes thereto are attached hereto as Exhibit 99.1 and are incorporated herein by reference.

 

The audited consolidated financial statements of APSG as of and for the years ended December 31, 2021 and 2020, and the related notes and report of independent registered public accounting firm thereto, are set forth in the Proxy Statement/Prospectus beginning on page F-3 and are incorporated herein by reference.

 

20 

 

 

The disclosure contained in (a) the Proxy Statement/Prospectus in the section titled “GBT’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” beginning on page 298 and (b) Management Discussion and Analysis of Financial Condition and Results of Operations of Legacy GBT as of and for the three months ended March 31, 2022, and the related notes thereto are attached hereto as Exhibit 99.2 and, in each case, are incorporated herein by reference.

 

The unaudited condensed consolidated financial statements of APSG as of and for the three months ended March 31, 2022 are attached hereto as Exhibit 99.3 and are incorporated herein by reference.

 

(b)Pro forma financial information.

 

Certain pro forma financial information of the Company is attached hereto as Exhibit 99.4 and is incorporated herein by reference.

 

(c)Exhibits.

 

Exhibit
Number
Description
2.1 Business Combination Agreement, dated as of December 2, 2021, by and between Apollo Strategic Growth Capital and GBT JerseyCo Limited (incorporated by reference to Exhibit 2.1 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
3.1 Form of Certificate of Incorporation of Global Business Travel Group, Inc. (incorporated by reference to Exhibit 3.2 to APSG’s current report on Form 8-K filed with the SEC on October 6, 2020).
3.2 Form of Bylaws of Global Business Travel Group, Inc. (incorporated by reference to Exhibit 3.3 to APSG’s current report on Form 8-K filed with the SEC on October 6, 2020)
4.1 Warrant Agreement, dated October 1, 2020, between Apollo Strategic Growth Capital and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to APSG’s current report on Form 8-K filed with the SEC on October 6, 2020).
10.1 Form of PubCo Subscribed Ordinary Shares Subscription Agreement (incorporated by reference to Exhibit 10.1 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.2 Form of PubCo Class B Common Stock Subscription Agreement (incorporated by reference to Exhibit 10.2 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.3 Form of PubCo Class B Common Stock Distribution Agreement, by and among GBT JerseyCo Limited, American Express Travel Holdings Netherlands Coöperatief U.A., Juweel Investors (SPC) Limited and EG Corporate Travel Holdings LLC (incorporated by reference to Exhibit 10.11 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.4 Form of Amended & Restated Registration Rights Agreement entered into by and among Global Business Travel Group, Inc., APSG Sponsor, L.P. and the other parties thereto (incorporated by reference to Exhibit 10.10 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.5 Form of Exchange Agreement, by and among Global Business Travel Group, Inc., GBT JerseyCo Limited and equityholders of GBT JerseyCo Limited (incorporated by reference to Exhibit 10.7 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.6^ Form of Shareholders Agreement by and among by and among Global Business Travel Group, Inc., GBT JerseyCo Limited, American Express Travel Holdings Netherlands Coöperatief U.A., Juweel Investors (SPC) Limited and EG Corporate Travel Holdings LLC (incorporated by reference to Exhibit 10.4 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.7 Sponsor Side Letter Amendment, dated May 28, 2022, by and among the Sponsor, the Insiders, APSG and Legacy GBT.
10.8 Global Business Travel Group, Inc. 2022 Equity Incentive Plan.

 

21 

 

 

10.9 Global Business Travel Group, Inc. Employee Stock Purchase Plan.
10.10 Employment Agreement, dated April 1, 2019, by and between GBT US LLC and Michael Qualantone (incorporated by reference to Exhibit 10.20 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.11 Employment Contract, dated November 26, 2019, by and between GBT Travel Services UK Limited and Andrew Crawley (incorporated by reference to Exhibit 10.21 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.12 Service Agreement, dated June 5, 2020, by and between GBT Travel Services UK Limited and Paul Abbott (incorporated by reference to Exhibit 10.22 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.13 Supplemental Severance Agreement, dated November 2, 2021, by and between GBT US LLC and Michael Qualantone (incorporated by reference to Exhibit 10.23 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.14 Supplemental Severance Agreement, dated December 2, 2021, by and between GBT Travel Services UK Limited and Andrew Crawley (incorporated by reference to Exhibit 10.24 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.15 Supplemental Severance Agreement, dated December 7, 2021, by and between GBT Travel Services UK Limited and Paul Abbott (incorporated by reference to Exhibit 10.25 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.16 Global Business Travel Group, Inc., Management Incentive Plan, amended and restated as of May 27, 2022.
10.17 Form of Time Based Option Award Agreement under the Global Business Travel Group, Inc., Management Incentive Plan.
10.18 Form of Time-Based Option Grant Agreement (United Kingdom) under the GBT JerseyCo Limited Amended and Restated Management Incentive Plan (incorporated by reference to Exhibit 10.34 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.19 Form of Time-Based Option Grant Agreement (United States) under the GBT JerseyCo Limited Amended and Restated Management Incentive Plan (incorporated by reference to Exhibit 10.35 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.20 Form of Time-Based Option Grant Agreement under the GBT JerseyCo Limited Management Incentive Plan (incorporated by reference to Exhibit 10.36 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.21 GBT JerseyCo Limited 2021 Executive Long-Term Cash Incentive Award Plan, effective as of November 5, 2021 (incorporated by reference to Exhibit 10.37 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.22 Form of Award Agreement (United Kingdom) under the GBT JerseyCo Limited 2021 Executive Long-Term Cash Incentive Award Plan (incorporated by reference to Exhibit 10.38 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.23 Form of Award Agreement (United States) under the GBT JerseyCo Limited 2021 Executive Long-Term Cash Incentive Award Plan (incorporated by reference to Exhibit 10.39 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.24 GBT JerseyCo Limited 2020 Executive Long-Term Cash Incentive Award Plan, effective as of November 5, 2020 (incorporated by reference to Exhibit 10.40 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.25 Form of Award Agreement (United Kingdom) under the GBT JerseyCo Limited 2020 Executive Long-Term Cash Incentive Award Plan (incorporated by reference to Exhibit 10.41 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.26 Form of Award Agreement (United States) under the GBT JerseyCo Limited 2020 Executive Long-Term Cash Incentive Award Plan (incorporated by reference to Exhibit 10.42 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.27^ Form of Amended and Restated Trademark License Agreement, dated May 27, 2022, by and between American Express Travel Related Services Company, Inc. and GBT Travel Services UK Limited and, solely for the purposes of specified sections therein, GBT JerseyCo Limited, GBT US LLC, GBT III B.V. and Global Business Travel Group, Inc. (incorporated by reference to Exhibit 10.26 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).

 

22 

 

 

10.28^ Form of Consumer Services Operating Agreement, dated as of June 30, 2014, by and between American Express Travel Related Services Company, Inc. and GBT Travel Services UK Limited (as assignee of GBT III B.V.), as amended (incorporated by reference to Exhibit 10.27 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.28.1^ Form of First Amendment to Consumer Services Operating Agreement, dated as of December 31, 2015, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.27.1 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.28.2^ Form of Second Amendment to Consumer Services Operating Agreement, dated as of July 24, 2017, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.27.2 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.28.3 Form of Third Amendment to Consumer Services Operating Agreement, dated as of November 19, 2019, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.27.3 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.28.4^ Form of Fourth Amendment to Consumer Services Operating Agreement, by and between American Express Travel Related Services Company, BT Inc. and G Travel Services UK Limited (as assignee of GBT III B.V.) (incorporated by reference to Exhibit 10.27.4 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.29^ Form of Global Corporate Payments Operating Agreement, dated as of June 30, 2014, by and between American Express Travel Related Services Company, Inc., and GBT III B.V (incorporated by reference to Exhibit 10.28 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.29.1^ Form of First Amendment to Global Commercial Services Operating Agreement, by and between American Express Travel Related Services Company, Inc., GBT III B.V. and GBT Travel Services UK Limited (incorporated by reference to Exhibit 10.28.1 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.30^ Form of Travel & Lifestyle Services Operating Agreement, dated as of June 30, 2014, by and between American Express Travel Related Services Company, Inc. and GBT Travel Services UK Limited (as assignee of GBT III B.V.), as amended (incorporated by reference to Exhibit 10.29 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.30.1^ Form of First Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of January 1, 2015, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.1 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.30.2 Form of Second Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of December 31, 2018, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.2 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.30.3 Form of Third Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of March 29, 2019, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.3 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.30.4 Form of Fourth Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of April 29, 2019, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.4 of APSG’s Registration Statement on Form S-4/A (Reg. No. 333-261820) filed with the SEC on March 22, 2022).
10.30.5^ Form of Fifth Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of January 1, 2020, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.5 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).

 

23 

 

 

10.30.6^ Form of Sixth Amendment to the Travel & Lifestyle Services Operating Agreement, dated as of March 21, 2020, by and between American Express Travel Related Services Company, Inc. and GBT III B.V (incorporated by reference to Exhibit 10.29.6 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
10.30.7^ Form of Seventh Amendment to Travel & Lifestyle Services Operating Agreement, dated as of May 27, 2022, by and between American Express Travel Related Services Company, Inc. and GBT Travel Services UK Limited (as assignee of GBT III B.V.) (incorporated by reference to Exhibit 10.29.7 of APSG’s Registration Statement on Form S-4 (Reg. No. 333-261820), filed with the SEC on December 21, 2021).
21.1 List of Subsidiaries.
99.1 The unaudited condensed consolidated financial statements of Legacy GBT as of March 31, 2022 and for the three months ended March 31, 2022 and March 31, 2021.
99.2 Management Discussion and Analysis of Financial Condition and Results of Operations of Legacy GBT as of and for the three months ended March 31, 2022
99.3 The unaudited condensed consolidated financial statements of APSG as of March 31, 2022 and for the three months ended March 31, 2022 (incorporated by reference to APSG’s Form 10-Q, filed with the SEC on May 9, 2022).
99.4 Unaudited Pro Forma Condensed Combined Financial Information of APSG and Legacy GBT as of and for the three months ended March 31, 2022 and the year ended December 31, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

Certain of the exhibits and schedule to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 

^Certain portions of these Exhibits have been omitted in accordance with Regulation S-K Item 601 because they are both (i) not material to investors and (ii) the type of information that the Registrant customarily and actually treats as private or confidential, and have been marked with ‘‘[***]’’ to indicate where omissions have been made. The Registrant agrees to furnish supplementally an unredacted copy of the Exhibit to the SEC upon its request.

 

24 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Global Business Travel Group, Inc.
 
  By: /s/ Eric J. Bock
    Name: Eric J. Bock
    Title: Chief Legal Officer, Global Head of M&A and Corporate Secretary
 
Date: June 3, 2022  

 

 

Exhibit 10.7

 

May 27, 2022

 

Apollo Strategic Growth Capital
9 West 57th Street, 43rd Floor
New York, NY 10019

 

and

 

GBT JerseyCo Limited
c/o GBT US LLC
General Counsel’s Office 666 Third Avenue
New York, NY 10017

 

Re: Amendment to Sponsor Side Letter

 

Reference is made to that certain (i) Business Combination Agreement, dated as of December 2, 2021 (as amended, supplemented, restated or otherwise modified from time to time, the “Transaction Agreement”), by and among Apollo Strategic Growth Capital, a Cayman Islands exempted company limited by shares (which shall migrate to and domesticate as a Delaware corporation at the Closing) (“Acquiror”), and GBT JerseyCo Limited, a company limited by shares incorporated under the laws of Jersey (the “Company”) and (ii) letter agreement, dated as of December 2, 2021 (as amended, supplemented, restated or otherwise modified from time to time, the “Sponsor Side Letter”), by and among APSG Sponsor, L.P., a Cayman Islands exempted limited partnership (“Sponsor”), the undersigned individuals, each of whom is currently a member of Acquiror’s Board of Directors and/or management team (collectively, the “Insiders” and together with Sponsor, the “Sponsor Parties”), Acquiror and the Company. Capitalized terms used herein but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Sponsor Side Letter.

 

Substantially concurrently with the execution and delivery of the Transaction Agreement, the Sponsor Parties, Acquiror and the Company entered into the Sponsor Side Letter, pursuant to which, among other things, Sponsor agreed to certain vesting and forfeiture provisions pertaining to the Sponsor Shares. In connection with the consummation of the Transactions, Sponsor has agreed to decrease the number of Immediately Vested Sponsor Shares and increase the number of $12.50 Threshold Shares, and consequently increase the total number of Vesting Sponsor Shares, as set forth herein. The parties hereto, being the original signatories to the Sponsor Side Letter, desire to enter into this amendment to the Sponsor Side Letter (this “Amendment”) pursuant to paragraph 8.e. thereof.

 

   

 

 

In consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree to amend the Sponsor Side Letter as follows:

 

1.Paragraph 4.a. of the Sponsor Side Letter is hereby amended as follows:

 

a.the reference to “13,631,318” in the definition of “Immediately Vested Sponsor Shares” is hereby deleted and replaced with “12,268,186”;

 

b.the reference to “6,713,932” in the definition of “Vesting Sponsor Shares” is hereby deleted and replaced with “8,077,064”; and

 

c.the reference to “3,356,966” in the definition of “$12.50 Threshold Shares” is hereby deleted and replaced with “4,720,098”.

 

Except as expressly amended by this Amendment, the Sponsor Side Letter remains in full force and effect and nothing in this Amendment shall otherwise affect any other provision of the Sponsor Side Letter or the rights and obligations of the parties thereto. On and after the date hereof, each reference to the Sponsor Side Letter shall mean and be a reference to the Sponsor Side Letter as amended hereby, and this Amendment and the Sponsor Side Letter shall be read together and construed as a single instrument.

 

[The remainder of this page left intentionally blank.]

 

 2 

 

 

Please indicate your agreement to the terms of this Amendment by signing where indicated below.

 

  Very truly yours,
     
  APSG SPONSOR, L.P.
     
  By: AP Caps II Holdings GP, LLC, its general partner
     
  By: Apollo Principal Holdings III, L.P., its managing member
     
  By: Apollo Principal Holdings III GP, Ltd., its general partner
     
  By: /s/ James Elworth
  Name: James Elworth
  Title: Vice President

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ James Crossen
  Name: James Crossen

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ Mitch Garber
  Name: Mitch Garber

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ Sanjay Patel
  Name: Sanjay Patel

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ James H. Simmons III
  Name: James H. Simmons III

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ Scott Kleinman
  Name: Scott Kleinman

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

    /s/ Jennifer Fleiss
  Name: Jennifer Fleiss

 

  Address for Notices:
     
     
     
     
  ATTN:    
  EMAIL:    

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

Acknowledged and agreed
as of the date of this Letter Agreement

 

APOLLO STRATEGIC GROWTH CAPITAL

 

By: /s/ Sanjay Patel  
Name: Sanjay Patel  
Title: Chief Executive Officer  

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

 

Acknowledged and agreed
as of the date of this Letter Agreement

 

GBT JERSEYCO LIMITED

 

By: /s/ Eric Bock  
Name: Eric Bock  
Title: Chief Legal Officer and Global head of Mergers and Acquisitions  

 

[Signature Page to Amendment to Sponsor Side Letter]

 

   

 

Exhibit 10.8

 

GLOBAL BUSINESS TRAVEL GROUP, INC.

 

2022 EQUITY INCENTIVE PLAN

 

Section 1.               Purpose of the Plan.

 

The purpose of the Global Business Travel Group, Inc. 2022 Equity Incentive Plan (the “Plan”) is to assist the Company and its Subsidiaries in attracting and retaining valued Employees, Consultants and Non-Employee Directors by offering them a greater stake in the Company’s success and a closer identity with it, and to encourage ownership of the Company’s shares by such Employees, Consultants and Non-Employee Directors.

 

Section 2.               Definitions.

 

As used herein, the following definitions shall apply:

 

2.1.          Award” means the grant of Options, SARs, Restricted Stock, Restricted Stock Units, Performance Stock, Performance Stock Units and Other Stock-Based Awards under the Plan.

 

2.2.           Award Agreement” means the written agreement, instrument or document evidencing an Award.

 

2.3.           Board” means the Board of Directors of the Company.

 

2.4.           Cause” means,

 

(a)            if the applicable Participant is party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary, and such term is defined therein, “Cause” shall have the meaning provided in such agreement;

 

(b)            if the applicable Participant is not a party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary or if no definition of “Cause” is set forth in the applicable employment, consulting, severance or similar agreement, “Cause” shall have the meaning provided in the applicable Award Agreement;

 

(c)            if neither clause (a) nor clause (b) applies, then “Cause” shall mean (i) engaging in (A) willful or gross misconduct or (B) willful or gross neglect; (ii) failing to follow the lawful directions of superiors or the Board or the written policies and practices of the Company or any Subsidiary; (iii) the Participant’s indictment for, being charged with, conviction of, plea of guilty or no contest to, or commission of, a felony or a crime involving any of the following: moral turpitude, dishonesty, breach of trust or unethical business conduct; (iv) the Participant’s indictment for, being charged with, conviction of, plea of guilty or no contest to, or commission of, any crime involving the Company or any Subsidiary; (v) fraud, misappropriation or embezzlement; (vi) a material breach of the Participant’s employment agreement (if any) with the Company or any Subsidiary, whether or not such breach results in the termination of the Participant’s employment; (vii) acts or omissions constituting a material failure to perform substantially and adequately the duties assigned to the Participant that are consistent with his or her position(s); (viii) any illegal act detrimental to the Company or any Subsidiary; (ix) repeated failure to devote substantially all of the Participant’s business time and efforts to the Company or any Subsidiary if required by the Participant’s employment agreement; or (x) the Participant’s abuse of illegal drugs or other controlled substances or the Participant’s habitual intoxication while providing services to the Company or any Subsidiary.

 

 

 

A Participant’s resignation or death, in either case, at a time when Cause to terminate the Participant’s employment or other service exists shall be treated as a termination for Cause for all purposes of the Plan and the Participant’s Awards and Award Agreements. In addition, if after the Participant's termination of employment or other service, the Company or a Subsidiary learns of facts that occurred during the Participant's employment or service with the Company or a Subsidiary that would have supported a termination for Cause, the Committee may retroactively reclassify the Participant's termination of employment or service as a termination for Cause.

 

2.5.           Business Combination Agreement” means the Business Combination Agreement, dated as of December 2, 2021, by and between Apollo Strategic Growth Capital and GBT JerseyCo Limited.

 

2.6.           Change in Control” means, unless otherwise provided in an Award Agreement, after the Effective Date:

 

(a)            the acquisition in one or more transactions (whether by purchase, merger, amalgamation or otherwise) by any “Person” (as such term is used for purposes of Section 13(d) or Section 14(d) of the Exchange Act) of “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act), of more than fifty percent (50%) of the combined voting power of the Company’s then outstanding voting securities (the “Voting Securities”);

 

(b)            a change in the composition of the Board such that the individuals who as of any date constitute the Board (the “Incumbent Board”) cease to constitute a majority of the Board at any time during the 24-month period immediately following such date; provided, however, that if the election, or nomination for election by the Company’s stockholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, such new director shall be considered as a member of the Incumbent Board, and provided further that any reductions in the size of the Board that are instituted voluntarily by the Incumbent Board shall not constitute a Change in Control, and after any such reduction the “Incumbent Board” shall mean the Board as so reduced;

 

(c)            a complete liquidation or dissolution or winding up of the Company (other than pursuant to a transaction in which the assets of the Company are distributed to an entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company); or

 

(d)           the sale, directly or indirectly, of all or substantially all of the Company’s and its Subsidiaries’ assets (determined on a consolidated basis).

 

Notwithstanding the foregoing, (i) a Change in Control shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately following which the holders of shares of Voting Securities immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions and (ii) for each Award that constitutes deferred compensation under Code Section 409A, and to the extent required to avoid accelerated taxation and/or tax penalties under Code Section 409A, a Change in Control shall be deemed to have occurred under the Plan with respect to such Award only if a change in the ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the Company shall also be deemed to have occurred under Code Section 409A. For purposes of this definition of Change in Control, the term “Person” shall not include (i) the Company or any Subsidiary thereof, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary thereof, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities, or (iv) a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company.

 

2

 

 

2.7.          Code” means the Internal Revenue Code of 1986, as amended.

 

2.8.          Company” means Global Business Travel Group, Inc., a Delaware corporation, or any successor corporation or company.

 

2.9.          Committee” means the Compensation Committee of the Board, provided that the Committee shall at all times have at least two members, each of whom shall be a “non-employee director” as defined in Rule 16b-3 under the Exchange Act and the regulations issued thereunder and an “independent director” under the rules of any applicable stock exchange.

 

2.10.        Consultant” means a natural person (within the meaning of Form S-8 of the Securities Act) who provides bona fide services to the Company or any Subsidiary other than in connection with the offer or sale of Shares or other securities or shares in a capital-raising transaction and is not engaged in activities that directly or indirectly promote or maintain a market for the Shares or other securities of the Company.

 

2.11.        Disability” means,

 

(a)            if the applicable Participant is party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary, and such term (or the term "disabled," "permanent disability" or similar phrases) is defined therein, then “Disability” shall have the meaning provided for such term in such agreement;

 

(b)            if the applicable Participant is not a party to an effective employment, consulting, severance or similar agreement with the Company or a Subsidiary or if no definition of “Disability” is set forth in the applicable employment, consulting, severance or similar agreement, “Disability” shall have the meaning provided in the applicable Award Agreement;

 

(c)            if neither clause (a) nor clause (b) applies, then “Disability” shall mean that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.

 

3

 

 

2.12.        Effective Date” means May 27, 2022.

 

2.13.        Employee” means an officer or other employee of the Company or a Subsidiary, including without limitation a director who is such an employee.

 

2.14.        Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

2.15.        Fair Market Value” means, on any given date (i) if the Shares are listed on any established stock exchange or a national market system, including without limitation the NYSE, the closing sales price for such Shares as quoted on such exchange or system on the day of determination, as reported in The Wall Street Journal or such other source as the Committee deems reliable (or, if no closing sales price was reported on that date, on the last trading date such closing sales price was reported); (ii) if clause (i) does not apply, then if the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the mean between the high bid and low asked prices for the Shares on the day of determination (or, if no bids and asks were reported on that date, on the last trading date such bids and asks were reported); or (iii) if neither clause (i) nor clause (ii) applies, such value as the Committee in its discretion may in good faith determine in accordance with Section 409A of the Code and the regulations thereunder (and, with respect to Incentive Stock Options, in accordance with Section 422 of the Code and the regulations thereunder).

 

2.16.        "Good Reason" has the meaning set forth in the Participant's Award Agreement, provided that if no definition of Good Reason is set forth therein, then the Participant shall not be entitled to any benefits under the Plan with respect to such Award that otherwise apply upon a termination for Good Reason.

 

2.17.        Incentive Stock Option” means an Option or portion thereof intended to meet the requirements of an incentive stock option as defined in Section 422 of the Code and designated as an Incentive Stock Option, and which in fact meets such requirements of Section 422 of the Code.

 

2.18.        Incumbent Director” means a director who either (1) is a member of the Board as of the Effective Date or (2) is elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination.

 

2.19.        Non-Employee Director” means a member of the Board who is not an Employee.

 

2.20.        Non-Qualified Option” means an Option or portion thereof that is designated as not being an Incentive Stock Option or that does not otherwise qualify as an Incentive Stock Option.

 

2.21.        Option” means a right granted under Section 6.1 of the Plan to purchase a specified number of Shares at a specified price. An Option may be an Incentive Stock Option or a Non-Qualified Option; provided, however, that unless otherwise explicitly stated in an Award Agreement, each Option is hereby designated as a Non-Qualified Option.

 

2.22.         Other Stock-Based Award” means a right granted under Section 6.5 of the Plan.

 

4

 

 

2.23.        Participant” means any Employee, Non-Employee Director or Consultant who receives an Award.

 

2.24.        Performance Goals” means any goals established by the Committee in its sole discretion. Performance Goals may be described in terms of Company-wide objectives or objectives that are related to the performance of the individual Participant or a Subsidiary, division, department or function within the Company or a Subsidiary. Performance Goals may be measured on an absolute or relative basis. Relative performance may be measured, for example, by a group of peer companies or by a financial market index. Performance Goals may include, but are not limited to: total shareholder return, earnings before interest, taxes, depreciation and amortization, net income (loss) (either before or after interest, taxes, depreciation and/or amortization), changes in the market price of the Shares, economic value-added, funds from operations or similar measure, sales or revenue, acquisitions or strategic transactions, operating income (loss), cash flow (including, but not limited to, operating cash flow and free cash flow), return on capital, assets, equity, or investment, return on sales, gross or net profit levels, productivity, expense, margins, operating efficiency, customer satisfaction, working capital, earnings (loss) per Share, sales or market shares and number of customers, any of which may be measured either in absolute terms or as compared to any incremental increase or as compared to results of a peer group, and any combination of any of the foregoing criteria. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company or a Subsidiary, or the manner in which it conducts its business, or other events or circumstances render the Performance Goals unsuitable, the Committee may modify such Performance Goals and/or the related minimum, target, maximum and/or other acceptable levels of achievement, in whole or in part, as the Committee deems appropriate and equitable.

 

2.25.        Performance Period” means the period selected by the Committee during which performance is measured for the purpose of determining the extent to which a Performance Goal has been achieved.

 

2.26.        Performance Stock” means Restricted Stock awarded by the Committee under Section 6.3 of the Plan that vest and/or are earned, in whole or in part, based on the achievement of one or more Performance Goals.

 

2.27.        Performance Stock Unit” means Restricted Stock Units awarded by the Committee under Section 6.4 of the Plan that vest and/or are earned, in whole or in part, based on the achievement of one or more Performance Goals.

 

2.28.        Person” means an individual, corporation, partnership, association, limited liability company, estate or other entity.

 

2.29.        "Prior Plan" means the GBT JerseyCo Limited Management Incentive Plan, as amended and/or restated from time to time, and including any predecessor version thereof.

 

2.30.        Restricted Stock” means a Share awarded by the Committee under Section 6.3 of the Plan.

 

2.31.        Restricted Stock Unit” means the right granted under Section 6.4 of the Plan to receive, on the date of settlement, one Share or an amount equal to the Fair Market Value of one Share. An Award of Restricted Stock Units may be settled in cash, Shares or any combination of the foregoing; provided, however, that unless otherwise provided in an Award Agreement, Restricted Stock Units shall be settled in Shares.

 

5

 

 

2.32.        Restriction Period” means the period during which Performance Stock, Performance Stock Units, Restricted Stock and Restricted Stock Units are subject to forfeiture.

 

2.33.        SAR” means a stock appreciation right awarded by the Committee under Section 6.2 of the Plan.

 

2.34.        Securities Act” means the Securities Act of 1933, as amended.

 

2.35.        Share” means one share of the Company’s Class A common stock.

 

2.36.        Subsidiary” means any corporation, partnership, joint venture, company or other business entity of which 50% or more of the outstanding voting power is beneficially owned, directly or indirectly, by the Company.

 

2.37.        Ten Percent Stockholder” means a Person who on any given date owns, either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), shares possessing more than 10% of the total combined voting power of all classes of shares of the Company, a “parent” or a “subsidiary” (as the terms “parent” and “subsidiary” are defined in Code Section 424).

 

Section 3.               Eligibility.

 

Any Employee, Non-Employee Director or Consultant shall be eligible to be selected to receive an Award under the Plan, as determined in the sole discretion of the Committee.

 

Section 4.               Administration of the Plan.

 

4.1.          The Plan and all Award Agreements shall be administered by the Committee. Any action of the Committee in administering the Plan and an Award Agreement shall be final, conclusive and binding on all Persons, including without limitation the Company, its Subsidiaries, Participants, Persons claiming rights from or through Participants and stockholders of the Company. No member of the Committee (or any person to whom the Committee has delegated authority to act under the Plan) shall be personally liable for any action, determination or interpretation taken or made in good faith by the Committee (or such person) with respect to the Plan or any Awards granted hereunder, and all members of the Committee (and such persons to whom the Committee has delegated authority to act under the Plan) shall be fully indemnified and protected by the Company in respect of any such action, determination or interpretation to the fullest extent permitted by law.

 

4.2.          Subject to the provisions of the Plan, the Committee shall have full and final authority in its discretion to (i) select the Employees, Non-Employee Directors and Consultants who will receive Awards pursuant to the Plan; provided that Awards granted to Non-Employee Directors shall be subject to approval by the full Board; (ii) determine the type or types of Awards to be granted to each Participant; (iii) determine the number of Shares to which an Award will relate, the terms and conditions of any Award granted under the Plan (including, but not limited to, restrictions as to vesting, Performance Goals relating to an Award, transferability or forfeiture, exercisability or settlement of an Award, waivers or accelerations thereof, and waivers of or modifications to Performance Goals relating to an Award, based in each case on such considerations as the Committee shall determine) and all other matters to be determined in connection with an Award; (iv) determine the exercise price or purchase price (if any) of an Award; (v) determine whether, to what extent, and under what circumstances an Award may be cancelled, forfeited, or surrendered; (vi) determine whether (and, if necessary, certify that) Performance Goals to which an Award is subject are satisfied; (vii) determine whether Participants will be permitted to defer the settlement of certain Awards; (viii) correct any defect or supply any omission or reconcile any inconsistency in the Plan and Award Agreements, and adopt, amend and rescind such rules, regulations, guidelines, forms of agreements and instruments relating to the Plan and Award Agreements as it may deem necessary or advisable; (ix) construe and interpret the Plan and Award Agreements; and (x) make all other determinations as it may deem necessary or advisable for the administration of the Plan and Award Agreements. Notwithstanding anything in the Plan or an Award Agreement to the contrary, no underwater Option or underwater SAR may be repriced, replaced or regranted through cancellation, nor may any underwater Option or underwater SAR be repurchased for cash, in any case, without the approval of the stockholders of the Company, provided that nothing herein shall prevent the Committee from taking any action provided for in Sections 7 or 8 of the Plan.

 

6

 

 

4.3.          To the extent permitted by applicable law and the Company’s by-laws, the Committee may delegate some or all of its authority with respect to the Plan and Awards to any executive officer of the Company or any other person or persons designated by the Committee, in each case, acting individually or as a committee, provided that the Committee may not delegate its authority hereunder to any person to make Awards to (a) Employees who are (i) subject to the requirements of Rule 16b-3 of the Exchange Act or (ii) officers or other Employees who are delegated authority by the Committee pursuant to this Section 4.3 or (b) members of the Board. Any delegation hereunder shall be subject to the restrictions and limits that the Committee specifies at the time of such delegation or thereafter in its sole discretion. The Committee may at any time rescind the authority delegated to any person pursuant to this Section 4.3. Any action undertaken by any such person or persons in accordance with the Committee’s delegation of authority pursuant to this Section 4.3 shall have the same force and effect as if undertaken directly by the Committee.

 

4.4.          Notwithstanding any other provision to the contrary, Awards granted to Non-Employee Directors shall be administered by the full Board, and any authority reserved under the Plan for the Committee with regard to Awards granted to Non-Employee Directors shall be exercised by the full Board.

 

Section 5.              Shares Subject to the Plan.

 

5.1.          Subject to adjustment as provided in Section 8 hereof and this Section 5, the maximum number of Shares that may be issued pursuant to Awards under the Plan shall be 47,870,291 Shares (the “Cap”); provided, however, that in the event that an award under the Prior Plan is cancelled, forfeited or terminated, in each case, in whole or in part on or after the Effective Date, then the Cap shall be increased by the number of Shares subject to the portion of such award so cancelled, forfeited or terminated. No more than 47,870,291 Shares issued under the Plan may be issued pursuant to the exercise of Incentive Stock Options. The Shares issued under the Plan may, at the election of the Board, be (i) authorized but previously unissued Shares or (ii) Shares previously issued and outstanding and reacquired by the Company. Notwithstanding the foregoing, Shares issued under Awards granted in assumption, substitution or exchange for previously granted awards of a company acquired by the Company or any Subsidiary (“Substitute Awards”) shall not count against the Cap, and to the extent permitted by the rules of the stock exchange on which the Shares are then listed or quoted, shares under a stockholder approved plan of an acquired company (adjusted to reflect the transaction) may be used for Awards under the Plan and do not count against the Cap. While the Plan remains in effect with respect to the granting of new Awards, no Non-Employee Director may be paid, issued, or granted by the Company or any of its Subsidiaries, in any calendar year, equity awards (including any Awards issued under this Plan) with an aggregate value (the value of which will be based on their grant date fair value determined in accordance with U.S. generally accepted accounting principles) and any other compensation (including without limitation any cash retainers or fees) but excluding expense reimbursements, that in the aggregate, exceed $750,000. Any Awards or other compensation paid or provided to an individual for his or her services as an Employee, or for his or her services as a Consultant (other than as a Non-Employee Director), will not count for purposes of the limitation in the immediately preceding sentence.

 

7

 

 

5.2.           If any Shares subject to an Award under the Plan are forfeited or an Award otherwise terminates in whole or in part for any reason whatsoever without Shares being issued in respect of such termination, any Shares counted against the number of Shares available for issuance pursuant to the Plan with respect to such Award shall, to the extent of any such forfeiture or termination, be added back to the Cap and shall again be available for Awards under the Plan; provided, however, that (i) such treatment shall not apply for Substitute Awards and (ii) the Committee may adopt procedures for the counting of Shares relating to any Award to ensure appropriate counting, avoid double counting, provide for adjustments in any case in which the number of Shares actually distributed differs from the number of Shares previously counted in connection with such Award, and if necessary, to comply with applicable law or regulations. In addition, and notwithstanding anything contained herein to the contrary, Shares tendered in payment of the exercise price or withholding taxes with respect to an Award shall not become, or again be, available for Awards under the Plan.

 

Section 6.               Awards.

 

Awards may be granted on the terms and conditions set forth in this Section 6. In addition, the Committee may impose on any Award or the settlement or exercise thereof, at the grant date or thereafter, such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including without limitation terms requiring forfeiture of Awards in the event of a Participant’s termination of employment or other service with the Company or any Subsidiary; provided, however, that the Committee shall retain full power to accelerate or waive any such additional term or condition as it may have previously imposed (provided that, in any case, any such action is permitted under Code Section 409A). The right of a Participant to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such Performance Goals as may be determined by the Committee. Each Award, and the terms and conditions applicable thereto, shall be evidenced by an Award Agreement.

 

8

 

 

6.1.           Options. Options give a Participant the right to purchase a specified number of Shares from the Company for a specified time period at a fixed exercise price, as provided in the applicable Award Agreement. Options may be either Incentive Stock Options or Non-Qualified Options; provided that Incentive Stock Options may be granted only to employees of the Company or a “subsidiary” (as defined in Code Section 424(f)) of the Company. The grant of Options shall be subject to the following terms and conditions:

 

(a)            Exercise Price. The price per Share at which Shares may be purchased upon exercise of an Option shall be determined by the Committee and specified in the Award Agreement, but shall be not less than the Fair Market Value of one Share on the grant date (or 110% of the Fair Market Value of one Share on the grant date in the case of an Incentive Stock Option granted to a Ten Percent Stockholder).

 

(b)            Term of Options. The term of an Option shall be specified in the Award Agreement, but shall in no event be greater than ten years from the grant date (or five years from the grant date in the case of an Incentive Stock Option granted to a Ten Percent Stockholder).

 

(c)            Exercise of Option. Each Award Agreement with respect to an Option shall specify the time or times at which an Option may be exercised in whole or in part and the terms and conditions applicable thereto, including without limitation (i) a vesting schedule which may be based upon the passage of time, attainment of Performance Goals or a combination thereof, (ii) whether the exercise price for an Option shall be paid in cash, with Shares, with any combination of cash and Shares, or with other legal consideration that the Committee may deem appropriate and to the extent permitted by applicable law, (iii) the methods of payment, which may include payment through cashless and net exercise arrangements, to the extent permitted by applicable law and (iv) the methods by which, or the time or times at which, Shares will be delivered or deemed to be delivered to Participants upon the exercise of such Option. Payment of the exercise price shall in all events be made within three days after the date of exercise of an Option.

 

(d)            Incentive Stock Options. Each Participant awarded an Incentive Stock Option under the Plan shall notify the Company in writing immediately after the date he or she makes a “disqualifying disposition” (as defined in Section 421(b) of the Code) of any Shares acquired pursuant to the exercise of such Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by it, retain possession of any Shares acquired pursuant to the exercise of an Incentive Stock Option as agent for the applicable Participant until the end of any period during which a disqualifying disposition could occur, subject to complying with any instructions from such Participant as to the sale of such Shares. The aggregate Fair Market Value, determined as of the grant date, for Awards granted under the Plan (or any other stock or share option plan required to be taken into account under Section 422(d) of the Code) that are intended to be Incentive Stock Options which are first exercisable by the Participant during any calendar year shall not exceed $100,000. To the extent an Award purporting to be an Incentive Stock Option exceeds the limitation in the previous sentence or does not otherwise qualify as an Incentive Stock Option, the portion of the Award in excess of such limit or that does not so qualify shall be a Non-Qualified Option.

 

(e)            No Dividend Equivalent Rights. No Participant shall be entitled to dividend equivalent rights or payments with respect to any Shares underlying the Participant’s Options.

 

9

 

 

6.2.          Stock Appreciation Rights. A SAR shall confer on the Participant a right to receive, upon exercise thereof, the excess of (i) the Fair Market Value of one Share on the date of exercise over (ii) the grant price of the SAR as determined by the Committee, but which may never be less than the Fair Market Value of one Share on the grant date. No payment from the Participant shall be required to exercise a SAR. The grant of SARs shall be subject to the following terms and conditions:

 

(a)            General. Each Award Agreement with respect to a SAR shall specify the number of SARs granted, the grant price of the SAR, the time or times at which the SAR may be exercised in whole or in part (including without limitation vesting upon the passage of time, the attainment of Performance Goals or a combination thereof), the method of exercise, method of settlement (in cash, Shares or a combination thereof), method by which Shares will be delivered or deemed to be delivered to Participants (if applicable) and any other terms and conditions of the SAR. Unless provided otherwise in an Award Agreement, all SARs shall be settled in Shares.

 

(b)           Term. The term of a SAR shall be specified in the Award Agreement, but shall in no event be greater than ten years from the grant date.

 

(c)           No Dividend Equivalent Rights. No Participant shall be entitled to dividend equivalent rights or payments with respect to any Shares underlying the Participant’s SARs.

 

6.3.          Restricted Stock. An Award of Restricted Stock is a grant by the Company of a specified number of Shares to the Participant, which Shares are subject to forfeiture upon the occurrence of specified events during the Restriction Period. Such an Award shall be subject to the following terms and conditions:

 

(a)           General. Each Award Agreement with respect to Restricted Stock shall specify the duration of the Restriction Period and/or each installment thereof, the conditions under which the Restricted Stock may be forfeited to the Company, and the amount, if any, the Participant must pay to receive the Restricted Stock. Such restrictions may include a vesting schedule based upon the passage of time and/or the attainment of one or more Performance Goals.

 

(b)           Transferability. During the Restriction Period, the transferability of Restricted Stock shall be prohibited or restricted in the manner and to the extent prescribed in the applicable Award Agreement. Such restrictions may include, without limitation, rights of repurchase or first refusal in the Company or provisions subjecting the Restricted Stock to a continuing substantial risk of forfeiture in the hands of any transferee.

 

(c)           Stockholder Rights. Unless otherwise provided in the applicable Award Agreement, during the Restriction Period the Participant shall have all the rights of a stockholder with respect to Restricted Stock, including, without limitation, the right to receive dividends thereon (whether in cash or Shares) and to vote such Shares of Restricted Stock in accordance with the Company’s by-laws. Dividends may, in the discretion of the Committee, be paid currently or subject to the same restrictions as the underlying Restricted Stock, in either case, as set forth in the applicable Award Agreement (and the Committee may, in its sole discretion, withhold any cash dividends paid on Restricted Stock until the restrictions applicable to such Restricted Stock have lapsed); provided, however, that dividends paid on unvested Restricted Stock that is subject to Performance Goals shall not be paid or released unless and until the applicable Performance Goals have been achieved.

 

10

 

 

(d)           Additional Matters. Upon the Award of Restricted Stock, the Committee may direct the number of Shares subject to such Award be issued to the Participant or placed in a restricted stock account (including without limitation an electronic account) with the transfer agent and in either case designating the Participant as the registered owner. The certificate(s), if any, representing such Shares shall be physically or electronically legended, as applicable, as to sale, transfer, assignment, pledge or other encumbrances during the Restriction Period and, if issued to the Participant, returned to the Company to be held in escrow during the Restriction Period. In all cases, the Participant shall sign a stock power or share transfer form (as appropriate) endorsed in blank to the Company to be held in escrow during the Restriction Period.

 

6.4.          Restricted Stock Units. Restricted Stock Units are solely a device for the measurement and determination of the amounts to be paid to a Participant under the Plan. Restricted Stock Units do not constitute Shares and shall not be treated as (or as giving rise to) property or as a trust fund of any kind; provided, however, that the Company may establish a bookkeeping reserve to meet its obligations hereunder or a trust or other funding vehicle that would not cause the Plan to be deemed to be funded for tax purposes or for purposes of Title I of the Employee Retirement Income Security Act of 1974, as amended. The right of any Participant in respect of an Award of Restricted Stock Units shall be no greater than the right of any unsecured general creditor of the Company. The grant of Restricted Stock Units shall be subject to the following terms and conditions:

 

(a)           Restriction Period. Each Award Agreement with respect to Restricted Stock Units shall specify the duration of the Restriction Period, if any, and/or each installment thereof and the conditions under which such Award may be forfeited to the Company. Such restrictions may include a vesting schedule based upon the passage of time and/or the achievement of one or more Performance Goals.

 

(b)           Settlement. Unless otherwise provided in an Award Agreement (i) an Award of Restricted Stock Units shall be settled in Shares, provided that any fractional Restricted Stock Units shall be settled in cash and (ii) subject to the Participant’s continued employment or other service with the Company or a Subsidiary from the date of grant through the expiration of the Restriction Period (or applicable portion thereof), the vested portion of an Award of Restricted Stock Units shall be settled within 60 days after the expiration of the Restriction Period (or applicable portion thereof).

 

(c)            Stockholder Rights. Nothing contained in the Plan shall be construed to give any Participant rights as a stockholder with respect to an Award of Restricted Stock Units (including, without limitation, any voting, dividend or derivative or other similar rights). Notwithstanding the foregoing, the Committee may provide in an Award Agreement that amounts equal to any dividends declared during the Restriction Period or deferral period on the Shares represented by an Award of Restricted Stock Units will be credited to the Participant’s account and settled in Shares unless otherwise specified in the applicable Award Agreement at the same time (and subject to the same forfeiture restrictions) as the Restricted Stock Units to which such dividend equivalents relate (with the number of Shares released in payment of such dividend equivalents to equal the amount of dividend equivalents then being settled, divided by the Fair Market Value of one Share on the settlement date of such dividend equivalents); provided, however, that the Committee may determine at or after the grant date to settle any such dividend equivalents in cash.

 

11

 

 

6.5.          Other Stock-Based Awards. The Committee is authorized, subject to limitations under applicable law, to grant to Participants any type of Award (in addition to those Awards provided in Sections 6.1, 6.2, 6.3 and 6.4 hereof) that is payable in, or valued in whole or in part by reference to, Shares, and that is deemed by the Committee to be consistent with the purposes of the Plan, including, without limitation, fully vested Shares and dividend equivalents.

 

6.6.          Termination of Employment or Other Service. Unless otherwise provided in an Award Agreement, and except as otherwise provided in Section 7.2 hereof, upon a Participant’s termination of employment or other service with the Company and its Subsidiaries (x) for any reason other than for Cause, the unvested portion of each Award shall be immediately forfeited upon such termination with no compensation or other payment due the Participant, and the vested portion of each Option and SAR shall be exercisable for the period set forth in the Award Agreement (but not beyond the stated term of such vested Option or vested SAR) or (y) for Cause, all vested and unvested Awards granted to such Participant shall be immediately forfeited upon such termination with no compensation or other payment due the Participant.

 

Section 7.              Change in Control.

 

7.1.         General. Unless otherwise provided in an Award Agreement, a Change in Control shall not, in and of itself, accelerate the vesting, settlement or exercisability of outstanding Awards. Awards in a Change in Control may, without the consent of any Participant, be assumed by the successor corporation or company (or one of its Affiliates) or may be cancelled in exchange for a substitute award issued by the successor corporation or company (or one of its Affiliates) determined by the Committee to preserve the rights of the Participant in the cancelled Award. Notwithstanding the foregoing and unless otherwise provided in an Award Agreement, if (i) the successor corporation or company (or one of its direct or indirect parents) does not agree to assume an outstanding Award or does not agree to substitute or replace such Award with an award involving the ordinary equity securities of such successor corporation (or one of its direct or indirect parents) on terms and conditions necessary to preserve the rights of the applicable Participant with respect to such Award, (ii) the securities of the Company or the successor corporation or company (or one of its direct or indirect parents) will not be publicly traded immediately following such Change in Control or (iii) the Change in Control is not approved by a majority of the Incumbent Directors immediately prior to such Change in Control, then the Committee, in its sole discretion, may take one or more of the following actions with respect to all, some or any such Awards: (a) accelerate the vesting and, if applicable, exercisability of such Awards such that the Awards are fully vested and, if applicable, exercisable (effective immediately prior to such Change in Control); (b) with respect to any Awards that do not constitute “non-qualified deferred compensation” within the meaning of, or are not subject to, Code Section 409A, accelerate the settlement of such Awards upon such Change in Control; (c) with respect to Awards that constitute “non-qualified deferred compensation” within the meaning of, and are subject to, Code Section 409A, terminate all such Awards and settle all such Awards for a payment (in cash and/or securities) equal to the Fair Market Value of the Shares underlying such Awards less the amount the Participant is required to pay for such Shares, if any, provided that (I) such Change in Control satisfies the requirements of Treasury Regulation Section 1.409A-3(i)(5)(v), (vi) or (vii) and (II) all other arrangements that would be aggregated with such Awards under Code Section 409A are terminated and liquidated within 30 days before or 12 months after such Change in Control; (d) cancel any outstanding Option or SAR in exchange for a cash payment in an amount equal to the excess, if any, of the Fair Market Value as of the date of the Change in Control of the Shares underlying the portion of the Option or SAR being so cancelled over the exercise price or grant price, as the case may be, of such portion, provided that any Option or SAR with a per Share exercise price or grant price, as the case may be, that equals or exceeds the Fair Market Value of one Share on the date of the Change in Control shall be cancelled with no payment due the Participant and (e) take such other actions as the Committee deems appropriate (to the extent permitted by Code Section 409A, if applicable). If any action is taken with respect to any Award under items (a) through (d) of this Section 7.1 and such Award is subject to Performance Goals, such Performance Goals shall be deemed satisfied based on the actual level of achievement of the applicable Performance Goals through the date of the Change in Control or, if determined by the Committee in its sole discretion prior to such Change in Control, using the applicable target level of achievement rather than such actual level of achievement. The judgment of the Committee with respect to any matter referred to in this Section 7.1 shall be conclusive and binding upon each Participant (and all other Persons) without the need for any amendment to the Plan or any Award or Award Agreement. Notwithstanding the foregoing, no Award that constitutes “non-qualified deferred compensation” (within the meaning of, and that is subject to, Section 409A of the Code) shall be payable upon the occurrence of a Change in Control unless such Change in Control satisfies the requirements of Treasury Regulation Section 1.409A-3(i)(5)(v), (vi) or (vii).

 

12

 

 

7.2.          Termination Following a Change in Control. Notwithstanding anything contained in the Plan to the contrary, unless otherwise provided in an Award Agreement or as may be provided in the last sentence of this Section 7.2, in the event that Awards under the Plan are assumed in connection with a Change in Control or are substituted with new awards, in either case, pursuant to Section 7.1 above, and a Participant’s employment or other service with the Company and its Subsidiaries is terminated by the Company or a Subsidiary without Cause, by the Participant for Good Reason, due to the Participant's Disability or as the result of the Participant’s death, in any case, within 18 months following a Change in Control, (i) the unvested portion of such Participant’s Awards (including without limitation any awards received in substitution of an Award) shall vest in full (with any applicable Performance Goals being deemed to have been achieved at target or, if greater, actual levels of performance), (ii) such Participant's Awards of Options and SARs (including without limitation options and stock or share appreciation rights received in substitution of an Award) shall remain exercisable by the Participant or the Participant’s beneficiary or legal representative, as the case may be, for a period of one-year thereafter (but not beyond the stated term of such Option or SAR), (iii) all of such Participant's Restricted Stock Units and Performance Stock Units (including without limitation restricted stock units and performance stock units received in substitution of an Award) shall be settled within 30 days after such termination and (iv) all Other Stock-Based Awards held by such Participant (including without limitation any other stock-based awards received in substitution of an Award) shall be settled within 30 days after such termination; provided, however, that with respect to clauses (iii) and (iv), if settlement of such Awards on the date described in this Section 7.2 would violate Code Section 409A, then such Award instead shall be settled in full at the time it otherwise would have been settled in connection with a termination of employment or service without Cause, for Good Reason or due to death or Disability, as applicable. Notwithstanding the foregoing or anything else in the Plan to the contrary, this Section 7.2 shall not apply with respect to a Change in Control (i) involving a restructuring, reorganization or similar or analogous event in which the stockholders of the Company immediately before such event have “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act) of the Company, or of the resulting entity, immediately after such event in substantially the same proportions as their ownership of Shares of the Company immediately before such event, (ii) resulting from acquisitions by the Company or any of its Subsidiaries, (iii) resulting from the acquisition by any employee benefit plan of the Company or any of its Subsidiaries, (iv) resulting from an entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company, (v) resulting from an acquisition, directly or indirectly, by any Person who, on the Effective Date, directly or indirectly, owns (or has the right to acquire, exchange for, or convert into) at least 25% of the Company's Voting Securities or (vi) resulting from a Person who, as of immediately prior to such event, already has “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act) of at least 50% of the Company's Voting Securities.

 

13

 

 

Section 8.               Adjustments upon Changes in Capitalization.

 

8.1.           In order to prevent dilution or enlargement of the rights of Participants under the Plan as a result of any dividend payable in shares, recapitalization, forward share split or reverse share split, reorganization, spin-off, extraordinary cash distribution or other similar or analogous corporate transaction or event, in any case, that occurs on or after the date the Plan is approved by the Board (even if such date is prior to the Effective Date), that affects the Shares and which is effected without the receipt of consideration by the Company, the Committee shall adjust (i) the number and kind of securities which may thereafter be issued in connection with Awards, (ii) the number and kind of securities issuable in respect of outstanding Awards, (iii) the Cap and the specific Share limitations under Section 5 hereof and (iv) the exercise or grant price relating to any Award. Any such adjustment shall be made in an equitable manner which reflects the effect of such transaction or event. It is provided, however, that in the case of any such transaction or event, the Committee may make any additional adjustments to the items in clauses (i) through (iv) above which it deems appropriate in the circumstances, or make provision for a cash payment with respect to any outstanding Award.

 

8.2.          In addition to the adjustments described in Section 8.1 above, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards, including without limitation any Performance Goals, in recognition of unusual or nonrecurring events affecting the Company or any Subsidiary, or in response to changes in applicable laws, regulations, or accounting principles (including, without limitation, (a) asset write-downs; (b) significant litigation or claim judgments or settlements; (c) the effect of changes in tax laws, accounting standards or principles, or other laws or regulatory rules affecting reporting results; (d) any reorganization and/or restructuring programs or change in the corporate structure or capital structure of the Company or a Subsidiary; (e) extraordinary nonrecurring items as described in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s annual report to stockholders for the applicable year or period; (f) acquisitions or divestitures; (g) any other specific unusual or nonrecurring events or objectively determinable category thereof; (h) foreign exchange gains and losses; and (i) a change in the Company’s fiscal year).

 

14

 

 

8.3.          If Sections 7 and 8 hereof could both apply to an event, Section 7 hereof shall control.

 

Section 9.              Termination and Amendment.

 

9.1.          Changes to the Plan and Awards. The Board may amend, alter, suspend, discontinue, or terminate the Plan without the consent of the Company’s stockholders or Participants, except that any such amendment or alteration shall be subject to the approval of the Company’s stockholders if (i) such action would increase the number of Shares subject to the Plan (other than in connection with adjustments under Section 8.1 hereof) or (ii) such stockholder approval is required by any applicable federal, state or foreign law or regulation or the rules of any stock exchange or automated quotation system on which the Shares may then be listed or quoted, and the Board may otherwise, in its discretion, determine to submit such other changes to the Plan to the Company’s stockholders for approval; provided, however, that except as provided in Section 18 hereof, without the consent of an affected Participant, no amendment, alteration, suspension, discontinuation, or termination of the Plan may materially and adversely affect the rights of such Participant under any outstanding Award unless such amendment, alteration, suspension, discontinuation or termination is required by law or the rules of any applicable securities exchange.

 

9.2.          The Committee may waive any conditions or rights under, or amend, alter, suspend, discontinue, or terminate, any Award theretofore granted and any Award Agreement relating thereto; provided, however, that except as provided in Section 18 hereof, without the consent of an affected Participant, no such amendment, alteration, suspension, discontinuation, or termination of any Award may materially and adversely affect the rights of such Participant under such Award unless such amendment, alteration, suspension, discontinuation or termination is required by law or the rules of any applicable securities exchange.

 

9.3.          No Repricing. Notwithstanding anything in the Plan or an Award Agreement to the contrary, no underwater Option or underwater SAR may be repriced, replaced or regranted through cancellation, nor may any underwater Option or underwater SAR be repurchased for cash, in any case, without the approval of the stockholders of the Company.

 

9.4.          Override. Notwithstanding anything contained in this Section 9 to the contrary, nothing contained in this Section 9 shall prevent the Committee from taking any action provided for in Sections 7 and/or 8 hereof (and no Participant consent shall be needed to take any such action).

 

Section 10.            No Right to Award, Employment or Service.

 

No Employee, Consultant or Non-Employee Director shall have any claim to be granted any Award under the Plan, and there is no obligation that the terms of Awards be uniform or consistent among Participants. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or any Subsidiary. For purposes of the Plan, a transfer of employment or service between the Company and any of its Subsidiaries shall not be deemed a termination of employment or service; provided, however, that individuals employed by, or otherwise providing services to, an entity that ceases to be a Subsidiary shall be deemed to have incurred a termination of employment or service, as the case may be, as of the date such entity ceases to be a Subsidiary unless such individual becomes an employee of, or service provider to, the Company or another Subsidiary as of the date of such cessation. A change in status from Employee to Consultant shall be deemed to be a termination of employment, unless otherwise determined by the Committee. The Committee may adopt rules and make determinations on how a leave of absence will impact an Award, including, without limitation, tolling the vesting schedule or treating such leave of absence as a termination of employment or other service (such rules may be applied retroactively).

 

15

 

 

Section 11.            Taxes.

 

Each Participant must make appropriate arrangement acceptable to the Company in its discretion for the payment of any taxes relating to an Award granted hereunder. The Company or any Subsidiary is authorized to withhold from any payment relating to an Award under the Plan, including without limitation from a distribution of Shares or cash, amounts of withholding and other taxes due in connection with any transaction involving an Award, and to take such other action as the Committee may deem advisable, including using any other method of obtaining the necessary payment or proceeds, as permitted by law, to enable the Company and Participants to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award (including without limitation withholding from any payroll or other payment due to a Participant). This authority shall include the ability to withhold or receive Shares or other property and to make cash payments in respect thereof in satisfaction of a Participant’s tax obligations. The Committee may (in its sole discretion) determine to reduce the number of Shares that would otherwise be deliverable upon the exercise, settlement or vesting (as applicable) of an Award by the number of whole Shares having a Fair Market Value on the date of exercise, settlement or vesting (as applicable) equal to the withholding taxes then due (with cash to be paid by the Participant for any shortfall). Withholding of taxes in the form of Shares with respect to an Award shall not occur at a rate that equals or exceeds the rate that would result in liability accounting treatment.

 

Section 12.            Limits on Transferability; Beneficiaries.

 

No Award or other right or interest of a Participant under the Plan shall be (i) pledged, encumbered, or hypothecated to, or in favor of, or subject to any lien, obligation, or liability of such Participant to, any Person other than the Company or any Subsidiary, or (ii) assigned or transferred by such Participant other than by will or the laws of descent and distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or (with respect to Awards other than Incentive Stock Options) his or her guardian or legal representative. Notwithstanding the foregoing, the Committee may, in its discretion, provide that Non-Qualified Options, SARs, Performance Stock and Restricted Stock be transferable, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships and other family entities in which such family members are the only partners (any vesting conditions shall be unaffected by such transfer). The Committee may attach to such transferability feature such terms and conditions as it deems advisable. In addition, a Participant may, in the manner established by the Committee, designate a beneficiary (which may be a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to any Award upon the death of the Participant. A beneficiary, guardian, legal representative or other Person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary or appropriate by the Committee.

 

16

 

 

Section 13.            Foreign Nationals.

 

Without amending the Plan, Awards may be granted to Employees, Consultants and Non-Employee Directors who are foreign nationals or are employed or providing services outside the United States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the purpose of the Plan. Moreover, the Committee may approve such supplements to, or sub-plans, amendments, restatements or alternative versions of, the Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of the Plan as in effect for any other purpose, provided that no such supplements, sub-plans, amendments, restatements or alternative versions shall include any provisions that are prohibited by the terms of the Plan, as then in effect, unless the Plan could have been amended to eliminate such prohibition without further approval by the stockholders of the Company.

 

Section 14.            Securities Law Requirements.

 

14.1.        No Shares may be issued hereunder if the Company shall at any time determine that to do so would (i) violate the listing requirements of an applicable securities or stock exchange, or adversely affect the registration or qualification of the Company’s Shares under any state or federal law, or otherwise violate any law, rule or regulation, or (ii) require the consent or approval of any regulatory or supervising body or stockholders. In any of the events referred to in clause (i) or clause (ii) above, the issuance of such Shares shall be suspended and shall not be effective unless and until it is done in compliance with all applicable laws, rules and regulations, and such listing, registration, qualifications, consents or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole discretion, notwithstanding any termination of any Award or any portion of any Award during the period when issuance has been suspended (provided, however, that if permitted under Code Section 409A, the Committee may toll the expiration date of an Award such that it will not terminate during any such period of suspension).

 

14.2.        The Committee may require, as a condition to the issuance of Shares hereunder, representations, warranties and agreements to the effect that such Shares are being purchased or acquired by the Participant for investment only and without any present intention to sell or otherwise distribute such Shares, and that the Participant will not dispose of such Shares in transactions which, in the opinion of counsel to the Company, would violate the registration provisions of the Securities Act and the rules and regulations thereunder.

 

Section 15.            Termination.

 

Unless earlier terminated, the Plan shall terminate with respect to the grant of new Awards on the earlier of the 10-year anniversary of the date the Plan was approved by the stockholders of the Company or the 10-year anniversary of the date the Plan was approved by the Board, and no Awards under the Plan shall thereafter be granted; provided that no such termination shall impact Awards that were granted prior to such termination.

 

17

 

 

Section 16.            Fractional Shares.

 

The Company will not be required to issue any fractional Shares pursuant to the Plan. The Committee may provide for the elimination of fractions and settlement of such fractional Shares in cash, in its sole discretion.

 

Section 17.            Discretion.

 

In exercising, or declining to exercise, any grant of authority or discretion hereunder, the Committee may consider or ignore such factors or circumstances and may accord such weight to such factors and circumstances as the Committee alone and in its sole judgment deems appropriate and without regard to the effect such exercise, or declining to exercise such grant of authority or discretion, would have upon the affected Participant, any other Participant, any Employee, any Consultant, any Non-Employee Director, the Company, any Subsidiary, any affiliate, any stockholder or any other Person.

 

Section 18.            Code Section 409A.

 

The Plan and all Awards are intended to comply with, or be exempt from, Code Section 409A and all regulations, guidance, compliance programs and other interpretative authority thereunder, and shall be interpreted in a manner consistent therewith without increasing the cost to the Company. In the event that a Participant is a “specified employee” within the meaning of Code Section 409A, and a payment or benefit provided for under the Plan would be subject to additional tax under Code Section 409A if such payment or benefit is paid within six (6) months after such Participant’s “separation from service” (within the meaning of Code Section 409A), then such payment or benefit shall not be paid (or commence) during the six (6) month period immediately following such Participant’s separation from service except as provided in the immediately following sentence. In such an event, any payments or benefits that would otherwise have been made or provided during such six (6) month period and which would have incurred such additional tax under Code Section 409A shall instead be paid to the Participant in a lump-sum, without interest, on the earlier of (i) the first business day of the seventh month following the month in which such Participant’s separation from service occurs or (ii) the tenth business day following such Participant’s death (but not earlier than if such delay had not applied). A Participant’s right to receive any installment payments under an Award Agreement, including without limitation as the result of any deferral of an Award in accordance with Code Section 409A, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under Code Section 409A. Notwithstanding anything contained in the Plan or in an Award Agreement to the contrary, neither the Company, any member of the Committee nor any Subsidiary shall have any liability or obligation to any Participant or any other Person for taxes, interest, penalties or fines (including without limitation any of the foregoing resulting from (i) the application of Code Section 4999 or (ii) the failure of any Award granted hereunder to comply with, or be exempt from, Code Section 409A). For purposes of any Award that constitutes “non-qualified deferred compensation” under Code Section 409A, the terms “termination of employment” or “termination of service” and similar phrases to each shall mean “separation from service” within the meaning of Code Section 409A.

 

18

 

 

Section 19.            Governing Law; Dispute Resolution; WAIVER OF JURY TRIAL

 

Except where U.S. Federal law is applicable to or controls any part of this Plan, the validity, construction and effect of this Plan shall be construed and enforced in accordance exclusively under the laws of the State of Delaware, without giving effect to the choice of law principles thereof. Any dispute not amicably resolved between the Company or any of its Subsidiaries or Affiliates on the one hand and a Participant on the other shall be subject to the exclusive jurisdiction of the Federal courts located in the borough of Manhattan, New York City, New York (or if Federal jurisdiction does not exist, then the state courts located in the borough of Manhattan, New York City, New York). BY ACCEPTING ANY AWARD UNDER THIS PLAN, THE COMPANY, EACH SUBSIDIARY THEREOF AND EACH PARTICIPANT HEREBY WAIVES, TO THE EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY LITIGATION IN ANY COURT WITH RESPECT TO, IN CONNECTION WITH, OR ARISING OUT OF, THIS PLAN, ANY AWARD AGREEMENT OR ANY AWARD, OR THE VALIDITY, PROTECTION, INTERPRETATION, COLLECTION OR ENFORCEMENT OF ANY OF THE FOREGOING (WHETHER ARISING IN CONTRACT, EQUITY, TORT OR OTHERWISE).

 

Section 20.            Recoupment/Share Ownership.

 

Any Award granted pursuant to the Plan (and all Shares acquired hereunder) shall be subject to mandatory repayment and clawback pursuant to any clawback and recoupment policy of the Company as may be in effect from time to time (including any such policy enacted after the grant date of the applicable Award or acquisition of the applicable Share), and as may be otherwise required by law or the rules of any applicable securities exchange. Additional recoupment and clawback policies may be provided in the Participant’s Award Agreement. In addition, all Awards granted under the Plan (and all Shares acquired hereunder) shall be subject to the holding periods set forth in the Company’s stock ownership guidelines, as in effect from time to time.

 

Section 21.            Effective Date.

 

The Plan shall become effective upon the Effective Date.

 

[end of Plan]

 

19

 

 

 

Exhibit 10.9

 

GLOBAL BUSINESS TRAVEL GROUP, INC.

 

EMPLOYEE STOCK PURCHASE PLAN

 

Adopted by the Board of Directors May 27, 2022

 

Approved by the Stockholders May 25, 2022

 

 

 

GLOBAL BUSINESS TRAVEL GROUP, INC.
EMPLOYEE STOCK PURCHASE PLAN

 

SECTION 1.      PURPOSE OF THE PLAN.

 

The Global Business Travel Group, Inc. Employee Stock Purchase Plan (the “Plan”) is intended to provide Eligible Employees (as defined below) the opportunity to increase their proprietary interest in Global Business Travel Group, Inc. (the “Company”) by conveniently purchasing shares of the Company’s Class A common stock (the “Stock”).

 

The Plan is composed of two components: a 423 Component and a Non-423 Component. The 423 Component is intended to qualify under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). Accordingly, the provisions of the 423 Component will be construed in a manner consistent with the requirements of Section 423 of the Code. The Plan also authorizes participation in the Plan under the Non-423 Component under terms that do not meet the requirements of Section 423 of the Code.

 

The Company shall be permitted to grant rights to purchase Stock under separate offerings not having identical terms (provided that such terms are not inconsistent with the terms of the Plan and, with respect to an offering under the 423 Component, the requirements of Section 423 of the Code), and offerings may run concurrently (in whole or in part) with each other.

 

Each offering under the Non-423 Component shall be separate and distinct from (and shall not be included in or be part of) any offering under the 423 Component, and each offering to a Participating Company shall be treated as an offering that is separate from any other offering made to another Participating Company, in each case, even if such offerings are running concurrently (in whole or in part) and/or have common terms and conditions.

 

The Plan and any offering under the Plan shall be deemed to be a separate opportunity provided by the Company to Eligible Employees under the terms of the Plan and not part of any employment agreement with the Company or any of its Subsidiaries, Qualifying Subsidiaries or Affiliates.

 

SECTION 2.     DEFINITIONS.

 

(a)          423 Component” means the portion of the Plan under which any right to purchase Stock shall be granted in a manner that is intended to satisfy the requirements of Section 423 of the Code.

 

(b)           Affiliate” means any branch or representative office or other disregarded entity of the Company or a Qualifying Subsidiary or Subsidiary, as determined by the Committee, whether now or hereafter existing.

 

(c)            Board” means the Board of Directors of the Company, as constituted from time to time.

 

 

 

(d)            Change in Control” shall have the meaning set forth in the Company’s most recently adopted equity incentive plan as of the date of determination, as in effect from time to time.

 

(e)            Committee” means the duly constituted committee appointed by the Board to administer the Plan, as described in Section 3 of the Plan. If no such committee is appointed, the Compensation Committee of the Board shall be the Committee.

 

(f)             Compensation” means all of an Eligible Employee’s base salary or hourly wages. “Compensation” shall exclude (i) commissions, bonuses and special incentive payments (such as, without limitation, those under the annual incentive plan, sales incentive plan and the long-term incentive award plan), (ii) equity compensation and income attributable to equity-based awards (including, without limitation, amounts realized from the exercise of any stock option and any dividends paid with respect to equity awards), (iii) all non-cash items, (iv) pre-tax contributions made by the Participant under Sections 401(k) or 125 of the Code or under any similar arrangements available under laws outside the United States and (v) allowances and other miscellaneous payments, including, without limitation, moving or relocation allowances, cost-of-living equalization payments, car allowances, tuition reimbursements, imputed income attributable to cars or life insurance, severance pay, fringe benefits and benefits received under employee benefit plans. The Committee shall determine whether a particular item not listed in this Section 2(f) is included in Compensation. In addition, and notwithstanding the foregoing, with respect to any Offering Period, the Committee may modify the definition of Compensation for such Offering Period, provided that (i) such definition satisfies the requirements of Section 423 of the Code with respect to the 423 Component, (ii) such definition is established in writing and made available to Eligible Employees prior to the commencement of such Offering Period and (iii) such modified definition shall apply only for that Offering Period unless otherwise specified in writing by the Committee.

 

(g)            Effective Date” means May 27, 2022.

 

(h)            Eligible Employee” means any individual who (i) is an Employee of a Participating Company and (ii) does not own 5% or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Qualifying Subsidiary, including, for purposes of this provision, through application of the rules of Section 424(d) of the Code. The foregoing notwithstanding, an individual who is a citizen or resident of a jurisdiction other than the United States (even if he or she is also a citizen of the United States or a resident alien) shall not be considered an Eligible Employee if, as determined in the sole discretion of the Committee, (i) his or her participation in the Plan is prohibited by the laws or regulations of any country which has jurisdiction over him or her or (ii) compliance with the laws and regulations of the foreign country that has jurisdiction over him or her would cause the Plan or an offering under the 423 Component to violate Section 423 of the Code. In addition, and notwithstanding the foregoing, with respect to any Offering Period, the Committee may modify the definition of Eligible Employee for such Offering Period by excluding the following class or classes of Employees: (i) Employees who have been employed for less than two (2) years (or such lesser period of time as may be determined by the Committee in its discretion); (ii) Employees whose customary employment is for twenty (20) hours or less per week (or such lesser period of time as may be determined by the Committee in its discretion); (iii) Employees who are customarily employed for five (5) months or less in any calendar year (or such lesser period of time as may be determined by the Committee in its discretion), (iv) Employees who are “highly compensated employees” (within the meaning of Section 414(q) of the Code) of a Participating Company and (v) Employees who are “highly compensated employees” (within the meaning of Section 414(q) of the Code) of a Participating Company with compensation above a certain level; provided that (i) such definition satisfies the requirements of Section 423 of the Code with respect to the 423 Component, (ii) such definition is established in writing and made available to Employees prior to the commencement of such Offering Period, (iii) such modified definition shall apply only for that Offering Period unless otherwise specified in writing by the Committee and (iv) such definition shall be applied in an identical manner under each Offering Period to all Employees, in accordance with Treasury Regulation Section 1.423-2(e).

 

3 

 

 

(i)            Employee” means an individual who is a common-law employee of a Participating Company and, if such employee is employed in the United States, whose earnings are reported on a Form W-2. For the avoidance of doubt, the term “Employee” shall not include any consultant, independent contractor or non-employee director of a Participating Company.

 

(j)            Fair Market Value” means, on any given date (i) if the Stock is listed on any established U.S. stock exchange or a U.S. national market system, the closing sales price for such Stock as quoted on such exchange or system on the day of determination, as reported in The Wall Street Journal or such other source as the Committee deems reliable (or, if no closing sales price was reported on that date, as applicable, on the last preceding trading date such closing sales price was reported); (ii) if the foregoing clause (i) does not apply, then if the Stock is regularly quoted by a recognized U.S. securities dealer but selling prices are not reported, the mean between the high bid and low asked prices for the Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last preceding trading date such bids and asks were reported); or (iii) if the foregoing clauses (i) and (ii) do not apply, such value as the Committee in its discretion may in good faith determine in accordance with Section 423 of the Code.

 

(k)           Non-423 Component” means the portion of the Plan under which the right to purchase Stock may be granted in a manner that is not intended to satisfy the requirements of Section 423 of the Code.

 

(l)            Offering Period” means a period with respect to which the right to purchase Stock may be granted under the Plan, as determined pursuant to Section 4(a) of the Plan, which shall not exceed twenty-seven (27) months.

 

(m)          Parent” has the meaning given to such term under U.S. Treasury Regulation Section 1.424-1(f). As used in the Plan, “Parent” shall mean a Parent of the Company.

 

(n)           Participant” means an Eligible Employee who elects to participate in the Plan, as provided in Section 4(b) of the Plan.

 

(o)           Participating 423 Company” means any of the following that is designated by the Committee as participating in the 423 Component: (i) the Company, (ii) any present or future Parent and/or (iii) any present or future Qualifying Subsidiary.

 

4 

 

 

(p)            Participating Company” means each Participating 423 Company and Participating Non-423 Company.

 

(q)           Participating Non-423 Company” means any of the following that is designated by the Committee as participating in the Non-423 Component: (i) the Company, (ii) any present or future Parent, (iii) any present or future Subsidiary and/or (iv) any present or future Affiliate. Unless determined otherwise by the Committee, only entities incorporated or formed outside of the United States shall be Participating Non-423 Companies.

 

(r)             Plan Account” means the account established for each Participant pursuant to Section 8(a) of the Plan.

 

(s)           Purchase Price” means the price at which Participants may purchase Stock under the Plan, as determined pursuant to Section 8(b) of the Plan.

 

(t)            "Qualifying Subsidiary" means a "subsidiary," as defined under U.S. Treasury Regulation Section 1.424-1(f). As used in the Plan, “Qualifying Subsidiary” shall mean a Qualifying Subsidiary of the Company.

 

(u)           Subsidiary” means any corporation, partnership, joint venture, company or other business entity of which 50% or more of the outstanding voting power is beneficially owned, directly or indirectly, by the Company.

 

SECTION 3.      ADMINISTRATION OF THE PLAN.

 

(a)           General. The Plan shall be administered by the Committee. To the extent permitted by applicable law, the Committee may delegate some or all of its authority with respect to the Plan to any executive officer of the Company or any other person or persons (or entity or entities) designated by the Committee, in each case, acting individually or as a committee.

 

(b)           Committee Authorities. The Committee shall have the exclusive power and authority to administer the Plan, including, without limitation, the right and power to interpret the provisions of the Plan and make all determinations deemed necessary or advisable for the administration of the Plan (including, without limitation, a determination as to whether a Change in Control has occurred, whether to designate the Company, a Parent, a Qualifying Subsidiary or a Subsidiary as a Participating 423 Company or as a Participating Non-423 Company (as applicable) and whether to establish separate offerings). All such actions, interpretations and determinations that are done or made by the Committee shall be final, conclusive and binding on the Company, the Participating Companies, the Participants and all other persons and entities, and shall not subject the Committee (or its members) to any liability.

 

SECTION 4.      ENROLLMENT AND PARTICIPATION.

 

(a)           Offering Periods. Two Offering Periods shall commence in each calendar year, which shall be the periods commencing on January 1 and ending on June 30 and commencing on July 1 and ending on December 31; provided, however, that the first Offering Period may commence on a different date as determined by the Committee, but shall end on June 30 of the year commenced if commenced prior to June 30 or on December 31 of the year commenced if commenced after June 30. Notwithstanding the foregoing, the Committee may establish different beginning and ending dates for Offering Periods in its discretion.

 

5 

 

 

(b)            Enrollment. Any individual who, on the day preceding the first day of an Offering Period, qualifies as an Eligible Employee may elect to become a Participant in the Plan for such Offering Period by executing the enrollment form prescribed for this purpose by the Committee. The enrollment form shall be filed with the Company or its designee according to procedures established by the Committee.

 

(c)            Duration of Participation. Once enrolled in the Plan, a Participant shall continue to participate in the Plan (according to the elections made on the Participant’s most recently-filed enrollment form) until he or she ceases to be an Eligible Employee, withdraws from the Plan under Section 6(a) of the Plan or reaches the end of the Offering Period in which his or her contributions were discontinued under Section 5(c) or Section 9(b) of the Plan. A Participant who discontinued his or her contributions under Section 5(c) of the Plan or withdrew from the Plan under Section 6(a) of the Plan may again become a Participant, if he or she then is an Eligible Employee, by following the procedure described in Section 4(b) of the Plan. A Participant whose employee contributions were discontinued automatically under Section 9(b) of the Plan shall automatically resume participation at the beginning of the next Offering Period in which such Participant’s participation would not be limited by Section 9(b) of the Plan, if he or she then is an Eligible Employee.

 

SECTION 5.        EMPLOYEE CONTRIBUTIONS.

 

(a)            Frequency of Employee Contributions. A Participant may make contributions to the Plan for purchasing shares of Stock by means of payroll deductions (unless payroll deductions are not permitted under applicable laws or regulations or unless the Company determines that another means of making employee contributions is necessary or appropriate for legal or administrative reasons).

 

(b)            Amount of Employee Contributions. An Eligible Employee shall designate on the enrollment form the portion of his or her Compensation that he or she elects to contribute to the Plan with respect to the applicable Offering Period. Such portion shall be a whole percentage of the Eligible Employee’s Compensation but not less than 1% nor more than 15% of the Eligible Employee’s Compensation with respect to the applicable Offering Period. A Participant may not change the rate of his or her contributions during an Offering Period unless the Participant seeks (i) to discontinue contributions under Section 5(c) of the Plan or (ii) to withdraw from the Plan under Section 6(a) of the Plan, and, in either such case, the Company will cease contributions on behalf of the Participant as soon as reasonably practicable (which may not be until the payroll period following receipt of the applicable form or later). In addition, and notwithstanding the foregoing, with respect to any Offering Period, the Committee may modify the contribution limits for such Offering Period, provided that (i) such modification satisfies the requirements of Section 423 of the Code with respect to the 423 Component, (ii) such new contribution limits are established in writing and provided to Eligible Employees prior to the commencement of such Offering Period and (iii) such new contribution limits shall apply only for that Offering Period unless otherwise specified in writing by the Committee.

 

6 

 

 

(c)            Discontinuing Employee Contributions. A Participant may discontinue contributions by filing a new enrollment form. Any contributions made from payroll shall cease as soon as reasonably practicable (which may not be until the payroll period following receipt or later). A Participant who has discontinued employee contributions may not resume such contributions until the next Offering Period. If a Participant discontinues contributions, previously made contributions shall remain in the Participant’s Plan Account (and will be used to purchase Stock) unless and until the Participant withdraws from the Plan in accordance with the provisions of Section 6 of the Plan.

 

SECTION 6.      WITHDRAWAL FROM THE PLAN.

 

(a)            Withdrawal. A Participant may elect to withdraw from the Plan by filing the prescribed form with the Company or its designee at any time before the last day of an Offering Period. As soon as reasonably practicable thereafter, contributions shall cease and all employee contributions made by the Participant for the then current Offering Period shall be refunded to the Participant in cash, without interest. No partial withdrawals shall be permitted.

 

(b)            Re-enrollment After Withdrawal. A former Participant who has withdrawn from the Plan shall not be a Participant until he or she re-enrolls in the Plan under Section 4(b) of the Plan. Re-enrollment shall be effective only at the commencement of an Offering Period.

 

SECTION 7.      CHANGE IN EMPLOYMENT STATUS.

 

(a)           Termination of Employment. Termination of employment with a Participating Company, or otherwise ceasing to be an Eligible Employee, for any reason, including death, shall be treated as an automatic withdrawal from the Plan under Section 6(a) of the Plan, unless, with respect to an offering under the Non-423 Component, otherwise required by applicable laws or regulations. A transfer from one Participating Company to another shall not be treated as a termination of employment unless required to comply with Section 423 of the Code with respect to the 423 Component.

 

(b)           Leave of Absence. For purposes of the Plan, employment shall not be deemed to terminate when the Participant goes on a military leave, a sick leave or another bona fide leave of absence, if the leave was approved by a Participating Company in writing or if such leave of absence is protected under applicable laws or regulations. Employment shall be deemed to terminate in any event when the approved leave ends, unless the Participant immediately returns to work.

 

(c)            Death. In the event of the Participant’s death, any amounts then held in the Participant’s Plan Account and any shares of Stock then held in the Participant’s name by the Company or the broker designated by the Company shall be paid or transferred to the Participant’s estate or as otherwise required by applicable laws of descent and distribution, or as may be otherwise provided pursuant to Section 8(e) of the Plan.

 

7 

 

 

SECTION 8.      PLAN ACCOUNTS AND PURCHASE OF SHARES.

 

(a)            Plan Accounts. The Company shall maintain a Plan Account on its books in the name of each Participant. Whenever an amount is contributed to the Plan, such amount shall be credited to the Participant’s Plan Account. Amounts credited to Plan Accounts shall not be trust funds and may be commingled with the general assets of the Company or any Parent, Qualifying Subsidiary, Subsidiary or Affiliate and applied to general corporate purposes, unless otherwise required by applicable law or regulation. Unless required by applicable law or regulation, no interest will be paid or credited with respect to any amounts held in a Participant’s Plan Account.

 

(b)            Purchase Price. The Purchase Price for each share of Stock purchased at the close of an Offering Period shall be not less than the lesser of (i) 85% of the Fair Market Value of such share on the last day of such Offering Period and (ii) 85% of the Fair Market Value of such share on the first day of such Offering Period, as determined by the Committee prior to the commencement of the applicable Offering Period.

 

The Committee may round the Purchase Price up (but not down) to a whole cent, and in no event shall the Purchase Price be less than the par value of the shares of Stock being purchased.

 

(c)            Number of Shares Purchased. As of the last day of each Offering Period, each Participant shall be deemed to have elected to purchase the number of shares of Stock calculated in accordance with this Section 8(c), unless the Participant has withdrawn from the Plan under Section 6(a) or Section 7 of the Plan. The amount then in the Participant’s Plan Account shall be divided by the Purchase Price, and the number of shares that results shall be purchased with the funds in the Participant’s Plan Account. The foregoing notwithstanding, no Participant shall purchase more than 10,000 shares of Stock (subject to adjustment pursuant to Section 14(b) of the Plan) with respect to any Offering Period (or, if the Board determines that a different number of Offering Periods shall commence in each calendar year in accordance with Section 4(a) of the Plan, a proportionate number of shares of Stock (subject to adjustment pursuant to Section 14(b) of the Plan) with respect to any Offering Period) nor more than the amounts of Stock set forth in Sections 9(b) and 14(a) of the Plan. Any fractional share, as calculated under this Section 8(c), shall be rounded down to the next lower whole share (with the Purchase Price for such fractional share to be carried over to the next Offering Period). To the extent permitted by law, the Committee may adjust the individual share limit set forth in this Section 8(c) from time to time without stockholder or Participant approval, provided that any such change shall not apply until the Offering Period commencing after such change is made (and such change shall automatically adjust the share number set forth in Section 9(a)(iii) of the Plan to the same amount).

 

(d)           Available Shares Insufficient. In the event that the aggregate number of shares of Stock that all Participants elect to purchase during an Offering Period exceeds the maximum number of shares of Stock remaining available for issuance under Section 14(a) of the Plan, then the number of shares of Stock a Participant shall purchase shall be determined by multiplying the number of shares of Stock available for issuance by a fraction, the numerator of which is the number of shares of Stock that such Participant has elected to purchase and the denominator of which is the number of shares of Stock that all Participants have elected to purchase.

 

8 

 

 

(e)           Issuance of Shares. Shares of Stock shall be issued either in book entry form or in certificates. Certificates, if any, representing the shares of Stock purchased by a Participant under the Plan shall be issued to the Participant, or book entry in the Participant’s name shall be made, as soon as reasonably practicable after the close of the applicable Offering Period, except that the Committee may determine that such certificates shall be held for each Participant’s benefit by a broker designated by the Committee. Shares may be registered in the name of the Participant or jointly in the name of the Participant and his or her spouse as joint tenants with right of survivorship or as community property or in such other manner of taking title as may be permitted under applicable law or regulation; provided, however, that unless otherwise required by applicable law or specified by the Participant in writing, shares of Stock purchased under the Plan will be registered in the name of the Participant.

 

(f)            Transfer of Shares. If certificates representing shares of Stock are not otherwise issued to the Participant in connection with the purchase of such shares at the end of an Offering Period, a Participant may elect to transfer any number of shares of Stock previously purchased under the Plan by providing notification and transfer instructions to Company or the broker designated by the Company, in accordance with procedures established under the Plan. As soon as administratively practicable following receipt of a Participant’s election to transfer shares of Stock, the Company or the designated broker shall cause a transfer of the shares or a certificate representing the number of shares to be transferred to be delivered to the Participant or a broker designated by the Participant.

 

(g)           Unused Cash Balances. Any amount remaining in the Participant’s Plan Account that represents the Purchase Price for shares that could not be purchased by reason of Section 9(b) or Section 14(a) of the Plan or otherwise shall be refunded to the Participant in cash, without interest, promptly after the end of the applicable Offering Period (unless otherwise required by Section 8(c) with respect to fractional shares).

 

SECTION 9.      LIMITATIONS ON STOCK OWNERSHIP.

 

(a)            Five Percent Limit. Any other provision of the Plan notwithstanding, no Participant shall be granted a right to purchase Stock under the Plan if such Participant, immediately after his or her election to purchase such Stock, would own stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Qualifying Subsidiary. For purposes of this Section 9(a), the following rules shall apply:

 

(i)            the attribution rules of Section 424(d) of the Code shall be applied in determining ownership of Stock;

 

(ii)           each Participant shall be deemed to own any stock that he or she has a right or option to purchase under this Plan or any other plan or arrangement; and

 

(iii)        each Participant shall be deemed to have the right to purchase under this Plan with respect to each Offering Period 10,000 shares of Stock (as adjusted pursuant to Section 8(c) of the Plan), subject to adjustment pursuant to Section 14(b) of the Plan.

 

9 

 

 

(b)            Dollar Limit. Any other provision of the Plan notwithstanding, consistent with Treasury Regulation Section 1.423-2(i), no Participant shall purchase Stock under this Plan and all other employee stock purchase plans of the Company or any Parent or Qualifying Subsidiary at a rate that exceeds $25,000 in fair market value of the Stock (determined at the time the option is granted) for each calendar year in which any option granted to the Participant is outstanding at any time.

 

For purposes of this Section 9(b), the Fair Market Value of Stock shall be determined as of the first day of the Offering Period in which such Stock is purchased. Employee stock purchase plans not described in Section 423 of the Code shall be disregarded. If a Participant is precluded by this Section 9(b) from purchasing additional Stock under the Plan, then his or her employee contributions shall automatically be discontinued, and shall resume (in accordance with the Participant’s most recently-filed enrollment form) on the first day of the earliest Offering Period in which this Section 9(b) would not prohibit such participation, provided that he or she then is an Eligible Employee.

 

SECTION 10.     RIGHTS NOT TRANSFERABLE.

 

The rights of any Participant under the Plan, or the interest in any Stock or moneys to which any Participant may be entitled under the Plan, shall not be transferable by voluntary or involuntary assignment or by operation of law, or in any manner other than by beneficiary designation or the laws of descent and distribution. If a Participant attempts to transfer, assign or otherwise encumber his or her rights or interest under the Plan, other than as permitted by this Section 10, such act shall be treated as an election by the Participant to withdraw from the Plan under Section 6(a) of the Plan.

 

SECTION 11.     NO RIGHTS AS AN EMPLOYEE.

 

Nothing in the Plan or in any right granted under the Plan shall confer upon the Participant any right to continue in the employ of a Participating Company for any period or interfere with or otherwise restrict in any way the rights of the Participating Companies or of the Participant, which rights are hereby expressly reserved by each, to terminate his or her employment at any time and for any reason, with or without cause, to the fullest extent permitted by applicable laws or regulations.

 

SECTION 12.     NO RIGHTS AS A STOCKHOLDER.

 

A Participant shall have no rights as a stockholder with respect to any shares of Stock that he or she may have a right to purchase under the Plan until such shares have been purchased and transferred or credited to the Participant.

 

SECTION 13.     SECURITIES LAW REQUIREMENTS.

 

Shares of Stock shall not be issued under the Plan unless the issuance and delivery of such shares comply with (or are exempt from) all applicable requirements of law, including, without limitation, the U.S. Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, all state securities laws and regulations, any applicable non-U.S. securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities are then traded or listed.

 

10 

 

 

SECTION 14.    STOCK OFFERED UNDER THE PLAN.

 

(a)           Authorized Shares. The aggregate number of shares of Stock available for purchase under the Plan as of the Effective Date shall be 11,068,989 and on January 1 of each year during which the Plan is in effect, commencing on January 1, 2023, the number of shares of Stock available for purchase under the Plan shall be increased by the lesser of (x) 11,068,989 shares of Stock, (y) 1% of the number of shares of all classes of common stock of the Company outstanding as of the immediately preceding December 31 (calculated on a fully diluted basis, including derivative securities of the Company and securities of GBT JerseyCo Limited that may become convertible for equity securities of the Company), and (z) such lesser number of shares of Stock as the Board may determine, in each case, as subject to adjustment as provided in this Section 14. Shares of Stock issued under the Plan may be shares already outstanding or newly issued or treasury shares. Notwithstanding the foregoing or anything contained in the Plan to the contrary, not more than 65,085,654 shares of Stock may be issued under the 423 Component, and not more than 65,085,654 shares of Stock may be issued under the Non-423 Component.

 

(b)           Changes in Capitalization. In the event of a reorganization, recapitalization, stock split, spin-off, split-off, split-up, stock or extraordinary cash dividend or other distribution, combination of shares, merger, amalgamation, consolidation or any other change in the corporate structure of the Company, or a sale by the Company of all or part of its assets, in any case, that occurs on or after the date the Plan is approved by the Board (even if such date is prior to the Effective Date), the Committee shall make such adjustments to the aggregate number of shares of Stock offered under the Plan, the number of shares set forth in clause (x) of Section 14(a) of the Plan, the share limitation described in Section 8(c) of the Plan (and the corresponding number of shares specified in clause (iii) of Section 9(a) of the Plan) and/or the price of shares that any Participant may elect to purchase under the Plan as may be necessary to prevent the dilution or enlargement of Participants’ rights. The Plan shall in no event be construed to restrict in any way the Company’s right to undertake a dissolution, liquidation, merger, amalgamation, consolidation or other reorganization or corporate transaction of any kind or type.

 

(c)            Change in Control. Any other provision of the Plan notwithstanding, immediately prior to the effective time of a Change in Control, the Plan shall terminate and shares shall be purchased pursuant to Section 8 of the Plan as if the Offering Period during which such Change in Control occurs was scheduled to end on the day immediately preceding such Change in Control, unless the Plan is expressly assumed by the surviving corporation, the buyer or an affiliate of the foregoing. In addition, in anticipation of a Change in Control, the Committee may take any action under the Plan as it deems necessary or appropriate, including, without limitation, terminating the Plan and preventing Participants from continuing their contributions to the Plan.

 

11 

 

 

SECTION 15.    WITHHOLDING

 

To the extent any payments, exercises, purchases or distributions under the Plan, or at the time a Participant disposes of some or all of the shares of Stock he or she acquired under the Plan, are determined by any Participating Company to be subject to U.S. Federal, state or local taxes, or the taxes of a jurisdiction other than the United States, the Participating Company (and each affiliate thereof) is authorized (but not obligated) to withhold any required taxes. The withholding obligation may be satisfied by (i) withholding shares of Stock purchased under the Plan; (ii) withholding from the proceeds from the sale of shares of Stock purchased under the Plan, either through a voluntary sale or through a mandatory sale arranged by the Company; (iii) deducting cash from a Participant’s Plan Account; (iv) deducting cash from a Participant’s other cash compensation payable to him or her by any Participating Company (or any affiliate thereof) or (v) any other method deemed appropriate by the Participating Company (or any affiliate thereof), in each case, as approved by the Committee. A Participant’s election to participate in the Plan authorizes any Participating Company (and any affiliate thereof) to take any of the actions described in the preceding sentence. Withholding in shares of Stock shall occur at a rate that is less than the rate that would result in liability or variable accounting treatment. Participants who are subject to Section 16 of the Securities Exchange Act of 1934, as amended, with respect to the Company, any Parent or any Subsidiary may elect to have withholding occur by reducing the number of shares of Stock otherwise to be received by them upon the purchase of shares of Stock under the Plan (or by using shares of Stock otherwise credited to their Plan Account that have been held for more than six months).

 

SECTION 16.     GOVERNING LAW; DISPUTE RESOLUTION; WAIVER OF JURY TRIAL

 

Except where U.S. Federal law is applicable to or controls any part of this Plan, the validity, construction and effect of this Plan shall be construed and enforced in accordance exclusively under the laws of the State of Delaware, without giving effect to the choice of law principles thereof. Any dispute not amicably resolved between the Company or any of its Subsidiaries, Qualifying Subsidiaries or Affiliates on the one hand and a Participant on the other shall be subject to the exclusive jurisdiction of the Federal courts located in the borough of Manhattan, New York City, New York (or if Federal jurisdiction does not exist, then the state courts located in the borough of Manhattan, New York City, New York). BY PARTICIPATING IN THIS PLAN, THE COMPANY, EACH SUBSIDIARY, QUALIFYING SUBSIDIARY AND AFFILIATE AND EACH PARTICIPANT HEREBY WAIVES, TO THE EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY LITIGATION IN ANY COURT WITH RESPECT TO, IN CONNECTION WITH, OR ARISING OUT OF, THIS PLAN, OR THE VALIDITY, PROTECTION, INTERPRETATION, COLLECTION OR ENFORCEMENT THEREOF (WHETHER ARISING IN CONTRACT, EQUITY, TORT OR OTHERWISE).

 

SECTION 17.     NON-423 COMPONENT AND SUB-PLANS

 

The Board and/or the Committee may adopt procedures and sub-plans to this Plan that are necessary or appropriate to permit or facilitate participation in the Plan by Eligible Employees who are employed or located in a jurisdiction other than the United States or to generally operate the Plan in jurisdictions outside the United States (provided that such procedures or sub-plans would not result in (i) the Plan failing to be eligible to qualify under Section 423 of the Code or (ii) any offering under the 423 Component not complying with Section 423 of the Code). Without limiting the generality of, but consistent with, the foregoing, the Board and/or the Committee are expressly authorized to adopt rules, procedures, and sub-plans, which, for purposes of the Non-423 Component, may be beyond the scope of Section 423 of the Code, regarding, without limitation, eligibility to participate in the Plan, excluding Employees in certain countries under the Non-423 Component (even if employed by a Participating Company), handling and making of employee contributions under the Plan, satisfying payroll taxes, determining beneficiaries, withholding procedures and issuances of Stock, any of which may vary from time to time and between jurisdictions, as determined by the Board and/or the Committee.

 

12 

 

 

SECTION 18.    TAX QUALIFICATION.

 

The 423 Component is intended to be exempt from the application of Section 409A of the Code under Section 1.409A-1(b)(5)(ii) of the U.S. Treasury Regulations. Purchases of Stock by Participants who are U.S. taxpayers participating in the Non-423 Component are intended to be exempt from the application of Section 409A of the Code under the short-term deferral exception and any ambiguities will be construed and interpreted in accordance with such intent. Subject to the provisions of this Section 18, Participants who are U.S. taxpayers participating in the Non-423 Component shall be subject to such terms and conditions as shall permit his or her participation in the Plan to satisfy the requirements of the short-term deferral exception to Section 409A of the Code, including the requirement that the shares subject to the right to purchase Stock under the Plan be delivered within the short-term deferral period. Notwithstanding the foregoing or any other provision of the Plan to the contrary, neither the Company nor any Parent, Qualifying Subsidiary or Subsidiary shall have any liability to a Participant or any other person or entity if the right to purchase Stock under the Plan that is intended to be exempt from or compliant with Section 409A of the Code is not so exempt or compliant or for any action taken by the Committee, the Board, the Company or any Parent, Qualifying Subsidiary or Subsidiary in relation thereto. Notwithstanding the foregoing or any other provision of the Plan to the contrary, although the Company may endeavor to (i) qualify the 423 Component or Non-423 Component for special tax treatment under the laws and regulations of the United States or of a jurisdiction other than the United States or (ii) avoid adverse tax treatment (e.g., under Section 409A of the Code), the Company makes no representation to that effect and expressly disavows any covenant to maintain special, or to avoid unfavorable, tax treatment. The Company and each Parent, Qualifying Subsidiary, Subsidiary and Affiliate shall be unconstrained in their activities without regard to any potentially negative tax impact on any one or more Participants.

 

SECTION 19.    SEVERABILITY.

 

If any particular provision of the Plan is found to be invalid or otherwise unenforceable, such provision shall not affect the other provisions of the Plan, and the Plan shall be construed in all respects as if such invalid provision were omitted. Any provision of the Plan that would cause an offering under the 423 Component to violate Section 423 of the Code shall be null and void ab initio.

 

SECTION 20.    AMENDMENT AND TERMINATION.

 

The Board shall have the right to amend, suspend or terminate the Plan, and to shorten an Offering Period (and refund Participant contributions in the event of any such shortening, suspension or termination) at any time and without notice. Any increase in the aggregate number of shares of Stock to be issued under the Plan shall be subject to approval by a vote of the stockholders of the Company. In addition, any other amendment of the Plan shall be subject to approval by a vote of the stockholders of the Company to the extent required by applicable law, rule or regulation, including, without limitation, Section 423 of the Code, or by the rules of any applicable stock exchange. No amendment, termination or suspension of the Plan shall require the consent of any Participant unless otherwise required by applicable law or the rules of any applicable stock exchange. The Plan shall terminate on the earlier to occur of (i) a termination of the Plan by the Board (pursuant to this Section 20), (ii) the tenth anniversary of the date the Plan is approved by the Board or (iii) the tenth anniversary of the date the Plan is approved by the stockholders of the Company.

 

[End of Plan]

 

13 

 

 

 

Exhibit 10.16 

 

GLOBAL BUSINESS TRAVEL GROUP, INC.
MANAGEMENT INCENTIVE PLAN

 

Originally Adopted June 30, 2014 (the “Effective Date”)

Amended and Restated December 10, 2019

Amended and Restated December 2, 2021
Assumed and Restated as of May 27, 2022

 

1              Background; Purpose of the Plan

 

On December 10, 2019, GBT III B.V., a private company with limited liability organized under the laws of the Netherlands (“GBT III”), completed a restructuring whereby GBT JerseyCo Limited, a company limited by shares incorporated under the laws of Jersey (“GBT JerseyCo”), became the parent company of the GBT group (the “2019 Restructuring”). In connection with the 2019 Restructuring, the GBT III B.V. Management Incentive Plan (the “Original Plan”) was assumed by GBT JerseyCo, amended to reflect the 2019 Restructuring and renamed the GBT JerseyCo Limited Management Incentive Plan (the “Prior Plan”). Pursuant to Section 4.14 of the Original Plan, all of the options granted under the Original Plan that were outstanding at the closing of the 2019 Restructuring were converted into options to purchase shares of Common Stock of GBT JerseyCo and were treated as if they were originally granted under the Prior Plan.

 

On May 27, 2022, GBT JerseyCo completed a transaction whereby Global Business Travel Group, Inc. (the “Company”), acquired GBT JerseyCo and became the parent company of the GBT group (the “Transaction”). In connection with the Transaction, the Prior Plan was assumed by the Company, was amended to reflect the Transaction as set forth herein and renamed the Global Business Travel Group, Inc. Management Incentive Plan (the “Plan”). Pursuant to Section 4.14 of the Prior Plan, all of the options treated as granted under the Prior Plan that were outstanding at the closing (the “Closing”) of the Transaction (“Converted Options”) were converted into options to purchase shares of Common Stock (as defined below) and were treated as if they were originally granted under this Plan. Following the Closing, no new Options (as defined below) shall be granted under this Plan. References in this Plan to “the Company” in relation to events that occurred prior to the Transaction shall be deemed to refer to GBT JerseyCo or GBT III, as and where applicable. For purposes of the Options and the Option Grant Agreements (as defined below), the Transaction is, and will be treated as, an Initial Public Offering (as defined in the Prior Plan).

 

The purpose of the Plan is to promote the interests of the Company and its shareholders by providing the key employees, service providers and consultants of the Company and its subsidiaries with an appropriate incentive to encourage them to continue in the employ of the Company or its subsidiaries and to improve the growth, profitability and financial success of the Company and its subsidiaries.

 

2              Definitions

 

As used in this Plan and in any Option Grant Agreement, the following capitalized terms shall have the following meanings:

 

 

 

 

(a)             “Affiliate” shall mean, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under direct or indirect common control with such Person; provided, that no shareholder of the Company shall be deemed an Affiliate of any other shareholder solely by reason of any investment in the Company except that solely for purposes of the Plan, Amex and its subsidiaries shall be deemed to be Affiliates. For the purpose of this definition, the term “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise. For the avoidance of doubt, no Juweel Investor shall be considered an Affiliate of the Company unless expressly noted herein.

 

(b)             “Amex” shall mean American Express Company.

 

(c)             “Board” shall mean the Board of Directors of the Company.

 

(d)             Business Travel Entities” shall mean business entities with annual revenue of at least $10,000,000 (whether or not for profit) and governmental agencies.

 

(e)             Business Travel Services” shall mean business travel agency services provided to Business Travel Entities pursuant to a stand-alone contract to arrange for the business and commercial travel of their employees, excluding Travel Supplier Services, covering an entire enterprise or one or more business units, geographies or divisions thereof.

 

(f)             “Cause” shall mean, when used in connection with the termination of a Participant’s Employment, unless otherwise provided in the Participant’s Option Grant Agreement or the Participant’s effective, written contract of Employment or severance agreement with the Company or any of its direct and indirect subsidiaries, the Participant’s (i) willful and continued failure to adequately perform substantially all of the Participant’s duties; (ii) failure to devote substantially all of the Participant’s business time to the performance of the Participant’s duties for the Company and its subsidiaries (subject to the ability to engage in activities in accordance with applicable Company policy); (iii) willful misconduct; (iv) unlawful use of a controlled substance; (v) conviction of, or entry of a plea of guilty or no contest to any felony or any crime involving, dishonesty, theft, moral turpitude, breach of trust or breach of a fiduciary duty or their equivalent under local law; (vi) engagement in an act or omission that is detrimental to the business or reputational interests of the Company or its subsidiaries, including but not limited to an act of fraud, embezzlement, disparagement, theft or dishonesty, whether in the past or future (including any such acts occurring prior to the commencement of employment); (vii) habitual or gross negligence in the performance of the Participant’s duties; (viii) material or repeated violation of any policy or practice adopted by the Company or its subsidiaries applicable to the Participant; (ix) breach of any material term of any written employment, service or consulting agreement between the Participant and the Company or its subsidiaries; and (x) violation of any Company or subsidiary detrimental conduct provision. If, subsequent to the termination of a Participant’s Employment, it is discovered that Participant engaged in conduct which the Committee determines in good faith could have resulted in Participant’s Employment being terminated for Cause, as such term is defined above, or if the Participant Competes, the Participant’s Employment shall, at the election of the Committee, in its sole discretion, be deemed to have been terminated for Cause (regardless of how such termination was previously classified).

 

 

 

 

(g)             “Change in Control” shall mean the occurrence of any of the following events after the Effective Date: (i) any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all of the assets of the Company and its subsidiaries (determined on a consolidated basis) to any Good Faith Independent Purchaser or group of related Good Faith Independent Purchasers for purposes of Section 13(d) of the Exchange Act (a “Group”); (ii) the approval by the holders of the outstanding voting power of the Company of any plan or proposal for the liquidation or dissolution of the Company; or (iii) any Good Faith Independent Purchaser or related Group thereof becoming the beneficial owner (within the meaning of Section 13(d) of the Exchange Act), directly or indirectly, of securities representing more than 50% of the aggregate outstanding voting power of the Company and such Person or Group actually has the power to vote such securities in any such election of members of the Board. Notwithstanding the foregoing, the Transaction shall not be treated as a Change in Control.

 

(h)             Closing” has the meaning set forth in Section 1 above.

 

(i)              “Code” shall mean the Internal Revenue Code of 1986, as amended.

 

(j)              “Commission” shall mean the U.S. Securities and Exchange Commission.

 

(k)             “Committee” shall mean the Compensation Committee of the Board of Directors of the Company.

 

(l)              “Common Stock” shall mean the Class A common stock of the Company, par value $0.0001 per share.

 

(m)            “Compete” shall mean with respect to any Participant, unless otherwise provided in the Participant’s Option Grant Agreement, (i) during Employment and for the Restricted Period, (A) being an employee, director, or independent contractor of, or a consultant to, or performing any services for or on behalf of, or being an owner or investor in (other than the ownership of not more than 1% of the publicly traded voting securities of any company listed on a national securities exchange), any Person engaging in any Competing Business, or (B) directly or indirectly, whether on behalf of the Participant or another Person, soliciting (including any communication of any kind, regardless of by whom it is initiated) or hiring or attempting to solicit or hire (x) any actual or prospective customer or supplier of the Company or any of its subsidiaries in connection with any Competing Business or to terminate or alter in a manner adverse to the Company or its subsidiaries such customer’s or supplier’s relationship with the Company or its subsidiaries, or (y) any Employee or individual who was an Employee within the six-month period immediately prior thereto to terminate or otherwise alter his or her Employment with the Company or its subsidiaries or to provide services to another Person (whether as an employee, director, consultant or otherwise), provided that Participant’s employer’s or business organization’s conducting general advertising for employees not directed at any specific Person shall not in and of itself be a violation of this clause (B), or (ii) at any time during or following Employment, disclosing or using any Confidential Information, except as required by legal process or, during Employment, in good faith in furtherance of his or her job responsibilities to the Company and its subsidiaries (provided that if the Participant receives legal process with regard to disclosure of such Confidential Information, he/she shall promptly notify the Company and cooperate with the Company in seeking a protective order with respect to such Confidential Information or to otherwise limit its disclosure). “Competed” and “Competing” shall have correlative meanings. Further, in accordance with the Defend Trade Secrets Act of 2016, (I) the Participant shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal, and (II) if the Participant files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Participant may disclose a trade secret to the Participant’s attorney and use the trade secret information in the court proceeding, if the Participant files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.

 

 

 

 

(n)            “Competing Business” shall mean (i) the provision of Business Travel Services and (ii) any other business in which the Company or any of its subsidiaries was engaged, or is considering engaging in, during the Participant’s Employment or within the twenty-four (24) month period immediately following the Participant’s termination of Employment and of which the Participant was aware or reasonably should have been aware prior to his or her termination of Employment.

 

(o)            “Confidential Information” shall mean all information regarding the Company, Juweel, the Juweel Investors, any Affiliates of the Company, Juweel or the Juweel Investors or any of the employees, officers and directors of any of the foregoing Persons, including, without limitation, any activity, business, product, customer, client or supplier of any of the foregoing Persons, in any case, that is not generally known by the public or to Persons not employed by the Company, Juweel, the Juweel Investors or their respective Affiliates, including, without limiting the foregoing, information that would not be known to the public but for the actions of or disclosure by, directly or indirectly, the Participant.

 

(p)            “Disability” shall mean with respect to any Participant, unless otherwise provided in the Participant’s Option Grant Agreement, a permanent disability as defined in the Company’s or its subsidiaries’ long-term disability plans covering such Participant (if any), or as defined from time to time by the Company, in its sole discretion.

 

(q)            “Effective Date Chairman” means the chairman of the Board of Directors of GBT JerseyCo as of December 10, 2019.

 

(r)             “Employment” shall mean employment or other service relationship with the Company or any of its subsidiaries and shall include the provision of services as a director, service provider or consultant for the Company or any of its subsidiaries. “Employee” and “Employed” shall have correlative meanings. Employment will be deemed to continue, unless the Committee expressly determines otherwise in its sole discretion, so long as the Participant is employed by, or otherwise is providing services to the Company or one of its subsidiaries. If a Participant’s Employment is with a subsidiary and that entity ceases to be a subsidiary of the Company, the Participant’s Employment will be deemed to have terminated when the entity ceases to be a subsidiary of the Company unless the Participant transfers Employment to the Company or one of its remaining subsidiaries. All determinations regarding Employment and terminations thereof shall be made by the Committee in its sole discretion.

 

 

 

 

(s)             “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

 

(t)             “Exercise Date” shall have the meaning set forth in Section 4.11 herein.

 

(u)             “Exercise Notice” shall have the meaning set forth in Section 4.11 herein.

 

(v)            “Exercise Price” shall mean the price that the Participant must pay under the Option for each share of Common Stock, as determined by the Committee for each grant and initially specified in the Option Grant Agreement, which shall be no less than the Fair Market Value of a share of Common Stock on the Grant Date, subject to any increase or other adjustment that may be made following the Grant Date in accordance with the Plan. For the avoidance of doubt, with respect to any Premium Strike Option, the Exercise Price of such Option may, in the Committee’s sole discretion, be set at a price that is higher than the applicable Fair Market Value as of the Grant Date of such Option.

 

(w)            “Fair Market Value” shall mean, as of any date (i) prior to the date on which the Common Stock is first publicly traded on a recognized exchange, the value per share of Common Stock as determined by the Board; or (ii) on which the Common Stock is then publicly traded on a recognized exchange, (A) the closing price on such day of the shares of Common Stock as reported on the principal securities exchange on which the shares of Common Stock are then listed or admitted to trading or (B) if not so reported, the average of the closing bid and ask prices on such day as reported on the National Association of Securities Dealers Automated Quotation System or (C) if not so reported, as furnished by any member of the National Association of Securities Dealers, Inc. (“NASD”) selected by the Board. The Fair Market Value of the shares of Common Stock as of any such date on which the applicable exchange or inter-dealer quotation system through which trading in the shares of Common Stock regularly occurs is closed shall be the Fair Market Value determined pursuant to the preceding sentence as of the immediately preceding date on which the shares of Common Stock are traded, a bid and ask price is reported or a trading price is reported by any member of NASD selected by the Board (as applicable). In the event that the price of a share of Common Stock shall not be so reported or furnished, the Fair Market Value shall be determined by the Board. In any case, the Fair Market Value shall be determined in accordance with the requirements of Section 409A of the Code, to the extent applicable.

 

(x)              Good Faith Independent Purchaser” shall mean an independent third party, as determined by the Board, and expressly excludes each Majority Stockholder, the Juweel Investors, the Amex Permitted Transferees, Juweel Permitted Transferee and the Juweel Investors Permitted Transferees, in each case as defined in the Shareholders Agreement.

 

 

 

 

(y)            “Good Reason” shall mean with respect to any Participant who is an Employee of the Company or one of its subsidiaries, unless otherwise provided in the Participant’s Option Grant Agreement or an effective employment or severance agreement with the Company or any of its direct or indirect subsidiaries, following a Change in Control, (i) a material decrease in a Participant’s annual base salary (other than as part of an across-the-board reduction applicable to all similarly situated employees of the Company and/or its subsidiaries), or (ii) a relocation of a Participant’s primary work location more than 60 miles from the Participant’s primary work location in effect immediately prior to the Grant Date (provided that such relocation materially increases the Participant’s daily one-way commute to his or her primary work location), each such event occurring following a Change in Control without the Participant’s prior written consent; provided that, within thirty days following the occurrence of any of the events set forth herein, the Participant shall have delivered written notice to the Company of his or her intention to terminate his or her Employment for Good Reason, which notice specifies in reasonable detail the circumstances claimed to give rise to the Participant’s right to terminate Employment for Good Reason, and the Company shall not have cured such circumstances within thirty days following the Company’s receipt of such notice.

 

(z)             “Grant Date” shall mean the grant date designated by the Committee and specified in the Option Grant Agreement as of the date the Option is granted. The Grant Date of Converted Options shall be the date on which they were originally issued under the Original Plan or the Prior Plan (as applicable).

 

(aa)           Juweel Investors” shall mean, for so long as such entities remain invested (directly or indirectly) in the Company, Certares GBT Holdings Ltd., QH Travel, L.P., PecosCo Limited Partnership, HMC Juweel Holdings, LP, Macquarie Juweel Investor LP and BR Investors Juweel, L.P.

 

(bb)          “Majority Stockholder” shall mean, collectively or individually as the context requires, American Express Travel Holdings Netherlands Coöperatief U.A., Juweel Investors Coöperatief U.A. and/or their respective Affiliates (disregarding the Company and its subsidiaries), successors and assigns.

 

(cc)          “Option” shall mean the option to purchase shares of Common Stock treated as granted to any Participant under the Plan. Any references in the Plan to an “Option” will be deemed to include “Time-Based Options”, “Performance-Based Options” and “Premium Strike Options” unless specifically noted to the contrary. No Option is intended to be (or shall be treated as) an “incentive stock option” under Section 422 of the Code.

 

(dd)          “Option Grant Agreement” shall mean an agreement entered into by each Participant and the Company evidencing the grant of each Option.

 

(ee)           “Participant” shall mean a Person to whom a grant of an Option has been made and, where applicable, shall include Permitted Transferees.

 

(ff)            “Performance-Based Option” shall have the meaning set forth in Section 4.5(b).

 

(gg)          “Permitted Transferee” shall have the meaning set forth in Section 4.7.

 

 

 

 

(hh)           “Person” means an individual, partnership, corporation, limited liability company, unincorporated organization, trust or joint venture, or a governmental agency or political subdivision thereof.

 

(ii)             “Premium Strike Option” shall have the meaning set forth in Section 4.5(c).

 

(jj)             “Qualifying CIC Termination” shall mean, unless otherwise provided in the Participant’s Option Grant Agreement, with respect to a Participant, a termination of such Participant’s Employment by the Company or a subsidiary thereof without Cause or by the Participant for Good Reason, in each case within the one-year period following a Change in Control (other than a Change in Control that is also a SPAC Transaction).

 

(kk)           Restricted Period” shall mean, unless otherwise provided in the Participant’s Option Grant Agreement, the twenty-four month period following the termination of the Participant’s Employment.

 

(ll)             Restrictive Covenants” means the covenants contained in an Option Grant Agreement under the section titled “Restrictive Covenants.”

 

(mm)          Shareholders Agreement” shall mean the Shareholders Agreement by and among the Company, American Express Travel Holdings Netherlands Coöperatief U.A. and Juweel Investors Coöperatief U.A., as amended and/or restated from time to time.

 

(nn)          “Shares” shall mean the shares of capital stock of the Company.

 

(oo)          “Securities Act” shall mean the Securities Act of 1933, as amended.

 

(pp)          “Time-Based Option” shall have the meaning set forth in Section 4.5(a).

 

(qq)          “Transfer” shall mean any transfer, sale, assignment, hedge, gift, testamentary transfer, pledge, hypothecation or other disposition of any interest. “Transferee” and “Transferor” shall have correlative meanings.

 

(rr)             Travel Supplier Services” means the ownership or operation of hotels, resorts, other lodging providers, airlines, rail, car rental and other transportation providers.

 

(ss)           “Vesting Commencement Date” shall mean, with respect to a Time-Based Option, the date specified in the applicable Option Grant Agreement on which the vesting period of such Time-Based Option commences.

 

3              Administration of the Plan

 

The Committee shall administer the Plan.

 

 

 

 

3.1           Powers of the Committee. In addition to the other powers granted to the Committee under the Plan, the Committee shall have the power: (a) to determine, modify or waive the terms and conditions of any Option; (b) to prescribe the form of and terms and conditions of any instrument evidencing a grant of Options, so long as such terms and conditions are not otherwise inconsistent with the terms of the Plan; (c) to adopt, amend and rescind such rules and regulations as, in its opinion, may be advisable for the administration of the Plan; (d) to construe and interpret the Plan, such rules and regulations and the instruments evidencing grants of Options; (e) to reconcile any inconsistency, correct any defect and/or supply any omission in the Plan or any instrument evidencing any grant of Options; (f) to establish any black-out or exercise restrictions on Options as it deems appropriate in connection with the Closing or other events; (g) to make all other determinations necessary or advisable for the administration of the Plan and Options and otherwise do all things necessary to carry out the purposes of the Plan and Options.

 

3.2           Determinations of the Committee. Any grant, determination, prescription or other act of the Committee shall be final and conclusively binding upon all Persons.

 

3.3           Indemnification of the Committee. No member of the Committee nor the Effective Date Chairman, the Majority Stockholders, any Juweel Investor, nor their employees, partners, directors or associates shall be liable for any action or determination made in good faith with respect to the Plan or any grant of Options thereunder. To the full extent permitted by law, the Company shall indemnify and hold harmless each Person made or threatened to be made a party to any civil or criminal action or proceeding by reason of the fact that such Person, or such Person’s testator or intestate, is or was a member of the Committee, is or was the Effective Date Chairman or is or was a Majority Stockholder, a Juweel Investor or an employee, partner, director or associate thereof, to the extent such criminal or civil action or proceeding relates to the Plan or any grant made (or treated as made) pursuant to the Plan (provided that such Person acted in good faith and in a manner such Person reasonably believed to be in the best interests of, or not opposed to the best interests of, the Company).

 

3.4           Compliance with Applicable Law; Securities Matters; Effectiveness of Option Exercise. The Company shall be under no obligation to effect the registration pursuant to the Securities Act of the issuance of any shares of Common Stock to be issued hereunder or to effect similar compliance or registration under any state or non-U.S. laws. Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any certificates evidencing the shares of Common Stock pursuant to the exercise of any Options, which shares of Common Stock shall be evidenced by book-entry in the books and records of the Company, and may only issue such certificates or make such book entry in the event the Committee has determined, with advice of counsel, that the issuance and delivery of such certificates or making of such book entry is in compliance with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the shares of Common Stock are listed or traded. In addition to the terms and conditions provided herein, the Committee may require that a Participant make such reasonable covenants, agreements and representations as the Committee, in its sole discretion, deems advisable in order to comply with any such laws, regulations or requirements. The Company may, in its sole discretion, delay the exercisability of an Option hereunder to help ensure compliance under federal, state or non-U.S. securities laws and any exemptions therefrom on which the Company may be relying. The Company shall inform the Participant in writing of its decision to delay the exercise of an Option. During the period that the effectiveness of the exercise of an Option has been delayed, the Participant may, by written notice, withdraw such exercise.

 

 

 

 

3.5           Inconsistent Terms. In the event of a conflict between the terms of the Plan and the terms of any Option Grant Agreement, the terms of the Plan shall govern except as otherwise expressly provided herein.

 

3.6           No Additional Grants. The Committee shall not grant any new Options under this Plan after the Closing. All Options which remain outstanding after the Closing shall continue to be governed by the Plan and the applicable Option Grant Agreement.

 

3.7           Acceptance of Terms. By accepting (or, under such rules as the Committee may prescribe, being deemed to have accepted) an Option, the Participant shall be deemed to have agreed to the terms of the Option Grant Agreement and the Plan.

 

4              Options

 

4.1           Fractional Shares. Unless the Committee determines otherwise, no fractional shares of Common Stock will be delivered under the Plan.

 

4.2           Option Repricing. No underwater Option may be repriced, exchanged for another award or cancelled for a cash payment, in each case, unless approved by the Company’s shareholders; provided, however, that notwithstanding the foregoing or anything contained in the Plan or an Option Grant Agreement to the contrary, the Committee may take any of the actions provided for in Section 4.14 hereof, including with respect to an underwater Option, without the consent of the Company’s shareholders or any other Person.

 

4.3           Intentionally Omitted.

 

4.4           Intentionally Omitted.

 

4.5           Vesting of Options. The Committee shall specify in the Option Grant Agreement the conditions upon which the Option shall become vested.

 

(a)           Time-Based Option.

 

(i)           Generally. The Committee may provide in the Option Grant Agreement that some or all of an Option is a Time-Based Option. For purposes of the Plan, except as otherwise provided in the applicable Option Grant Agreement, a “Time-Based Option” shall mean an Option that vests in equal 20% installments on each of the first five anniversaries of the Vesting Commencement Date, subject in all cases to the Participant’s continued Employment through the applicable vesting date. Unless the Committee provides otherwise, the vesting of the Time-Based Option may be suspended during any leave of absence.

 

(ii)           Accelerated Vesting on a Qualifying CIC Termination. In the event that a Participant’s Employment is terminated as the result of a Qualifying CIC Termination, 100% of the then outstanding Time-Based Options held by the Participant shall immediately vest and become exercisable as of such Qualifying CIC Termination.

 

 

 

 

(b)           Performance-Based Option. The Committee may provide in the Option Grant Agreement that some or all of an Option is a Performance- Based Option. For purposes of the Plan, a “Performance-Based Option” shall mean an Option that vests in accordance with the performance-based targets set forth in the applicable Option Grant Agreement.

 

(c)           Premium Strike Options. The Committee may provide in the Option Grant Agreement that some or all of an Option (whether a Performance-Based Option or a Time-Based Option) is a Premium Strike Option. For purposes of the Plan, a “Premium Strike Option” shall mean an Option that has an Exercise Price that is greater than the Fair Market Value of a share of Common Stock on the Grant Date of such Option.

 

4.6           Expiration of Options. All Options, whether vested or unvested, shall expire on the tenth anniversary of their Grant Date unless such Options expire earlier as provided below or in the applicable Option Grant Agreement.

 

(a)           Effect of Termination of Employment on Unvested Options. With respect to each Participant, such Participant’s Option(s), or portion thereof, which have not become vested shall expire on the date such Participant’s Employment is terminated for any reason unless otherwise specified in the Option Grant Agreement or as specified below, or unless such termination is a Qualifying CIC Termination.

 

(i)           Death & Disability. Except as otherwise provided in an Option Grant Agreement, in the event the Participant’s Employment terminates due to the Participant’s death or Disability, the Participant’s unvested Options will remain outstanding and continue to vest or be eligible to vest during the twelve month period following such termination of Employment, and each such unvested Option that vests following such termination of Employment will remain outstanding and be exercisable until the earlier of (i) twelve months following the date on which such Option vested following the Participant’s death or Disability or (ii) the earlier of the tenth anniversary of the Grant Date for such Option(s) or such different expiration period (not to exceed ten years from the Grant Date) specified in the Option Grant Agreement, which expiration date or period shall supersede the foregoing expiration period.

 

(ii)           Termination of Employment by the Company or a Subsidiary without Cause. Except as otherwise provided in an Option Grant Agreement, in the event the Participant’s Employment is terminated by the Company or a subsidiary without Cause, the Participant’s unvested Options will remain outstanding and continue to vest or be eligible to vest during the six month period following such termination of Employment and each such unvested Option that vests following such termination of Employment will remain outstanding and be exercisable until the earlier of (i) 90 days following the date on which such Option vested following the Participant’s termination of Employment or (ii) the earlier of the tenth anniversary of the Grant Date for such Option(s) or such different expiration period specified in the Option Grant Agreement, which expiration date or period shall supersede the foregoing expiration period.

 

 

 

 

(b)           Effect of Termination of Employment on Vested Options. With respect to each Participant, such Participant’s Option(s), or any portion thereof, which have become vested on or before the date such Participant’s Employment is terminated shall, unless otherwise provided in the Participant’s Option Grant Agreement, expire on the earliest of (i) the commencement of business on the date the Participant’s Employment is terminated for Cause, or, following the Participant’s termination of Employment, the date on which the Committee in good faith determines that during his or her Employment, the Participant engaged in conduct which constitutes Cause; (ii) 90 days after the date the Participant’s Employment is terminated by the Company or a subsidiary or by the Participant for any reason other than (1) Cause (unless the Participant engaged in conduct which the Committee determined in good faith constitutes Cause), (2) a Qualifying CIC Termination or (3) the Participant’s death or Disability; (iii) one year after the date the Participant’s Employment is terminated by reason of death or Disability; or (iv) the earlier of the tenth anniversary of the Grant Date for such Option(s) or such different expiration date or period (not to exceed ten years from the Grant Date) specified in the Option Grant Agreement, which expiration date or period shall supersede the foregoing expiration period.

 

(c)           Permitted Transferees. Any Option, or portion thereof, that is vested and is held by a Permitted Transferee on account of the death of a Participant shall expire (i) in the event that such Participant terminated Employment prior to his or her death, on the date on which such Option would have expired had the Participant not died and had such Participant continued to hold such Option (unless otherwise provided in the Participant’s Option Grant Agreement) or (ii) in the event that such Participant died while Employed, unless otherwise provided in the Participant’s Option Grant Agreement, on the earlier of (x) one year after the date on which such deceased Participant’s Employment terminated by reason of death or (y) the earlier of the tenth anniversary of the Grant Date for such Option(s) or such different expiration period (not to exceed ten years from the Grant Date) specified in the Option Grant Agreement, which expiration date or period shall supersede the foregoing expiration period. Any Option or portion thereof that has been transferred to a Permitted Transferee during the lifetime of a Participant shall expire in connection with the Participant’s termination of Employment at the time set forth under this Section 4.6 as if the Option were held directly by the Participant, unless otherwise provided in the Participant’s Option Grant Agreement.

 

4.7           Limitation on Transfer. Each Option granted to a Participant shall be exercisable only by such Participant, except that a Participant may assign or transfer his or her rights with respect to any or all of the Options held by such Participant to: (i) such Participant’s beneficiaries or estate upon the death of the Participant (by will, by the laws of descent and distribution or otherwise) and (ii) subject to the prior written approval by the Committee and compliance with all applicable tax, securities and other laws and the rules of any applicable securities exchange on which the Common Stock is then listed or quoted, as may be necessary to fulfill a domestic relations order (each of (i) and (ii), a “Permitted Transferee”). Notwithstanding the foregoing, in no event will transfers to a Person that the Administrator determines provides services or financial or other support, directly or indirectly, to a competitor of the Company be permitted, even if such Person is otherwise a Permitted Transferee hereunder.

 

4.8           Condition Precedent to Transfer of Any Option. It shall be a condition precedent to any Transfer of any Option by any Participant that the Transferee shall agree prior to the Transfer in writing with the Company to be bound by the terms of the Plan and the Option Grant Agreement as if he, she or it had been an original signatory thereto, except that any provisions of the Plan or an Option Grant Agreement based on the Employment (or termination thereof) shall continue to be based on the Employment (or termination thereof) of the original Participant (and all other forfeiture and vesting conditions shall apply as if no such Transfer had occurred, unless otherwise determined by the Committee).

 

 

 

 

4.9           Effect of Void Transfers. In the event of any purported Transfer of any Options in violation of the provisions of the Plan, such purported Transfer shall, to the extent permitted by applicable law, be void and of no effect.

 

4.10         Exercise of Options. Following the Closing, a Participant (or his or her Permitted Transferee, guardian or legal representative, if applicable) may exercise vested Options subject to Section 3.4 hereof and otherwise in compliance with other applicable law, the rules of any applicable stock exchange and Company policy. Such exercises shall be in accordance with the rules, regulations and procedures established by the Committee from time to time. No unvested Options may be exercised.

 

4.11         Method of Exercise. Vested Options shall be exercised in accordance with procedures established by the Committee from time to time, which may include through the use of a third-party stock plan administrator’s online portal. Payment of the exercise price of the Option shall be in cash, by check, with previously acquired shares of Common Stock that have been held for at least six months and one day prior to exercise (or such longer period as is necessary to avoid adverse accounting treatment or liability accounting treatment) or in such other form of consideration as the Committee may accept in is sole discretion.

 

The partial exercise of an Option, alone, shall not cause the expiration, termination or cancellation of the remaining portion of such Option.

 

4.12         Intentionally Omitted.

 

4.13         Amendment of Terms of Options. The Committee may, in its sole discretion, amend the Plan or terms of any Option, provided, however, that any such amendment shall not materially impair or adversely affect the Participant’s existing rights under the Plan or such Option without such Participant’s written consent, unless the Committee expressly reserved the right to make such amendment at the time the Option was granted (which shall include, without limitation, the right to adjust or modify the Plan and outstanding Options pursuant to Section 4.14).

 

4.14         Effect of Certain Transactions. Subject to any action by the shareholders of the Company required by law, applicable tax rules or the rules of any exchange on which Shares are listed for trading:

 

(a)           Increase or Decrease in Issued Shares Without Consideration. In the event of any increase or decrease in the number of issued Shares resulting from a subdivision or consolidation of Shares or the payment on Shares of a stock dividend in Shares or any recapitalization, merger, combination or exchange of Shares or similar corporate change, the Committee shall, to the extent deemed appropriate by the Committee, adjust the type and/or number of shares of Common Stock subject to each outstanding Option and/or the exercise price per share of Common Stock of each such Option.

 

 

 

 

(b)           Certain Mergers and Other Transactions. In the event of any merger, consolidation or similar transaction as a result of which the holders of shares of Common Stock receive consideration consisting exclusively of securities of the surviving corporation in such transaction, the Committee shall, to the extent deemed appropriate by the Committee, adjust each Option outstanding on the date of such merger or consolidation so that it pertains and applies to the securities which a holder of the number of shares of Common Stock subject to such Option would have received in such merger or consolidation.

 

In the event of (i) a dissolution or liquidation of the Company, (ii) a sale of all or substantially all of the Company’s and its subsidiaries’ assets (on a consolidated basis), (iii) a merger, consolidation or similar transaction involving the Company in which the holders of shares of Common Stock receive securities and/or other property, including cash or (iv) a Change in Control, the Committee shall, to the extent deemed appropriate by the Committee, have the power to:

 

(i)           cancel, effective immediately prior to the occurrence of such event, each Option (whether or not then exercisable or vested), and, in full consideration of such cancellation, pay to the Participant in respect of each share of Common Stock underlying the portion of such Option being so cancelled the excess, if any, of (A) the value, as determined by the Committee in its sole discretion, of the property (including cash) received (or that would be received) in respect of one share of Common Stock as a result of such event over (B) the Exercise Price of such Option (provided that if the amount under clause (B) equals or exceeds the amount under clause (A), then such Option may be cancelled with no payment due to the holder thereof);

 

(ii)           provide for the exchange of each Option (whether or not then exercisable or vested) for an option with respect to (A) some or all of the property which a holder of the number of shares of Common Stock subject to such Option would have received in such transaction or (B) securities of the acquiror or surviving entity (or an Affiliate thereof) and, incident thereto, make an equitable adjustment as determined by the Committee in the exercise price of the Option and/or the number of securities or amount of property subject to the option or provide for a payment (in cash or other property) to the Participant to whom such Option was granted in partial consideration for the exchange of the Option; or

 

(iii)           take such other action as the Committee deems appropriate.

 

(c)           Other Changes. In the event of any change in the capitalization of the Company or corporate change other than those specifically referred to in this Section 4.14 above, or in the event of an extraordinary cash dividend, the Committee shall, to the extent deemed appropriate by the Committee, make such adjustments in the number and/or class of shares subject to Options outstanding on the date on which such change occurs, in the exercise price of outstanding Options and/or in such other terms of the Plan and such Options as the Committee may consider appropriate to prevent the enlargement or dilution of rights.

 

 

 

 

(d)           No Other Rights. Except as expressly provided in the Plan or any Option Grant Agreement or as otherwise determined by the Committee at or after the date of grant of an Option, no Participant shall have any rights by reason of any subdivision or consolidation of shares of stock of any class, the payment of any dividends or dividend equivalents, any increase or decrease in the number of shares of stock of any class or any dissolution, liquidation, merger or consolidation of the Company or any other corporation. Except as expressly provided in the Plan, no issuance by the Company of shares of stock of any class, or securities convertible into or exercisable for shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number of shares or amount of other property subject to, or the terms related to, any Option.

 

(e)           Savings Clause. No provision of this Section 4.14 shall be given effect to the extent that such provision would cause any tax to become due under Section 409A of the Code.

 

4.15         Lock-Up Period. Each Participant agrees that, notwithstanding any provision in this Plan or any Option Grant Agreement to the contrary, he or she will not, without the prior written consent of the Board, during the period following the Closing and ending on the date that is 180 days following the Closing (the “Lock-Up Period”), (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock acquired upon the exercise of an Option or otherwise (including without limitation, Shares which may be deemed to be beneficially owned by such Participant in accordance with the rules and regulations of the Securities and Exchange Commission), or (B) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock acquired upon the exercise of an Option or otherwise, whether any such transaction described in clause (A) or (B) above is to be settled by delivery of Shares or such other securities, in cash or otherwise.

 

5              Miscellaneous

 

5.1           Rights as Option Holders. The Participants shall not have any rights as stockholders with respect to any shares of Common Stock covered by or relating to the Options granted (or treated as granted) pursuant to the Plan until the date the Participants become the registered owners of such shares of Common Stock issued in accordance with and subject to the governing documents of the Company. Except as otherwise expressly provided in Section 4.14 hereof, no adjustment to the Options shall be made for dividends.

 

5.2           No Special Employment Rights. Nothing contained in the Plan shall confer upon the Participants any right with respect to the continuation of their Employment or interfere in any way with the right of the Company or any of its subsidiaries, subject to the terms of any separate employment agreements to the contrary, at any time to terminate such Employment or to increase or decrease the compensation of the Participants from the rate in existence at the time of the grant of any Option.

 

5.3           No Obligation to Exercise; No Compensation. The grant to the Participants of the Options shall impose no obligation upon the Participants to exercise such Options. Furthermore, the expiration of an Option prior to the exercise thereof shall not entitle the Participant or any Permitted Transferee or other Person to any compensation or payment in respect thereof. Any Option granted to a Participant shall be treated as a one-time special grant and shall not be pensionable or treated as the regular part of the Participant’s employment or compensation.

 

 

 

 

5.4           Intentionally Omitted.

 

5.5           Intentionally Omitted.

 

5.6           Notices. Each notice and other communication hereunder shall be in writing and shall be given and shall be deemed to have been duly given on the date it is delivered in person or by electronic mail, on the next business day if delivered by overnight mail or other reputable overnight courier, or the third business day if sent by registered mail, return receipt requested, to the parties as follows:

 

If to the Company:

 

Global Business Travel Group, Inc.

666 Third Avenue

New York, New York 10017
Attention: General Counsel

 

If to the Participant, to its most recent address shown on records of the Company or its subsidiary;

 

or in each case to such other address as any party may have furnished to the others in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

 

5.7           Descriptive Headings. The headings in the Plan are for convenience of reference only and shall not limit or otherwise affect the meaning of the terms contained herein.

 

5.8           Severability. In the event that any one or more of the provisions, subdivisions, words, clauses, phrases or sentences contained herein, or the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision, subdivision, word, clause, phrase or sentence in every other respect and of the remaining provisions, subdivisions, words, clauses, phrases or sentences hereof shall not in any way be impaired, it being intended that all rights, powers and privileges of the Company and Participants shall be enforceable to the fullest extent permitted by law; provided, however, that if any restrictive covenant contained herein is determined to be too broad in duration, scope or in any other respect, it shall be reformed to be enforceable to the maximum extent permitted by applicable law.

 

 

 

 

5.9          Governing Law; Venue. The provisions of the Plan and any Option Grant Agreement and all claims or disputes arising out of or based upon the Plan, any Option Grant Agreement and any Option or relating to the subject matter hereof or thereof shall be governed by, and construed and enforced in accordance with, the domestic substantive laws of the State of New York, without regard to the provisions governing choice or conflict of laws or rules that would cause the application of the domestic substantive laws of any other jurisdiction. The Company and each Participant hereby agree and consent to be subject to the exclusive jurisdiction of the courts of the State of New York sitting in New York County and the United States District Court for the Southern District of New York in any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, the Plan, any Option or any Option Grant Agreement. The Company and each Participant hereby irrevocably waive, to the fullest extent permitted by law, (i) any objection that it may now or hereafter have to laying venue of any suit, action or proceeding brought in such courts, and (ii) any claim that any suit, action or proceeding brought in such courts has been brought in an inconvenient forum.

 

5.10        Exchange Act Exemption. Notwithstanding anything to the contrary in the Plan or any Option Grant Agreement, until such time as the Company becomes subject to the reporting requirements of Sections 12 or 15(d) of the Exchange Act or is otherwise no longer relying on the exemption from registration under the Exchange Act set forth in Rule 12h-1(f) under the Exchange Act (the “Employee Options Exemption”) in connection with the issuance of Common Stock upon the exercise of Options, the Plan, the Options and the Option Grant Agreements are intended to comply with the Employee Options Exemption and, accordingly, to the maximum extent permitted, the Plan, such Options and such Option Grant Agreements shall be interpreted to be in compliance therewith.

 

5.11         Waiver of Jury Trial. By accepting an Option under the Plan, each Participant waives any right to a trial by jury in any action, proceeding or counterclaim concerning any rights under the Plan and any Option Grant Agreements, or under any amendment, waiver, consent, instrument, document or other agreement delivered or which in the future may be delivered in connection therewith, and agrees that any such action, proceedings or counterclaim shall be tried before a court and not before a jury. By accepting an Option, each Participant certifies that no officer, representative, or attorney of the Company or any of its Affiliates has represented, expressly or otherwise, that the Company or any of its Affiliates would not, in the event of any action, proceeding or counterclaim, seek to enforce the foregoing waivers.

 

5.12         Limitation of Liability. Notwithstanding anything to the contrary in the Plan, neither the Company, any Majority Stockholder or Juweel Investor, nor any Affiliate of the Company or any Juweel Investor, nor the Committee, nor the Effective Date Chairman, nor any Person acting on behalf of the Company, any Majority Stockholder, Juweel Investor or Affiliate of the Company or any Juweel Investor, or the Committee or Effective Date Chairman, will be liable to any Participant or to the estate or beneficiary of any Participant or to any other holder of an Option by reason of any acceleration of income, or any additional tax (including any interest and penalties), asserted by reason of the failure of an Option to satisfy the requirements of Section 422 or Section 409A of the Code or by reason of Section 4999 of the Code, or otherwise asserted with respect to the Option.

 

 

 

 

5.13         Applicable Regulatory Guidance and Clawback/Adjustment. Notwithstanding any provision contained herein to the contrary, except as expressly provided in any Option Grant Agreement, the Committee and/or management of the Company may in its discretion clawback Options, reduce or eliminate the amount of the Option that would otherwise be earned, clawback dividend equivalents paid in respect of Options, clawback shares of Common Stock acquired upon the exercise of an Option and/or clawback proceeds received from the sale of shares of Common Stock acquired upon the exercise of an Option if, in the Committee’s or management’s sole judgment, such reduction or elimination is appropriate. Circumstances where such negative discretion may be appropriate include instances where the Participant participated (which could include, depending on the circumstances, participation in a supervisory capacity by act or omission) in an activity without appropriate consideration of the risk to the Company or its Affiliates, such as the failure to provide any certifications pursuant to Section 3.6(h) of the Shareholders Agreement. Examples include but are not limited to the Participant’s failure to raise, identify and/or assess in a timely manner and as reasonably expected risks, such as a material compliance, legal, regulatory or reputational risk. Similarly, any Performance-Based Options are also subject to a clawback if such Options vest as a result of misstated financial results. Additionally, in the event that any Performance-Based Options vest as a result of misstated financial results, the Committee may, in its discretion, adjust the Options to reflect the corrected financial results.

 

5.14         Parachute Payments. If there is a change in ownership or effective control, or of a substantial portion of the assets, of the Company within the meaning of Section 280G of the Code (a “280G CIC”) and as of the effective time of such 280G CIC, (a) Section 280G of the Code applies to the Company or any of its subsidiaries at such time and (b) the Company is eligible to rely on the exemption available under Section 280G(b)(5)(B) to corporations no stock of which is readily tradeable on an established securities market, then, unless otherwise determined by the Committee or as otherwise provided below, if the Company determines that any right to receive any payment or other benefit under this Plan or the Option Grant Agreement (including, without limitation, the acceleration of the vesting and/or exercisability of the Option and taking into account the effect of this Section) to or for the benefit of the Participant (the “Payments”), would, in whole or part when aggregated with any other right, payment or benefit to or for the Participant under all other agreements, arrangements or benefit plans cause any such Payments or other rights, payments or benefits to be nondeductible by the Company or its subsidiaries (or other person making such payment or providing such benefit) as a result of Section 280G of the Code and/or would subject the Participant to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”) then, to the extent necessary (whether or not sufficient) to make the Payments and all such rights, payments and benefits deductible and to exempt the Payments and all such rights, payments and benefits from the Excise Tax (but only to such extent and after taking into account any reduction in the Payments relating to Section 280G of the Code under any other plan, arrangement or agreement), the Option and any other right, payment or benefit under this Plan, any Option Grant Agreement or otherwise shall not become exercisable, vested or paid. Notwithstanding any other provision of this Plan, the foregoing provisions shall not apply to reduce such amounts if the amounts that would otherwise be nondeductible under Section 280G of the Code and/or would subject the Participant to the Excise Tax are waived by the applicable Participant in writing and disclosed to and approved by the Company’s stockholders in accordance with Section 280G(b)(5)(B) of the Code and the Department of Treasury regulations thereunder.

 

 

 

 

If there is a 280G CIC and as of the effective time of such 280G CIC, (a) Section 280G of the Code applies to the Company or its subsidiaries, and (b) the Company is not eligible to rely on the exemption available under Section 280G of the Code to corporations no stock of which is readily tradeable on an established securities market, then in the event that it shall be (or is subsequently) determined that any Payment would, in whole or part when aggregated with any other right, payment or benefit to or for the Participant under all other agreements, arrangements or benefit plans, cause any such Payments or other rights, payments or benefits to be subject to the Excise Tax, then the Payments and all such rights, payments and benefits shall be reduced (or appropriately adjusted) to an amount that is one dollar less than the smallest amount that would give rise to the Excise Tax (the “Reduced Amount”) if such Reduced Amount would be greater than the net after-tax proceeds (taking into account both the Excise Tax and any interest or penalties payable with respect to the Excise Tax) of the unreduced Payments and all such other rights, payments and benefits. If the Payments and such other rights, payments or benefits are required to be reduced hereunder, there shall be no discretion in the ordering of the Payments and such other rights, payments or benefits so reduced, and such reductions shall be applied in the order which results in the best economic benefit to the Participant; and to the extent such ordering of reductions is economically equivalent, such Payments and such other rights, payments or benefits shall be reduced on a pro rata basis.

 

5.15        Code Section 409A. This Plan, all Options and all Option Grant Agreements are intended to be exempt from, or compliant with, Code Section 409A and shall be construed and interpreted accordingly.

 

[End of Plan]

 

 

 

Exhibit 10.17 

 

GBTG TIME BASED OPTION GRANT AGREEMENT

 

THIS GBTG TIME BASED OPTION GRANT AGREEMENT (this “Agreement”), is made as of this      day of      , 2022 between Global Business Travel Group, Inc., a Delaware corporation (the “Company”) and [_________] (the “Participant”).

 

WHEREAS, on May 27, 2022, the Company completed a transaction whereby the Company acquired GBT JerseyCo Limited, a company limited by shares incorporated under the laws of Jersey (“GBT JerseyCo”) and became the parent company of the GBT group (the “Transaction”);

 

WHEREAS, immediately prior to the closing of the Transaction, the Participant held the options (each, a “GBT JerseyCo Option”) to acquire Common Stock of GBT JerseyCo set forth on Schedule A attached hereto (“Schedule A”) that were granted on the dates set forth on Schedule A and were subject to the terms of the GBT JerseyCo Limited Amended and Restated Management Incentive Plan (as amended and/or restated from time to time, the “JerseyCo Plan”);

 

WHEREAS, in connection with the Transaction, the GBT JerseyCo Plan was assumed by the Company, was amended to reflect the Transaction and was renamed the Global Business Travel Group, Inc. Management Incentive Plan (the “Plan”) (a copy of the Plan is attached hereto as Exhibit A);

 

WHEREAS, pursuant to Section 4.14 of the GBT JerseyCo Plan, all of the GBT JerseyCo Options treated as granted under the GBT JerseyCo Plan that were outstanding immediately prior to the closing of the Transaction were converted into options to purchase shares of the Class A Common Stock of the Company, par value $0.0001 per share (“Common Stock”) and were treated as if they were originally granted under the Plan; and

 

WHEREAS, the Company and the Participant desire to enter into this Agreement to reflect the terms of each GBTG Option (as defined below).

 

NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows:

 

1.             GBTG Option. At the closing of the Transaction (which occurred on May 27, 2022), each GBT JerseyCo Option was cancelled and in exchange for each such cancelled GBT JerseyCo Option, Participant was granted an option to purchase the number of shares of Common Stock of the Company and at a per share exercise price set forth on Schedule B attached hereto (“Schedule B,” and each such option, a “GBTG Option”), subject to the terms set forth in this Agreement and in the Plan. All dollar amounts set forth in this Agreement are in US Dollars. Participant acknowledges and agrees that until Participant executes this Agreement and returns a copy to the Company, Participant has no rights with respect to any GBTG Option.

 

1

 

 

2.             Incorporation of Plan. All terms, conditions and restrictions of the Plan are incorporated herein and made part hereof as if stated herein. If there is any conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan, as interpreted by the Committee, shall govern, except to the extent this Agreement expressly changes the default provisions contained in the Plan as permitted pursuant to the Plan, in which case the applicable provisions of this Agreement shall govern. All capitalized terms used and not defined herein shall have the meaning given to such terms in the Plan.

 

3.             Vesting; Termination of Employment. Each GBTG Option shall vest as set forth on Schedule B. All matters relating to a termination of Employment with respect to each GBTG Option (including, without limitation, the duration of any exercise period, the continued vesting of any GBTG Option and the time at which unvested as well as unexercised GBTG Options are forfeited) shall be as set forth in the Plan, or if different than the Plan, as set forth in the Time Based Option Grant Agreement granting the GBT JerseyCo Option in respect of which the applicable GBTG Option was granted.

 

4.             Method of Exercise; Expiration. Each GBTG Option may be exercised only in accordance with Sections 4.10 and 4.11 of the Plan. Unless expired, cancelled, forfeited or terminated earlier (in each case, as set forth herein or in the Plan), each GBTG Option shall expire (and shall thereafter cease to be outstanding and exercisable) at the time set forth on Schedule B.

 

5.             Adjustment. Each GBTG Option shall be subject to adjustment as provided in the Plan (including, without limitation, Section 4.14 thereof).

 

6.             Construction of Agreement. Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such jurisdiction or rendering that or any other provision of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant (including, without limitation, any of the Restrictive Covenants (as defined below)) should be deemed invalid, illegal or unenforceable because its scope, geographic area or any other term is considered excessive, such covenant shall be modified so that the offending provision is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Company shall be implied by the Company’s forbearance or failure to take action. This Agreement is intended to be exempt from Section 409A of the Code and shall be interpreted accordingly.

 

7.             Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party hereto upon any breach or default of any party under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provision or condition of this Agreement, shall be in a writing signed by the parties hereto and shall be effective only to the extent specifically set forth in such writing.

 

2

 

 

8.             Limitation on Transfer. Each GBTG Option shall be exercisable only by the Participant or the Participant’s Permitted Transferee(s), as determined in accordance with the terms of the Plan (including without limitation the requirement that the Participant obtain the prior written approval by the Committee of any proposed Transfer to a Permitted Transferee during the lifetime of the Participant). Each Permitted Transferee shall be subject to all the restrictions, obligations, and responsibilities as apply to the Participant under the Plan and this Agreement and shall be entitled to all the rights of the Participant under the Plan, provided that in respect of any Permitted Transferee, each GBTG Option shall become vested, exercisable and expire based on the Employment and termination of Employment of the Participant, and shall otherwise be subject to forfeiture and clawback as if no such Transfer had occurred. Shares of Common Stock issued upon exercise of a GBTG Option or otherwise delivered in satisfaction of a GBTG Option will bear such legends as may be required or provided for under the terms of the Plan.

 

9.             Restrictive Covenants. The Participant agreed to certain non-competition, non-solicitation, non-disparagement and confidential information restrictive covenants in Section 11 of each GBT JerseyCo Option agreement pursuant to which a GBT JerseyCo Option was granted or evidenced (as the same may have been modified by any amendment or side letter to any such option agreement, the “Restrictive Covenants”). The Participant hereby ratifies and reaffirms the Restrictive Covenants as if set forth in this Agreement, and agrees that such Restrictive Covenants are incorporated herein by reference as if fully set forth in this Agreement. The Participant agrees to comply with the Restrictive Covenants. The Participant agrees that notwithstanding anything in the Plan or this Agreement to the contrary, in the event that the Participant violates any of the Restrictive Covenants, the Participant shall forfeit each GBTG Option (as the successor to Participant’s GBT JerseyCo Options) in full for no consideration (regardless of the extent to which a GBTG Option is vested at the time of such violation), and the Company and its subsidiaries may seek other remedies at law and at equity.

 

10.           Integration. This Agreement and the Plan contain the entire understanding of the parties hereto with respect to the subject matter hereof. There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and in the Plan. This Agreement and the Plan supersede all prior agreements and understandings between the parties hereto with respect to the subject matter hereof. In addition, the Participant acknowledges and agrees that, (i) the Participant does not hold, or have a right to acquire, any equity or other securities of GBT III, B.V. or GBT JerseyCo, (ii) each GBT JerseyCo Option agreement (including all amendments and side letters thereto) evidencing a GBT JerseyCo Option is terminated (except for the Restrictive Covenants, as described herein), (iii) the Participant has no rights under or with respect to any of the GBT JerseyCo Options (and none of the GBT JerseyCo Options are outstanding or may be exercised) and (iv) this Agreement and the Plan govern the terms of each of the GBTG Options. For clarification, notwithstanding anything to the contrary in this Agreement or any other instrument entered into by Participant, the Restrictive Covenants in the GBT JerseyCo Options shall remain in full force and effect and are not superseded by this Agreement but shall be in addition to this Agreement.

 

3

 

 

11.           Taxes. To the extent required by applicable federal, state, local or foreign law, the Participant shall make arrangements satisfactory to the Company for the satisfaction of any tax obligations that arise with respect to any GBTG Option, and to the extent permitted by law, the Company and its subsidiaries (in their sole discretion) may withhold from any amounts, payment or property (including shares of Common Stock to be acquired upon exercise of such GBTG Option) otherwise payable to the Participant an amount sufficient to satisfy any such tax obligations. Withholding of taxes in the form of shares of Common Stock shall not occur at a rate that equals or exceeds the rate that would result in liability accounting treatment.

 

12.           Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.

 

13.           Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the domestic substantive laws of the State of New York, without regard to the provisions governing choice or conflict of laws or rules that would cause the application of the domestic substantive laws of any other jurisdiction.

 

14.           Effect on Employment. Nothing contained in this Agreement shall confer upon the Participant any right with respect to the continuation of Employment or interfere in any way with the right of the Company or any of its subsidiaries, subject to the terms of any separate written employment agreements to the contrary, at any time and for any reason to terminate such Employment or to increase or decrease the compensation of the Participant from the rate in existence on the date of this Agreement.

 

15.           Participant Representations; Acknowledgments

 

(a)             By executing this Agreement, the Participant hereby represents and warrants to the Company that the statements in this Section 15(a) are true and correct as of the date of this Agreement and will continue to be true and correct as long as any GBTG Option is outstanding:

 

(i)             he/she is an “accredited investor,” as defined in Rule 501(a) under the Securities Act, which means that you are:

 

(1)             A person whose individual net worth, or joint net worth with your spouse, exceeds U.S. $1,000,000 (without including the person’s primary residence as an asset); or

 

(2)             A person whose income exceeded U.S. $200,000 in each of the two most recent years, or joint income with your spouse exceeded U.S. $300,000 in each of those years, and you have a reasonable expectation of reaching the same income level in this year;

 

4

 

 

(ii)             he/she possesses such expertise, knowledge, and sophistication in financial and business matters generally and that he/she is capable of evaluating the merits and risks of receiving each GBTG Option; and

 

(iii)             he/she has had access to all of the information and individuals with respect to each GBTG Option and his/her receipt thereof, including without limitation information relating to the Company and risks related to any investment therein, that he/she deems necessary to make a complete evaluation thereof.

 

(b)            The Participant hereby acknowledges receipt of a copy of the Plan. The Participant hereby acknowledges that all decisions, determinations and interpretations of the Committee in respect of the Plan, this Agreement and any GBTG Option shall be final and conclusive. The Participant further acknowledges that if, following the date the Participant receives a GBTG Option pursuant to this Agreement, the Company determines that any of the representations made by the Participant under this Section 15 is inaccurate, the grant of such GBTG Option to the Participant pursuant to this Agreement may, in the sole discretion of the Board, be rescinded and deemed null and void.

 

16.           Lock-Up. In place of executing the Management Stockholders Agreement referenced in the GBT JerseyCo Option Plan or any option granted thereunder, which Participant agrees Participant would be required to do absent the Company’s waiver of such requirement, Participant hereby agrees to the following lock-up provision: Participant agrees that, notwithstanding any provision in this Agreement, in the Plan or in any other agreement to the contrary, Participant will not, without the prior written consent of the Board, during the period following the closing of the Transaction and ending on the date that is 180 days following the closing of the Transaction (the “Lock-Up Period”), (A) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock acquired upon the exercise of any GBTG Option or otherwise (including without limitation, shares which may be deemed to be beneficially owned by the Participant in accordance with the rules and regulations of the Securities and Exchange Commission), or (B) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of shares of Common Stock acquired upon the exercise of any GBTG Option or otherwise, whether any such transaction described in clause (A) or (B) above is to be settled by delivery of shares or such other securities, in cash or otherwise.

 

5

 

 

17.           Special Compensation. Each GBTG Option is a special one-time grant to the Participant and there is no expectation that any future equity award will be granted to the Participant nor any entitlement to any such award.  No GBTG Option is part of the Participant’s regular wages, salary or compensation and shall not be pensionable, nor shall any GBTG Option be included in any severance, termination or pay in lieu of notice obligation or calculation to the Participant.

 

[Remainder of Page Intentionally Blank]

 

6

 

 

IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed by its duly authorized officer and said Participant has hereunto signed this Agreement on his/her own behalf, thereby representing that he/she has carefully read and understands this Agreement and the Plan as of the day and year first written above.

 

Global Business Travel Group, Inc.
   
   
By:
  Title:
   
   
  [Participant’s name]

 

7

 

 

SCHEDULE A

 

GBT JerseyCo Options

 

GBT JerseyCo Option Date of Grant Number of Shares Subject to GBT JerseyCo Option as of Immediately Prior to Closing Exercise Price as of Immediately Prior to Closing Vesting Schedule Expiration Date
GBT JerseyCo Option 1          
GBT JerseyCo Option 2          

 

A-1

 

 

SCHEDULE B

 

GBTG Options

 

GBT JerseyCo Option Being Replaced Number of Shares of Common Stock Subject to GBTG Option Per Share Exercise Price of GBTG Option Vesting Schedule of GBTG Option Expiration Date of GBTG Option
GBT JerseyCo Option 1     Same as GBT JerseyCo Option 1 Same as GBT JerseyCo Option 1
GBT JerseyCo Option 2     Same as GBT JerseyCo Option 2 Same as GBT JerseyCo Option 2

 

B-1

 

 

EXHIBIT A

 

Global Business Travel Group Inc. Management Incentive Plan

 

 

 

 

Exhibit 21.1

 

 

Subsidiary Jurisdiction of
Incorporation
30 SecondsToFly (Thailand) Co., Ltd. Thailand
Advanced Reservation Centre S.r.l. Italy
ATLAS REISEN GmbH Germany
ATLAS/ RVS Reiseburo Verwaltungs Service GmbH Germany
Banks and Sadler Inc. United States, Delaware
Banks Sadler Group Limited United Kingdom
Banks Sadler Limited United Kingdom
Banks Sadler SARL France
Chartwell Travel Ltd United Kingdom
Church Street (Belgium) CVBA Belgium
Compagnie Dens Ocean NV Belgium
DER Business Travel GmbH Germany
Egencia (China) Information Technology Co., Ltd. China
Egencia AS Norway
Egencia Australia Pty Limited Australia
Egencia Belgium Belgium
Egencia Canada Corp. Canada
Egencia Cayman Holdings Ltd. Cayman Islands
Egencia Denmark A/S Denmark
Egencia Europe France

 

 

 

 

 

Egencia Finland Oy Finland
Egencia France France
Egencia GmbH Germany
Egencia Holdings UK Ltd United Kingdom
Egencia Hong Kong Limited China
Egencia K.K. Japan
Egencia LLC United States, Nevada
Egencia Netherlands B.V. Netherlands
Egencia New Zealand Limited New Zealand
Egencia New Zealand Limited - Branch - Australia Australia
Egencia Norway AS Norway
Egencia Philippines, Inc. Philippines
Egencia Singapore Pte. Ltd. Singapore
Egencia South Africa (PTY) LTD South Africa
Egencia Sweden AB Sweden
Egencia Switzerland Sarl Switzerland
Egencia Travel India Private Limited India
Egencia UK Ltd United Kingdom
Eurocentre (Travel) Limited United Kingdom
eWings.com GmbH Germany
Executive Travel Associates LLC United States, New York

 

 

 

 

 

Farnborough Limited United Kingdom
Ferieverden AS Norway
GB Travel Canada Inc. Canada
GBT (Thailand) Co. Ltd. Thailand
GBT 2 (Thailand) Co. Ltd. Thailand
GBT Australia Pty Ltd Australia
GBT CR, s.r.o. Czech Republic
GBT CR, s.r.o. - Branch - Slovakia Slovakia
GBT Deutschland GmbH Germany
GBT Euro Travel Holdings B.V. Netherlands
GBT Finland Limited Finland
GBT Group Services B.V. Netherlands
GBT II Argentina S.R.L. Argentina
GBT II B.V. Netherlands
GBT III B.V. Netherlands
GBT III B.V. - Branch - Geneva Switzerland
GBT III B.V. - Branch - Germany Germany
GBT III B.V. - Branch - Ireland Ireland
GBT India Private Limited India
GBT Sweden AB Sweden
GBT Travel Services Colombia S.A.S. Colombia

 

 

 

 

 

GBT Travel Services Mexico S. de R.L. de C.V. Mexico
GBT Travel Services UK Limited United Kingdom
GBT UK Topco Limited United Kingdom
GBT US III LLC United States, Delaware
GBT US LLC United States, Delaware
Global Business Travel (Singapore) Pte. Ltd. Singapore
Global Business Travel ApS Denmark
Global Business Travel AS Norway
Global Business Travel Brasil Limitada Brazil
Global Business Travel BV Belgium
Global Business Travel France France
Global Business Travel Holding (Japan) Ltd Japan
Global Business Travel Holdings (Hong Kong) Limited Hong Kong
Global Business Travel Holdings Limited United Kingdom
Global Business Travel Hong Kong Limited Hong Kong
Global Business Travel Hungary Ltd. Hungary
Global Business Travel Poland S.A. Poland
Global Business Travel Spain, S.L.U. Spain
Global Business Travel Switzerland Ltd. Switzerland
H T General Agency Limited United Kingdom
Hanseat Reiseburo GmbH Germany

 

 

 

 

 

Hogg Robinson (1987) Pension Scheme Trustee Limited United Kingdom

Hogg Robinson (Transport and Financial Services) Dormants Limited

United Kingdom
Hogg Robinson (Travel) Limited United Kingdom
Hogg Robinson Australia Holdings Pty Limited Australia
Hogg Robinson Australia Pty Ltd Australia

Hogg Robinson Business Travel Hungary Limited Liability Company

Hungary
Hogg Robinson Group Limited United Kingdom
Hogg Robinson Holdings B.V. Netherlands
Hogg Robinson Holdings Canada Inc. Canada
Hogg Robinson Hong Kong Limited Hong Kong
Hogg Robinson Italia S.r.L. Italy
Hogg Robinson Limited United Kingdom
Hogg Robinson Money Matters Limited United Kingdom
Hogg Robinson Nordic AB Sweden
Hogg Robinson Nordic AB - Branch – Denmark Denmark
Hogg Robinson Nordic AS Norway
Hogg Robinson Nordic Holdings AS Norway
Hogg Robinson USA Holdings LLC United States, Delaware
Hogg Robinson USA LLC United States, New York
HRG Belgium NV Belgium
HRG Debtco Limited United Kingdom

 

 

 

 

 

HRG Mobility Services GmbH Germany
KDS Deutschland GmbH Germany
KDS UK Limited United Kingdom
Klee Data System SAS France
Medical Projects International Limited United Kingdom
Ovation Travel Group UK Limited United Kingdom
Ovation Travel, LLC United States, Delaware
Rennie Hogg Ships Agents Limited United Kingdom
Sepals Limited Gibraltar
Taiwan Global Business Travel Agency Taiwan Limited Taiwan
TripNavigator-Egencia Spain SL Spain
Wilson Albany Limited United Kingdom

 

 

 

 

 

 

Exhibit 99.1

 

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

Page 

   
Unaudited Condensed Consolidated Financial Statements of GBT JerseyCo Limited  
Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021 2
Condensed Consolidated Statements of Operations for the three months ended March 31, 2022, and March 31, 2021 (Unaudited) 3
Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2022, and March 31, 2021 (Unaudited) 4
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022, and March 31, 2021 (Unaudited) 5
Condensed Consolidated Statements of Changes in Total Shareholders’ Equity for the three months ended March 31, 2022, and March 31, 2021 (Unaudited) 6
Notes to the Condensed Consolidated Financial Statements (Unaudited) 7

 

 1 

 

 

GBT JERSEYCO LIMITED

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   As of 

 

(in $ millions except share and per share data)

 

March 31,
2022

   December 31,
2021
 
   (Unaudited)     
Assets        
Current assets:          
Cash and cash equivalents  $329   $516 
Accounts receivable (net of allowances for doubtful accounts of $5 and $4 as of March 31, 2022 and December 31, 2021, respectively)   562    381 
Due from affiliates   9    18 
Prepaid expenses and other current assets   143    137 
Total current assets   1,043    1,052 
Property and equipment, net   213    216 
Equity method investments   16    17 
Goodwill   1,346    1,358 
Other intangible assets, net   718    746 
Operating lease right-of-use assets   54    59 
Deferred tax assets   300    282 
Other non-current assets   46    41 
Total assets  $3,736   $3,771 
Liabilities, preferred shares, and shareholders’ equity          
Current liabilities:          
Accounts payable  $289   $137 
Due to affiliates   41    41 
Accrued expenses and other current liabilities   448    519 
Current portion of operating lease liabilities   20    21 
Current portion of long-term debt   3    3 
Total current liabilities   801    721 
Long-term debt, non-current, net of unamortized debt discount and debt issuance costs   1,020    1,020 
Deferred tax liabilities   119    119 
Pension liabilities   316    333 
Long-term operating lease liabilities   55    61 
Other non-current liabilities   26    23 
Total liabilities   2,337    2,277 
Commitments and Contingencies (see note 11)          
Preferred shares (par value $€0.00001; 3,000,000 shares authorized; 1,500,000 shares issued and outstanding as of both March 31, 2022 and December 31, 2021; redemption amount of $165 and $160 as of March 31, 2022 and December 31, 2021, respectively)   165    160 
Shareholders’ equity:          
Voting ordinary shares (par value €0.00001; 40,000,000 shares authorized; 36,000,000 shares issued and outstanding as of both March 31, 2022 and December 31, 2021)        
Non-Voting ordinary shares (par value €0.00001; 15,000,000 shares authorized; 8,413,972 shares issued and outstanding as of both March 31, 2022, and December 31, 2021)        
Profit Shares (par value €0.00001; 800,000 shares authorized, issued and outstanding as of both March 31, 2022 and December 31, 2021)        
Management Incentive Plan Shares (par value €0.00001, 4,764,000 shares authorized; Nil shares issued and outstanding as of both March 31, 2022 and December 31, 2021)        
Additional paid-in capital   2,558    2,560 
Accumulated deficit   (1,156)   (1,065)
Accumulated other comprehensive loss   (169)   (162)
Total equity of the Company’s shareholders   1,233    1,333 
Equity attributable to noncontrolling interest in subsidiaries   1    1 
Total shareholders’ equity   1,234    1,334 
Total liabilities, preferred shares, and shareholders’ equity  $3,736   $3,771 

 

See notes to condensed consolidated financial statements

 

 2 

 

 

GBT JERSEYCO LIMITED

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(Unaudited)

 

   Three months ended March 31, 
(in $ millions, except share and per share data)  2022   2021 
Revenue  $350   $126 
Costs and expenses:          
Cost of revenue (excluding depreciation and amortization shown separately below)   173    82 
Sales and marketing   72    43 
Technology and content   90    57 
General and administrative   65    39 
Restructuring charges   2     
Depreciation and amortization   44    34 
Total operating expenses   446    255 
Operating loss   (96)   (129)
Interest expense   (19)   (11)
Other income, net       5 
Loss before income taxes and share of losses from equity method investments   (115)   (135)
Benefit from income taxes   25    22 
Share of losses from equity method investments   (1)   (1)
Net loss   (91)   (114)
Net loss attributable to non-controlling interests in subsidiaries        
Net loss attributable to the Company   (91)   (114)
Preferred shares dividend   (5)    
Net loss attributable to the shareholders of the Company’s ordinary shares  $(96)  $(114)
           
Loss per share attributable to the shareholders of the Company’s ordinary shares – Basic and Diluted:          
Loss per share  $(2.15)  $(3.16)
 Weighted average number of shares outstanding   44,413,972    36,000,000 

 

See notes to condensed consolidated financial statements

 

 3 

 

 

GBT JERSEYCO LIMITED

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

(Unaudited)

 

   Three months ended March 31, 
(in $ millions)  2022   2021 
Net loss  $(91)  $(114)
Other comprehensive loss, net of tax:          
Change in currency translation adjustments, net of tax   (16)   (9)
Unrealized gains on cash flow hedge, net of tax   9     
Other comprehensive loss, net of tax   (7)   (9)
Comprehensive loss   (98)   (123)
Comprehensive loss attributable to non-controlling interests in subsidiaries        
Preferred Shares dividend   (5)    
Comprehensive loss attributable to the Company  $(103)  $(123)

 

See notes to condensed consolidated financial statements

 

 4 

 

 

GBT JERSEYCO LIMITED

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(Unaudited)

 

   Three months ended March 31, 
(in $ millions)  2022   2021 
Operating activities:          
Net loss  $(91)  $(114)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   44    34 
Deferred tax benefit   (26)   (22)
Equity-based compensation   3     
Release of allowance for doubtful accounts       (2)
Share of losses from equity-method investments   1    1 
Amortization of debt discount and debt issuance costs   1    1 
Pension contributions   (6)   (5)
Changes in working capital, net of effects from acquisitions          
Accounts receivables   (189)   6 
Prepaid expenses and other current assets   (3)   38 
Due from affiliates   9    (4)
Due to affiliates       1 
Accounts payable, accrued expenses and other current liabilities   93    (43)
Other   10    (5)
Net cash used in operating activities   (154)   (114)
           
Investing activities:          
Purchase of property and equipment   (21)   (9)
Business acquisition, net of cash acquired       (53)
Net cash used in investing activities   (21)   (62)
           
Financing activities:          
Proceeds from issuance of preferred shares       50 
Proceeds from senior secured prior tranche B-2 term loans       50 
Repayment of senior secured term loans   (1)   (2)
Repayment of finance lease obligations   (2)   (2)
Payment of lender fees and issuance costs for senior secured term loans facilities       (6)
Payment of offering costs   (4)    
Capital distributions to shareholders       (1)
Net cash (used in) from financing activities   (7)   89 
Effect of exchange rates changes on cash, cash equivalents and restricted cash   (3)   (3)
Net decrease in cash, cash equivalents and restricted cash   (185)   (90)
Cash, cash equivalents and restricted cash, beginning of period   525    593 
Cash, cash equivalents and restricted cash, end of period  $340   $503 
           
Supplemental cash flow information:          
Cash (received) paid for income taxes (net of refunds)  $(1)  $2 
Cash paid for interest (net of interest received)  $18   $10 
Dividend accrued on preferred shares  $5   $ 
Non-cash additions for operating lease right-of-use assets  $   $11 
Deferred offering costs accrued during the period  $4   $ 

 

See notes to condensed consolidated financial statements

 

 5 

 

 

GBT JERSEYCO LIMITED

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL SHAREHOLDERS’ EQUITY

 

(Unaudited)

 

   Voting ordinary shares   Non-Voting ordinary shares   Profit shares        

Accumulated

   Total equity
   Equity
attributable
to non-
    
(in $ millions, except share data)  Number   Amount   Number   Amount   Number   Amount   Additional
paid-in
capital
   Accumulated
deficit
   other
comprehensive
loss
   of the
Company’s
shareholders
   controlling
interest in
subsidiaries
   Total
shareholders’
equity
 
Balance as of December 31, 2021   36,000,000        8,413,972        800,000        2,560    (1,065)   (162)   1,333    1    1,334 
Dividend on preferred shares (see note –13)                           (5)           (5)       (5)
Equity-based compensation                           3            3        3 
Other comprehensive loss, net of tax                                   (7)   (7)       (7)
Net loss                               (91)       (91)       (91)
Balance as of March 31, 2022   36,000,000   $    8,413,972    $    800,000   $   $2,558   $(1,156)  $(169)  $1,233   $1   $1,234 

 

   Voting ordinary shares   Non-Voting ordinary shares   Profit shares        

Accumulated

   Total equity
   Equity
attributable
to non-
    
(in $ millions, except share data)  Number   Amount   Number   Amount   Number   Amount   Additional
paid-in
capital
   Accumulated
deficit
   other
comprehensive
loss
   of the
Company’s
shareholders
   controlling
interest in
subsidiaries
   Total
shareholders’
equity
 
Balance as of December 31, 2020   36,000,000                800,000        1,752    (592)   (179)   981    3    984 
Other comprehensive loss, net of tax                                   (9)   (9)       (9)
Net loss                               (114)       (114)       (114)
Balance as of March 31, 2021   36,000,000                800,000        1,752    (706)   (188)   858    3    861 

 

Management incentive plan shares have been excluded from the above statement as there are no related shares issued and outstanding as of both March 31, 2022 and March 31, 2021.

 

See notes to condensed consolidated financial statements

 

 6 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

(1)Business Description and Basis of Presentation

 

GBT JerseyCo Limited (“Global Business Travel” or “GBT”) was incorporated on November 28, 2019 under the Companies (Jersey) Law 1991. GBT is a joint venture with 50% of its voting shares held by American Express Travel Holdings Netherlands Coöperatief U.A. (“Amex Coop”), a resident of the Netherlands and the other 50% of its voting shares held by Juweel Investors (SPC) Limited (a successor entity of Juweel Investors Limited) (“Juweel”), a resident of Cayman Islands. Following acquisition of the Egencia business (“Egencia”) from EG Corporate Travel Holdings LLC (“Expedia”) on November 1, 2021, GBT issued 8,413,972 non-voting ordinary shares to Expedia and as of March 31, 2022, Amex Coop, Juweel and Expedia own approximately 40.5%, 40.5% and 19.0%, respectively, of the equity interest in GBT, excluding preferred shares, Profit Shares, MIP Shares (see note 13 – Shareholders’ Equity) and MIP Options (see note 12 – Equity-Based Compensation) as of such date. GBT is a tax resident in the United Kingdom (“U.K.”). GBT and its consolidated subsidiaries are herein referred to as the “Company.”

 

On December 2, 2021, GBT entered into a definitive business combination agreement (“Business Combination Agreement”) with Apollo Strategic Growth Capital (“APSG”), a special purpose acquisition company, listed on the New York Stock Exchange (the “Business Combination”). The Business Combination closed on May 27, 2022 upon satisfaction of the closing conditions provided in the Business Combination Agreement, including approval by APSG’s shareholders and certain regulatory approvals. Upon closing of the Business Combination, APSG was renamed as Global Business Travel Group, Inc. (“GBTG”). The Business Combination will be accounted for as a reverse recapitalization, with no assets or liabilities fair valued or any goodwill and other intangible assets recognized (see note 18 – Subsequent Events).

 

The Company has one reportable segment.

 

Business Description

 

The Company provides a business-to-business travel platform with a full suite of differentiated, technology-enabled solutions to business travelers and corporate clients, suppliers of travel content (such as airlines, hotels, ground transportation and aggregators) and third-party travel agencies. The Company manages end-to-end logistics of corporate travel and provides a link between businesses, their employees, travel suppliers and other industry participants.

 

Impact of COVID-19

 

Since March 2020, the outbreak of the novel strain of the coronavirus, COVID-19 (the "COVID-19 pandemic"), has severely restricted the level of economic activity around the world and continues to have an unprecedented effect on the global travel and hospitality industry. In response to the COVID-19 pandemic, many governments around the world implemented, and continue to implement, a variety of measures to reduce the spread of COVID-19 pandemic, including travel restrictions, practicing social distancing, quarantine advisories or requirements, restrictions on business operations and closure of non-essential businesses. The various government measures to contain spread of COVID-19 pandemic significantly reduced business travel and hotel bookings and continue to have a material adverse impact on the number of new bookings.

 

While many countries have vaccinated a reasonable proportion of their population, the rate and pace of vaccination globally, the severity and duration of resurgence, as well as uncertainty over the efficacy of the vaccines against new variants of the virus, may contribute to delays in economic recovery. Overall, the ultimate impact and duration of the COVID-19 pandemic remains uncertain and will depend upon future developments, which are difficult to predict.

 

However, with the spread of the virus now being contained to varying degrees in certain countries during different times, travel restrictions have been lifted and clients have become more comfortable traveling, particularly to domestic locations. This has led to a moderation of the more severe declines in business travel bookings experienced at certain points since the COVID-19 pandemic began. Despite the continued negative impact of the COVID-19 pandemic on the Company’s business, the Company has seen improvement in its transaction volume during the second half of 2021 and first quarter of 2022 as compared to the prior year / period as COVID-19 vaccines continued to be administered and some travel restrictions relaxed. The Company incurred a net loss of $91 million and had cash outflows from operations of $154 million during the three months ended March 31, 2022 compared to a net loss of $114 million and cash outflows from operations of $114 million during the three months ended March 31, 2021.

 

 7 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

As of March 31, 2022, the Company’s pro forma liquidity was over $700 million and primarily consisted of:

 

$557 million of pro forma cash and cash equivalents (comprising of (i) $329 million of cash and cash equivalents as of March 31, 2022 (ii) $128 million net proceeds received upon closing of the Business Combination and (iii) $100 million of principal amount of senior secured tranche B-3 term loans borrowed in May 2022 (see note 10 – Long-term Debt and note 18 – Subsequent Events)),

 

$100 million of currently undrawn commitments remaining under the senior secured tranche B-3 term loan facilities, which are available on a delayed-draw basis until mid-June 2022, subject to certain customary borrowing conditions, and

   

$50 million of undrawn commitments under the senior secured revolving credit facility (subject to the satisfaction of applicable borrowing conditions and compliance with applicable covenants related to borrowings thereunder).

 

On May 25, 2022, the Company issued a notice to the administrative agent under the senior secured credit agreement requesting an additional borrowing of the last remaining $100 million of delayed draw commitments under the senior secured tranche B-3 term loan facilities (see note 10 – Long-term Debt and note 18 – Subsequent Events). Further, the Company continues to consider measures to optimize efficiency and reduce costs as they become necessary. The Company also continued to access government funding in some of its operating territories.

 

The Company believes this liquidity is important given its limited ability to predict its future financial performance due to the uncertainty associated with the COVID-19 pandemic and the measures implemented in response to the COVID-19 pandemic. Based on the financial mitigation measures taken and available funding capacity and the expected Business Combination transaction, the Company believes it has adequate liquidity to meet its expected future operating, investing and financing needs of the business for a minimum period of twelve months after the date the condensed consolidated financial statements are available for issuance.

 

Basis of Presentation

 

The Company’s condensed consolidated financial statements include the accounts of GBT, GBT’s wholly-owned subsidiaries and entities controlled by GBT. There are no entities that have been consolidated due to control through operating agreements, financing agreements or as the primary beneficiary of a variable interest entity. The Company reports the non-controlling ownership interests in subsidiaries that are held by third-party owners as equity attributable to non-controlling interests in subsidiaries on the condensed consolidated balance sheets. The portion of income or loss attributable to third-party owners for the reporting periods is reported as net income (loss) attributable to non-controlling interests in subsidiaries on the condensed consolidated statements of operations. The Company has eliminated intercompany transactions and balances in its condensed consolidated financial statements.

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial reporting. The Company has included all adjustments necessary for a fair presentation of the results of the interim period. These adjustments consist of normal recurring items. The Company’s interim unaudited condensed consolidated financial statements are not necessarily indicative of results that may be expected for any other interim period or for the full year. These interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2021.

 

 8 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, supplier revenue, collectability of receivables, depreciable lives of property and equipment, acquisition purchase price allocations including valuation of acquired intangible assets and goodwill, equity-based compensation, valuation of operating lease right-of-use (“ROU”) assets, impairment of goodwill, other intangible assets, long-lived assets and investments in equity method investments, valuation allowances on deferred income taxes and contingencies. Actual results could differ materially from those estimates.

 

The COVID-19 pandemic has created and may continue to create significant uncertainty in macroeconomic conditions, which may cause further business disruptions and adversely impact the Company’s results of operations. As a result, many of the Company’s estimates and assumptions required increased judgment. As events continue to evolve and additional information becomes available, the Company’s estimates may change materially in future periods.

 

(2)Recently Issued accounting Pronouncements

 

Accounting Pronouncements – Adopted

 

Income Taxes

 

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes” that amends the guidance to simplify accounting for income taxes, including elimination of certain exceptions in current guidance related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments (changes from a subsidiary to equity method investments and vice versa), etc. The Company adopted this guidance on January 1, 2022 and did not have any material impact on its condensed consolidated financial statements upon the adoption of this guidance.

 

Freestanding Equity-Classified Written Call Options

 

In May 2021, the FASB issued ASU No. 2021-04, “Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” which provides a principles-based framework for issuers to account for a modification or exchange of freestanding equity-classified written call options. The new guidance clarifies that to the extent applicable, issuers should first reference other accounting principles to account for the effect of a modification. If other accounting principles are not applicable, the guidance clarifies whether to account for the modification or exchange as (1) an adjustment to equity, with the related earnings per share implications, or (2) an expense, and if so, the manner and pattern of recognition. The accounting depends on the substance of the transaction, such as whether the modification or exchange is the result of raising equity, a financing transaction, or some other event. The Company adopted this guidance on January 1, 2022 and did not have any material impact on its condensed consolidated financial statements upon the adoption of this guidance.

 

Disclosures about Government Assistance

 

In November 2021, the FASB issued ASU No. 2021-10, “Disclosures by Business Entities about Government Assistance” which provides for disclosures by business entities about government assistance. The amendments in this update require disclosures about transactions with a government that have been accounted for by analogizing to a grant or contribution accounting model to increase transparency about (1) the nature and types of transactions, (2) the accounting for the transactions, and (3) the effect of the transactions on an entity’s financial statements. The guidance is effective for the Company for annual periods beginning after December 15, 2021, with early application permitted, and can be applied either prospectively or retrospectively. The Company adopted this guidance on January 1, 2022 and did not have any material impact on its condensed consolidated financial statements upon the adoption of this guidance.

 

 9 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Governments of multiple countries extended several programs to help businesses during the COVID-19 pandemic through loans, wage subsidies, tax relief or deferrals and other financial aid. The Company has participated in several of these government programs. A substantial portion of these government support payments were to ensure that the Company continues to pay and maintain the employees on its payroll and does not make them redundant as the demand for travel services significantly reduced due to the Covid-19 pandemic. During the three months ended March 31, 2022 and 2021, the Company recognized in its condensed consolidated statements of operations government grants and other assistance benefits for salaries and wages (mainly furlough support payments) of $6 million and $26 million, respectively, as a reduction of expenses. As at March 31, 2022 and December 31, 2021, the Company had a receivable of $8 million and $6 million, respectively, in relation to such government grants, that is included in the accounts receivable balance in the condensed consolidated balance sheets. These relate to payments that are expected to be received under the government programs where the Company has met the qualifying requirements and it is probable that payments will be received. The majority of this receivable is expected to be received during 2022.

 

Accounting Pronouncements – Not Yet Adopted

 

Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, a new guidance on the measurement of credit losses for financial assets measured at amortized cost, which includes accounts receivable. The new guidance replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. The adoption date of this guidance was subsequently deferred by one year and is now effective for the Company for annual periods beginning after December 15, 2022, including interim periods within those annual periods. The Company is currently evaluating the impact of the adoption of the guidance on its condensed consolidated financial statements.

 

Reference rate reforms

 

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This ASU provides expedients and exceptions to existing guidance on contract modifications and hedge accounting that is optional to facilitate the market transition from a reference rate, including the London Interbank Offered Rate (“LIBOR”) expected to be discontinued because of reference rate reform, to a new reference rate. The provisions of this ASU would impact contract modifications and other changes that occur while LIBOR is phased out. The guidance is effective upon issuance and generally can be applied to applicable contract modifications through December 31, 2022. The Company is in the process of evaluating the optional relief guidance provided within this ASU and is also reviewing its debt and hedge instruments that utilizes LIBOR as the reference rate. The Company will continue to evaluate and monitor developments and its assessment of this guidance during the LIBOR transition period.

 

Contracts with Customers Acquired in a Business Combination

 

In October 2021, the FASB issued ASU No. 2021-08, “Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” to add contract assets and contract liabilities acquired in a business combination to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with the revenue recognition guidance. This updated guidance amends the current business combination guidance where an acquirer generally recognizes such items at fair value on the acquisition date. The guidance is effective for the Company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and is to be applied prospectively to all business combinations that occur on or after the date of initial application. The Company is currently evaluating the impact of the adoption of the guidance on its condensed consolidated financial statements.

 

 10 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

(3)Revenue from Contracts with Customers

 

The Company disaggregates revenue based on (i) Travel Revenue which include all revenue relating to servicing a transaction, which can be air, hotel, car rental, rail or other travel-related booking or reservation and (ii) Product and Professional Services Revenue which include all revenue relating to using the Company’s platform, products and value-added services. The following table presents the Company’s disaggregated revenue by nature of service. Sales and usage-based taxes are excluded from revenue.

 

   Three months ended March 31, 
(in $ millions)  2022   2021 
Travel revenue  $256   $62 
Products and professional services revenue   94    64 
Total revenue  $350   $126 

 

Payments from clients and suppliers are generally due within 30 to 45 days of invoicing.

 

Contract Balances

 

Contract assets represent the Company’s right to consideration in exchange for services transferred to a customer when that right is conditioned on the Company’s future performance obligations. Contract liabilities represent the Company’s obligation to transfer services to a customer for which the Company has received consideration (or the amount is due) from the customer.

 

The opening and closing balances of the Company’s accounts receivables, net, contract assets and contract liabilities are as follows:

 

       Contract assets
(liabilities)
  

 

Contract liabilities

 

 

(in $ millions)

 

Accounts
receivables, net (1)

  

Client incentives, net
(non-current)

  

Deferred revenue
(current)

 
Balance as of March 31, 2022  $554   $(8)  $25 
Balance as of December 31, 2021  $375   $(3)  $18 

 

 

(1)Accounts receivables, net, exclude balances not related to contracts with customers.

 

Deferred revenue is recorded when a performance obligation has not been satisfied but an invoice has been raised. Cash payments received from customers in advance of the Company completing its performance obligations are included in deferred revenue in the Company's condensed consolidated balance sheets. The Company generally expects to complete its performance obligations under the contracts within one year. During the three months ended March 31, 2022, the cash payments received or due in advance of the satisfaction of the Company’s performance obligations were offset by $5 million of revenue recognized that was included in the deferred revenue balance as of December 31, 2021.

 

Remaining Performance Obligations

 

As of March 31, 2022, the aggregate amount of the transaction price allocated to the Company’s remaining performance obligations was approximately $29 million, which the Company expects to recognize as revenue as performance obligations are satisfied over the next 24 months.

 

The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected term of one year or less.

 

 11 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

(4)Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets consist of:

 

   As of 

 

(in $ millions)

 

March 31,
2022

   December 31,
2021
 
Prepaid expenses  $48   $42 
Income tax receivable   31    32 
Deferred offering costs   24    21 
Value added and similar taxes receivables   14    11 
Other prepayments and receivables   26    31 
Prepaid expenses and other current assets  $143   $137 

 

(5)Property and Equipment, Net

 

Property and equipment, net consist of:

 

   As of 
(in $ millions) 

March 31,
2022

   December 31,
2021
 
Capitalized software for internal use  $306   $304 
Computer equipment   67    65 
Leasehold improvements   52    52 
Furniture, fixtures and other equipment   6    6 
Capital projects in progress   14    9 
    445    436 
Less: accumulated depreciation and amortization   (232)   (220)
Property and equipment, net  $213   $216 

 

Depreciation and amortization expense for the three months ended March 31, 2022 and 2021 was $21 million and $19 million, respectively. Depreciation and amortization includes $14 million and $13 million of amortization related to capitalized software for internal use for the three months ended March 31, 2022 and 2021, respectively.

 

(6)Business Acquisition

 

There was no business acquisition during the three months ended March 31, 2022.

 

Acquisition of Ovation Group

 

On January 21, 2021, the Company, through its wholly-owned subsidiary, GBT US LLC, acquired all of the outstanding shares of Ovation Travel, LLC, (along with its subsidiaries, the “Ovation Group”) for a total cash purchase consideration of $57 million (including approximately $4 million of deferred consideration), net of cash acquired. The results of Ovation Group’s operations have been included in the consolidated financial statements of the Company since the date of its acquisition.

 

The terms of the acquisition included contingent consideration of approximately $4 million and is subject to the continued employment of certain Ovation employees for a specified duration of employment as set out under the business purchase agreement. The Company accrues for this expense as compensation expense.

 

The fair value of the acquisition was allocated primarily to goodwill of $36 million, amortizing intangible assets of $29 million (corporate client relationships of $25 million and Tradenames of $4 million) and net liabilities assumed of $8 million. Goodwill generated from the acquisition is attributable to acquired workforce and expected synergies from centralized management and future growth. The acquired corporate client relationships and tradenames are being amortized over their estimated useful lives of 10 years and 5 years, respectively. The Company incurred $3 million in acquisition related costs which was expensed as incurred.

 

 12 

 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

The amount of revenue and net loss of the Ovation Group since the acquisition date included in the condensed consolidated statements of operations for the three month period ended March 31, 2021 was $2 million and $4 million, respectively. Assuming an acquisition date of January 1, 2020, the unaudited pro forma revenue and net loss of the Company for the three months ended March 31, 2021 would not have been materially different to the amount of revenue and net loss presented in the condensed consolidated statements of operations for the three months ended March 31, 2021. The pro forma financial information adjusts for the effects of material business combination items primarily related to amortization of acquired intangible assets and the corresponding income tax effects.

 

Acquisition of Egencia

 

On November 1, 2021, the Company completed its acquisition of Egencia, a business-to-business digital travel management company serving corporate clients, from an affiliate of Expedia, Inc., EG Corporate Travel Holdings LLC (“Expedia”). As purchase consideration for this acquisition, the Company issued 8,413,972 non-voting ordinary shares, fair value of which was determined to be $816 million. As a result, Expedia became an indirect holder of non-voting ordinary shares of GBT, which represents approximately 19% of GBT’s equity interests, excluding preferred shares, Profit Shares, MIP Options and MIP Shares. This value was determined on the basis of the estimated total enterprise value of GBT (post acquisition of Egencia) and calculated based on a multiple of Adjusted EBITDA. Such equity interest is subject to changes based on final debt/cash and working capital adjustments. The acquisition of Egencia will complement the Company’s existing business and is expected to further accelerate its growth strategy in the small-to-medium-sized enterprise sector.

 

The Company’s preliminary purchase price allocation is based on information that is currently available. The preliminary purchase price allocations are subject to, among other items, debt/cash and working capital adjustments and further analysis of tax accounts, including deferred tax assets and liabilities.

 

The financial results of Egencia have been included in the Company’s consolidated financial statements since the date of its acquisition. The amount of revenue and net loss of the Egencia business for the three months ended March 31, 2022 were $66 million and $28 million, respectively. Further, during the three months ended March 31, 2022, the Company made an adjustment of $2 million to Goodwill (see note 7 – Goodwill and Other Intangible Assets, Net).

 

Assuming an acquisition date of January 1, 2020, the unaudited pro forma revenue and net loss of the Company for the three months ended March 31, 2021 would have been $148 million and $201 million, respectively.

 

(7)Goodwill and Other Intangible Assets, Net

 

The following table sets forth changes in goodwill during the three months ended March 31, 2022:

 

(in $ millions)  Amount 
Balance as of December 31, 2021  $1,358 
Egencia acquisition adjustments   2 
Currency translation adjustments   (14)
Balance as of March 31, 2022  $1,346 

 

There were no goodwill impairment losses recorded for the three months ended March 31, 2022 and 2021 and there are no accumulated goodwill impairment losses as of March 31, 2022.

 

 13 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

The following table sets forth the Company’s other intangible assets with definite lives as of March 31, 2022 and December 31, 2021:

 

  

March 31, 2022

  

December 31, 2021

 

 

(in $ millions)

 

 

Cost

   Accumulated
depreciation
  

 

Net

  

 

Cost

   Accumulated
depreciation
  

 

Net

 
Trademarks/tradenames  $115   $(64)  $51   $115   $(62)  $53 
Corporate client relationships   815    (209)   606    815    (189)   626 
Supplier relationship   254    (194)   60    254    (188)   66 
Travel partner network   4    (3)   1    4    (3)   1 
Other intangible assets  $1,188   $(470)  $718   $1,188   $(442)  $746 

 

Amortization expense relating to definite-lived intangible assets was $23 million and $15 million for the three months ended March 31, 2022 and 2021, respectively.

 

(8)Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of:

 

   As of 

 

(in $ millions)

 

March 31,
2022

   December 31,
2021
 
Accrued payroll and related costs  $160   $198 
Accrued operating expenses   131    147 
Accrued restructuring costs (see note 9)   57    69 
Client deposits   45    59 
Deferred revenue   25    18 
Value added and similar taxes payable   9    6 
Income tax payable   7    7 
Other payables   14    15 
Accrued expenses and other current liabilities  $448   $519 

 

(9)Restructuring Charges

 

The table below sets forth accrued restructuring cost included in accrued expenses and other current liabilities, for the three months ended March 31, 2022:

 

(in $ millions)  Employee related   Facility   Total 
Balance as of December 31, 2021  $64   $5   $69 
Charges   2        2 
Cash settled   (13)   (1)   (14)
Balance as of March 31, 2022   53    4    57 

 

 14 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

(10) Long-term Debt

 

The outstanding amount of the Company’s long-term debt consists of:

 

   As of 

 

(in $ millions)

  March 31,
2022
   December 31,
2021
 
Senior Secured Credit Agreement          
Principal amount of senior secured initial term loans (Maturity – August 2025) (1)  $241   $242 
Principal amount of senior secured tranche B-3 term loans (Maturity – December 2026) (2)   800    800 
Principal amount of senior secured revolving credit facility (Maturity – August 2023) (3)        
    1,041    1,042 
Less: Unamortized debt discount and debt issuance costs   (18)   (19)
Total debt, net of unamortized debt discount and debt issuance costs   1,023    1,023 
Less: Current portion of long-term debt   3    3 
Long-term debt, non-current, net of unamortized debt discount and debt issuance costs  $1,020   $1,020 

 

 

(1)Stated interest rate of LIBOR + 2.50% as of March 31, 2022 and December 31, 2021.

(2)Stated interest rate of LIBOR + 6.50% (with a LIBOR floor of 1.00%) as of March 31, 2022 and December 31, 2021.

(3)Stated interest rate of LIBOR + 2.25% as of March 31, 2022 and December 31, 2021.

 

During the three months ended March 31, 2022, the Company repaid the contractual quarterly installment of $1 million of principal amount of senior secured initial term loans. During the three months ended March 31, 2021, the Company had borrowed $50 million principal amount of senior secured tranche B-2 term loans, which were fully repaid in December 2021.

 

As of March 31, 2022, the Company had $200 million of unutilized commitments remaining under the senior secured tranche B-3 term loan facilities that are available on a delayed-draw basis for a six-month period after the date of such initial borrowings in December 2021, subject to certain customary borrowing conditions (“Tranche B-3 DDTL Facility”). The Company is required to pay a fee of 3.00% per annum on the actual daily unused commitments under the Tranche B-3 DDTL Facility, payable quarterly in arrears. On May 19, 2022, the Company borrowed a principal amount of $100 million of senior secured tranche B-3 term loans under the Tranche B-3 DDTL Facility. Further, on May 25, 2022, the Company issued a notice to the administrative agent under the senior secured credit agreement requesting an additional borrowing of the last remaining $100 million of the delayed draw commitments under the Tranche B-3 DDTL Facility (see note 18 – Subsequent Events).

 

At the option of Group Services B.V., a wholly owned subsidiary of GBT (the “Borrower”), upon prior written notice, amounts borrowed under one or more of the senior secured credit facilities (as selected by the Borrower) may be voluntarily prepaid, and/or unused commitments thereunder may be voluntarily reduced or terminated, in each case, in whole or in part, at any time without premium or penalty (other than (i) any applicable prepayment premium required to be paid pursuant to the senior secured credit agreement, and (ii) customary breakage costs in connection with certain prepayments of loans bearing interest at a rate based on LIBOR). Subject to certain exceptions set forth in the senior secured credit agreement, the Borrower is required to prepay the senior secured term loans with (i) 50% (subject to leverage-based step-downs) of annual excess cash flow (as defined in the credit agreement) in excess of a threshold amount, (ii) 100% (subject to leverage-based step-downs) of the net cash proceeds from certain asset sales and casualty events, subject to customary reinvestment rights, (iii) 100% of the net cash proceeds from the incurrence of certain indebtedness and (iv) other than in connection with the consummation of the business combination with APSG pursuant to the Business Combination Agreement, 50% of the net cash proceeds from the consummation of any initial public offering (or similar transaction) of the common stock of GBT (or a parent entity thereof).

 

 15 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

The senior secured revolving credit facility has (i) a $30 million sublimit for extensions of credit denominated in certain currencies other than U.S. dollars, (ii) a $10 million sublimit for letters of credit, and (iii) a $10 million sublimit for swingline borrowings. Extensions of credit under the senior secured revolving credit facility are subject to customary borrowing conditions. The Borrower is required to pay a fee of 0.375% per annum on the average daily unused commitments under the senior secured revolving credit facility, payable quarterly in arrears. As of both March 31, 2022 and December 31, 2021, no borrowings or letters of credit were outstanding under the senior secured revolving credit facility.

 

Interest on the senior secured credit facilities is payable quarterly in arrears (or, if earlier in the case of LIBOR loans, at the end of the applicable interest period). The effective interest rate on the senior secured term loans for the three months ended March 31, 2022 was approximately 7%.

 

Security; Guarantees

 

GBT UK TopCo Limited, a wholly-owned direct subsidiary of GBT, and certain of its direct and indirect subsidiaries, as guarantors (such guarantors, collectively with the Borrower, the “Loan Parties”), provide an unconditional guarantee, on a joint and several basis, of all obligations under the senior secured credit facilities and under cash management agreements and swap contracts with the lenders or their affiliates (with certain limited exceptions). Subject to certain cure rights, as of the end of each fiscal quarter, at least 70% of the consolidated total assets of the Loan Parties and their subsidiaries must be attributable, in the aggregate, to the Loan Parties; provided that such coverage test shall instead be calculated based on 70% of Consolidated EBITDA (as defined in the senior secured credit agreement) of the Loan Parties and their subsidiaries for the four prior fiscal quarters, commencing with the first quarterly test date after January 2021 on which Consolidated EBITDA of the Loan Parties and their subsidiaries exceeds $100 million. Further, the lenders have a first priority security interest in substantially all of the assets of the Loan Parties.

 

Covenants

 

The senior secured credit agreement contains various affirmative and negative covenants, including certain financial covenants (see below) and limitations (subject to exceptions) on the ability of the Loan Parties and their subsidiaries to: (i) incur indebtedness or issue preferred stock; (ii) incur liens on their assets; (iii) consummate certain fundamental changes (such as acquisitions, mergers, liquidations or changes in the nature of the business); (iv) dispose of all or any part of their assets; (v) pay dividends or other distributions with respect to, or repurchase, any equity interests of any Loan Party or any equity interests of any direct or indirect parent company or subsidiary of any Loan Party; (vi) make investments, loans or advances; (vii) enter into transactions with affiliates and certain other permitted holders; (viii) modify the terms of, or prepay, any of their subordinated or junior lien indebtedness; (ix) make certain changes to a Loan Party’s entity classification for U.S. federal income tax purposes or certain intercompany transfers of a Loan Party’s assets if, as a result thereof, an entity would cease to be a Loan Party due to adverse tax consequences; (x) enter into swap contracts; and (xi) enter into certain burdensome agreements.

 

The senior secured credit agreement also requires that an aggregate amount of Liquidity (as defined in the senior secured credit agreement) equal to at least $200 million be maintained, which, from and after the effectiveness of December 2021 amendments to the senior secured credit agreement is tested on a monthly basis.

 

The senior secured credit agreement also contains a financial covenant applicable solely to the senior secured revolving credit facility. Such financial covenant requires the first lien net leverage ratio (calculated in a manner set forth under the senior secured credit agreement) to be less than or equal to 3.25 to 1.00 as of the last day of any fiscal quarter on which the aggregate principal amount of outstanding loans and letters of credit under the senior secured revolving credit facility exceeds 35% of the aggregate principal amount of the senior secured revolving credit facility. The senior secured credit agreement provides that such financial covenant is suspended for a limited period of time if an event that constitutes a “Travel MAC” (as defined in the senior secured credit agreement) has occurred and the Loan Parties are unable to comply with such covenant as a result of such event. Such financial covenant did not apply for the period ended March 31, 2022.

 

 16 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

As of March 31, 2022, the Company was in compliance with all applicable covenants under the senior secured credit agreement.

 

Events of Default

 

The senior secured credit agreement contains default events (subject to certain materiality thresholds and grace periods), which could require early prepayment, termination of the senior secured credit agreement or other enforcement actions customary for facilities of this type. As of March 31, 2022, no event of default existed under the senior secured credit agreement.

 

(11)Commitments and Contingencies

 

Purchase Commitment

 

In the ordinary course of business, the Company makes various commitments to purchase goods and services from specific suppliers, including those related to capital expenditures. As of March 31, 2022, the Company had approximately $206 million of outstanding non-cancellable purchase commitments, primarily relating to service, hosting and licensing contracts for information technology, of which $71 million relates to the twelve months ending March 31, 2023. These purchase commitments extend through 2026.

 

Guarantees

 

The Company has obtained bank guarantees in respect of certain travel suppliers and real estate lease agreements amounting to $25 million. Certain of these bank guarantees require the Company to maintain cash collateral which has been presented as restricted cash within other non-current assets in the Company’s condensed consolidated balance sheet.

 

Legal Contingencies

 

The Company recognizes legal fees as incurred when the legal services are provided.

 

Based on its current knowledge, and taking into consideration its litigation-related liabilities, the Company believes it is not a party to any pending legal proceeding or governmental examination that would have a material adverse effect on the Company’s consolidated financial condition or liquidity.

 

(12)Equity-Based Compensation

 

The Company has an equity-based long-term management incentive plan (the “Plan”), the GBT JerseyCo Limited Amended and Restated Management Incentive Plan, originally adopted on June 30, 2014 and most recently amended and restated on December 2, 2021 under which options to purchase a class of GBT shares (referred to as “MIP Shares”) are generally granted to key management employees and certain directors of the Company. As of March 31, 2022, approximately 4.8 million MIP Shares were reserved for issuance under the Plan. Any MIP Shares issued under the Plan (i) will be non-voting; (ii) will entitle the holder thereof to proportionally share profits of the Company in accordance with separate allocation and distribution provisions set forth under the amended and restated shareholders agreement between Amex Coop and Juweel (the “Shareholders Agreement”); and (iii) will entitle the holder thereof to receive dividends declared on MIP Shares issued under the Plan, from time to time in accordance with allocation and distribution provisions set forth in the Shareholders Agreement. As a general matter, neither the options granted nor any MIP Shares issued under the Plan will be entitled to share in any profits or capital of GBT until certain thresholds of distributions to Amex Coop and Juweel have been satisfied. Under the current terms, neither the options granted nor any MIP Shares issued under the Plan will trade or be listed on any stock exchange. As of March 31, 2022, no MIP Shares were issued and outstanding under the Plan.

 

 17 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Under the Plan, the Company grants options to purchase MIP Shares to employees, which generally vest in three to five equal installments on each anniversary of the grant date. The options have a contractual life of ten years from the grant date. There are no performance conditions associated with the vesting of the options. The exercise price of options granted under the plan is 100% of the fair market value of the shares subject to the award, determined as of the date of grant, or such higher amount as the compensation committee may determine in connection with the grant.

 

The Black Scholes model is used to determine the weighted average fair value of the options. A market and income approach is used to determine the enterprise fair value of the Company. The equity fair value is then allocated to the options. There were no new grants or any forfeitures of the options for the three months ended March 31, 2022.

 

Total equity-based compensation expense recognized in the Company’s condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 amount to $3 million and $0, respectively, and is included within general and administrative expense on the condensed consolidated statements of operations. The Company expects compensation expense, related to unvested stock options, of approximately $32 million to be recognized over the remaining weighted average period of 2.7 years.

 

Upon the closing of Business Combination as discussed in note 1 - Business Description and Basis of Presentation, GBTG adopted the Amended & Restated Global Business Travel Group, Inc. Management Incentive Plan (the “GBTG MIP”) which superseded the existing GBT Management Incentive Plan, as amended and restated, from time to time. Pursuant to the terms of the GBT MIP, all options granted under the GBT MIP that were outstanding at the closing were converted into options to purchase shares of common stock of GBTG (“GBTG MIP Options”) and were treated as if they were originally granted under the GBTG MIP. Generally, the vesting and forfeiture terms of the GBTG MIP Options held by executive officers of GBT continue to be the same as provided under the GBT MIP. All GBT MIP options that were outstanding immediately prior to the closing of the Business Combination, whether vested or unvested, were equitably converted into GBTG’s MIP Options.

 

(13)Shareholders’ Equity

 

In August 2020, the then-existing shareholders of GBT entered into equity commitment letters with GBT pursuant to which each of Amex Coop and Juweel, in their respective capacities as shareholders of GBT, committed to provide up to $150 million each (up to $300 million in the aggregate) of preferred equity financing to GBT, subject to the terms and conditions set forth therein (the “Shareholders Equity Commitments”). The Shareholders Equity Commitments were originally scheduled to survive for a period of one year from the date of execution, which termination date was extended later to August 2022. As of March 31, 2022, the Company has an amount of $150 million available under Shareholders Equity Commitments that can be drawn at a future date until the earlier of August 2022 and closing of the Business Combination. The Shareholders Equity Commitments will terminate on closing of the Business Combination.

 

The following classes of GBT shares were issued and outstanding as of March 31, 2022:

 

Preferred Shares: GBT’s amended memorandum and articles of association includes authorized share capital consisting of 3 million preferred shares of nominal value €0.00001 per preferred share, as a class of share with no voting rights. Subject to the terms of the Shareholders Agreement, the holders of preferred shares are entitled to receive, when, as and if declared by the board of directors of GBT out of funds of GBT legally available therefor, cumulative dividends at the rate of 12% per share per annum; provided, that if any preferred share remains issued and outstanding following September 15, 2023, the dividend rate with respect to such preferred share increases to 14% per share per annum from and after September 15, 2023, for so long as such preferred share remains outstanding. Further, the total amount of dividends on such preferred shares is computed on a cumulative basis and compounded daily in accordance with the terms of the Shareholders Agreement and GBT’s memorandum and articles of association. The preferred shares are redeemable, in whole or in part, at the election of the Company, at any time at a price per share equal to the unreturned capital contributions associated with such preferred share plus accrued and unpaid cumulative dividends thereon to the date of redemption.

 

 18 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

There was no issuance of preferred shares during the three months ended March 31, 2022; however, the Company accrued a dividend of $5 million, for the three months ended March 31, 2022, on the outstanding balance of preferred shares. During the three months ended March 31, 2021, the Company issued 500,000 preferred shares in equal proportion to Amex Coop and Juweel for a total consideration of $50 million. As the preferred shares of GBT were issued to the ordinary shareholders, although the preferred shares are redeemable at the option of GBT, these have been classified as mezzanine equity.

 

Upon closing of the Business Combination on May 27, 2022, GBT redeemed, in full, the outstanding amount of preferred shares, including dividends accrued thereon (see note 18 – Subsequent Events). Upon redemption, all the preferred shares were cancelled and the Shareholders Equity Commitment terminated.

 

Voting Ordinary Shares: GBT has authorized 40 million of voting ordinary shares of nominal value €0.00001 per voting ordinary share representing, as a class, a right to equity capital and profits of the Company. This class of shares has voting rights. As of March 31, 2022, the Company had 36 million voting ordinary shares issued and outstanding.

 

Non-Voting Ordinary Shares: GBT has authorized 15 million of non-voting ordinary shares of nominal value €0.00001 per non-voting ordinary share representing, as a class, a right to equity capital and profits of the Company. This class of shares has no voting rights. The Company has 8,413,972 non-voting ordinary shares issued to Juweel that remained outstanding as of March 31, 2022.

 

Profit Shares: GBT has 800,000 authorized, issued and outstanding Profit Shares of nominal value €0.00001 per Profit Share representing, as a class, a right to share in 2% of the Company’s profits. Profit Shares have no voting rights. The entire Profit Shares have been issued to Juweel.

 

MIP Shares: See note 12 - Equity-based Compensation.

 

Upon closing of the Business Combination on May 27, 2022, GBT’s authorized, issued and outstanding shares was changed (see note 18 – Subsequent Events).

 

Transfer Restrictions and Other Shareholder Rights

 

Preferred shares, voting ordinary shares, non-voting ordinary shares and Profit Shares are subject to the terms of the Shareholders’ Agreement, including provisions regarding tax distributions and transfer restrictions. Shares issued under the Plan are subject to a Management Stockholders’ Agreement, which includes customary provisions regarding tax distributions, transfer restrictions and clawbacks, where permissible.

 

Distributions

 

Any payment in respect of the shares is to be allocated among the classes of shares as set out within the Shareholders Agreement.

 

For the three months ended March 31, 2022 and 2021, the Company paid cash of $0 and $1 million, respectively, in relation to accrued capital distribution to cover certain administrative costs of its shareholders. See the discussion above for dividends on preferred shares accrued during the three months ended March 31, 2022.

 

Antidilution and Related Adjustments

 

Notwithstanding anything in the Company’s articles of association, the Board of Directors shall have the right to make adjustments to the rights of the option (or shares issued thereof) holders without the consent of such option (or shares issued thereof) holders as it deems necessary or appropriate to avoid the dilution or enhancement of rights or interests in the event of any change in the capitalization of the Company.

 

 19 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Accumulated Other Comprehensive Income (Loss)

 

Accumulated other comprehensive income (loss) represents certain components of revenues, expenses, gains and losses that are included in comprehensive income (loss) but are excluded from net income (loss). Other comprehensive income (loss) amounts are recorded directly as an adjustment to total equity, net of tax. The changes in the accumulated other comprehensive loss, net of tax, were as follows:

 

(in $ millions)   Currency
translation
adjustments
    Defined
benefit plan
related
    Unrealized gain on
cash flow hedge and
hedge of investments
in foreign subsidiary
    Total accumulated
other comprehensive
loss
 
Balance as of December 31, 2021   $ (38 )   $ (128 )   $ 4     $ (162 )
Net changes during the period, net of tax benefit, $0     (16 )           9       (7 )
Balance as of March 31, 2022   $ (54 )   $ (128 )   $ 13     $ (169 )

 

(in $ millions)   Currency
translation
adjustments
    Defined
benefit plan
related
    Unrealized gain on
cash flow hedge and
hedge of investments
in foreign subsidiary
    Total accumulated
other comprehensive
loss
 
Balance as of December 31, 2020   $ (23 )   $ (160 )   $ 4     $ (179 )
Net changes during the period, net of tax benefit, $0     (9 )                 (9 )
Balance as of March 31, 2021   $ (32 )   $ (160 )   $ 4     $ (188 )

 

(14)Loss per share

 

Basic net income (loss) per share is computed by dividing the net income (loss) available to the Company by the weighted average number of ordinary shares outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to the Company by the weighted average number of ordinary shares outstanding and potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, calculated using the treasury stock method.

 

For each of the three months ended March 31, 2022 and 2021, the Company had less than 1 million of share equivalents primarily associated with the Company’s stock options that were excluded from the calculation of diluted earnings per share as their inclusion would have been antidilutive, as the Company had incurred a loss during the periods.

 

(15)Derivatives and Hedging

 

The Company is subject to market risk exposure arising from changes in interest rates on its term loan, which bears interest at a rate that is based on three-months LIBOR. In order to protect against potential higher interest costs resulting from anticipated increases in LIBOR, in February, 2022, the Borrower entered into an interest rate swap contract that fix the interest rate. The Company’s objective in using an interest rate swap derivative is to mitigate its exposure to increase / variability in LIBOR interest rates. The table below sets out the key terms of the interest rate swap:

 

Notional amount (in $ millions)   Period   Fixed Interest rate
$ 600   March 2022 to March 2025   2.0725 %

 

 20 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

For a portion of its debt, the interest rate swap fixes the variable component of the Company’s interest expense at 2.0725%. The interest rate swap has been designated as a cash flow hedge and is highly effective at offsetting the increases in cash outflows when three-month LIBOR exceeds 2.0725%. Changes in the fair value of the interest rate swap, net of tax, are recognized in other comprehensive income and are reclassified out of accumulated other comprehensive income (loss) and into interest expense when the hedged interest obligations affect earnings.

 

(16)Fair Value Measurements

 

Financial instruments which are measured at fair value, or for which a fair value is disclosed, are classified in the fair value hierarchy, as outlined below, on the basis of the observability of the inputs used in the fair value measurement:

 

Level 1 — Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

Level 2 — Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices in non-active markets or for which all significant inputs, other than quoted prices, are observable either directly or indirectly, or for which unobservable inputs are corroborated by market data.

 

Level 3 — Valuations based on inputs that are unobservable and significant to overall fair value measurement.

 

As of March 31, 2022, the Company’s financial assets and liabilities recorded at fair value on a recurring basis consist of its derivative instrument – interest rate swap. The fair value of interest rate swap has been calculated using a discounted cash flow analysis by taking the present value of the fixed and floating rate cash flows utilizing the forward LIBOR curve and the counterparty’s credit risk, which was determined to be not material.

 

Presented below is a summary of the gross fair value of the Company’s derivative contract, which have been designated as hedging instrument, recorded on the condensed consolidated balance sheets at fair value.

 

          As of 

 

(in $ millions)

 

 

Balance sheet location

  Fair Value
Hierarchy
  

March 31,
2022

   December 31,
2021
 
Interest rate swaps  Other non-current assets   Level 2   $9   $ 

 

The Company does not measure its debt at fair value in its consolidated balance sheets. Where the fair value of the Company’s long-term debt is determined based on quoted prices for identical or similar debt instruments when traded as assets, it is categorized within Level 2 of the fair value hierarchy. Where quoted prices are not available, fair value is estimated using discounted cash flows and market-based expectation of interest rates, credit risks and contractual term of the debt instruments and is categorized within Level 3 of the fair value hierarchy.

 

The fair values of the Company’s outstanding senior secured term loans are as follows:

 

   Fair   As of
March 31, 2022
   As of
December 31, 2021
 

 

(in $ millions)

  Value
Hierarch

 

Carrying
amount (1)

  

Fair
Value

   Carrying
amount (1)
  

Fair

Value

 
Senior secured initial term loans  Level 2  $235   $226   $236   $233 
Senior secured new tranche B-3 term loans  Level 3  $788   $767   $787   $800 

 

 

(1)Outstanding principal amount of senior secured term loans less unamortized debt discount and debt issuance costs.

 

 21 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

The carrying amounts of cash and cash equivalents, accounts receivable, other current assets, accounts payable, and accrued expenses and other current liabilities approximate fair value due to the short-term maturities of these assets and liabilities.

 

(17)Related Party Transactions

 

The following summaries relate to certain related party transactions entered into by the Company with certain of its shareholders, its shareholders affiliates and the Company’s affiliates.

 

Advisory Services Agreement

 

Certares Management Corp. (“Certares”), an indirect equity owner of the Company, provides certain advisory services to the Company for which fees of less than $1 million were incurred for each of the three months ended March 31, 2022 and 2021. As of March 31, 2022 and December 31, 2021, the Company had $5.0 million and $4.4 million as amounts payable to Certares under this agreement. The agreement is expected to terminate upon the closing of the Business Combination.

 

Commercial Agreements

 

The Company has various commercial agreements with the affiliates of Amex Coop. In respect of such agreement, included in the operating costs are costs of approximately $5 million and $2 million in charges from affiliates of Amex Coop for the three months ended March 31, 2022 and 2021, respectively. Revenues also include income from affiliates of Amex Coop for approximately $5 million and $4 million for the three months ended March 31, 2022 and 2021, respectively. Amounts payable to affiliates of Amex Coop under these agreements as of March 31, 2022 and December 31, 2021, were $18 million and $16 million, respectively. Amounts receivable from affiliates of Amex Coop under these agreements was $4 million and $15 million as of March 31, 2022 and December 31, 2021, respectively. In anticipation of, and effective upon, the closing of the Business Combination, the parties agreed to amend the terms of certain of these commercial arrangements.

 

Apart from above, there are certain tax indemnity and other agreements between the Company and affiliates of Amex Coop. Amounts payable to affiliates of Amex Coop in respect of such agreements was $ 2million as of both March 31, 2022 and December 31, 2021. Amounts receivable from affiliates of Amex Coop in respect of such agreements were $0.9 million and $0.3 million as of March 31, 2022 and December 31, 2021, respectively.

 

License of American Express Marks

 

GBT US LLC, a wholly owned subsidiary of GBT, has entered into a royalty-free trademark license agreement with American Express pursuant to which GBT US LLC was granted a license to use, and the right to sublicense to certain subsidiaries of GBT the right to use, the American Express trademarks used in the American Express Global Business Travel and American Express Meetings & Events brands for business travel, business consulting and meetings and events businesses on a royalty-free, exclusive, non-assignable, non-sublicensable (other than as set out in the agreement), and worldwide basis.

 

In connection with the consummation of the business combination with APSG, the parties will amend and restate the foregoing trademark license agreement to grant GBT Travel Services UK Limited (“GBT UK”), an indirect wholly owned subsidiary of GBT, a long-term, 11-year license (unless earlier terminated or extended) pursuant to which GBT UK, all wholly owned operating subsidiaries of GBT’s publicly listed entity and other permitted sublicensees will license the American Express trademarks used in the American Express Global Business Travel brand, transition the American Express Meetings & Events brand to the American Express GBT Meetings & Events brand, and license the American Express trademarks used in the American Express GBT Meetings & Events brand for business travel, meetings and events, business consulting and other services related to business travel (“Business Travel Services”). This amended and restated trademark license agreement will also provide GBT’s publicly listed entity the flexibility to operate non-Business Travel Services businesses under brands that do not use any trademarks owned by American Express, subject to certain permissibility and other requirements.

 

 22 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

Shareholders Agreement

 

GBT has entered into a shareholders’ agreement with its shareholders, which has been amended and restated from time-to-time. The shareholders’ agreement contains agreements among the parties with respect to, among other things, board designation rights, consent rights, drag-along and tag-along rights, pre-emptive rights, registration rights and restrictions on the transfer of GBT shares. The consent rights and restrictions on tag-along, drag-along and pre-emptive rights, as well as certain of the restrictions on transfers of shares under the shareholders agreement, terminate upon the consummation of the business combination with APSG. In connection with the business combination with APSG, the Company will enter into a new shareholders agreement that will supersede the current shareholders agreement and will include provisions with respect to tax matters and corporate governance following the business combination with APSG.

 

Commercial and Operating Agreements with Expedia

 

An affiliate of GBT and an affiliate of Expedia entered into a ten-year term marketing partner agreement to provide the GBT’s corporate clients with access to Expedia group’s hotel content. As a result of this agreement, the Company recognized revenue of $19 million for the three months ended March 31, 2022 and the Company had $9 million and $4 million receivable from the affiliate of Expedia as of March 31, 2022 and December 31, 2021, respectively.

 

GBT UK has entered into a Transition Services Agreement with Expedia, Inc. (the “Egencia TSA”), pursuant to which Expedia, Inc. (an affiliate of Expedia) and its affiliates provide certain transition services to GBT UK and its affiliates to facilitate an orderly transfer of Egencia from Expedia to GBT. For the three months ended March 31, 2022, the total cost charged to the Company was approximately $11 million that was included in the Company’s consolidated statements of operations and as of March 31, 2022 and December 31, 2021 the Company had a payable to Expedia Inc. of $11 million and $8 million, respectively. Further, as of March 31, 2022 and December 31, 2021, Egencia had a net payable of $4 million and $16 million to Expedia primarily on account of pre-acquisition transactions between Egencia and Expedia and as Expedia collected cash on behalf of Egencia for several of Egencia’s transactions during the three months ended March 31, 2022.

 

(18)Subsequent Events

 

The Company has evaluated and recognized or disclosed subsequent events, as appropriate, through June 3, 2022, the date the condensed consolidated financial statements as of and for the three months ended March 31, 2022 were available for issuance.

 

Borrowings under the senior secured credit agreement

 

On May 19, 2022, the Company borrowed a principal amount of $100 million of senior secured tranche B-3 term loans under the $200 million of delayed draw commitments that were established under the Tranche B-3 DDTL Facility. On May 25, 2022, the Company issued a notice to the administrative agent under the senior secured credit agreement requesting an additional borrowing of the last remaining $100 million of delayed draw commitments under the Tranche B-3 DDTL facility. It is expected that the funding of such requested borrowing will be completed on June 9, 2022, subject to certain customary borrowing conditions.

 

Closing of Business Combination with APSG

 

The Business Combination closed on May 27, 2022 upon satisfaction of the closing conditions, including approval by APSG’s shareholders and certain regulatory approvals. Upon closing, APSG was renamed as Global Business Travel Group, Inc. and GBT became a directly subsidiary of GBTG. The Business Combination will be accounted for as a reverse recapitalization, with no asset or liability fair valued or any goodwill and other intangible assets recognized.

 

 23 

 

 

GBT JERSEYCO LIMITED

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(Unaudited)

 

At the closing of the Business Combination:

  

GBT’s class of shares changed and the new shares comprised of: (i) A ordinary shares (ii) B ordinary shares (iii) C Ordinary shares and (iv) Z ordinary shares. The existing GBT shares were converted to new shares based on a conversion ratio as determined under the Business Combination Agreement.

 

GBT issued and sold to GBTG/APSG, and GBTG/APSG subscribed for and purchased from GBT, (i) 56,945,033 number of A ordinary shares of GBT equal to the number of shares of GBTG/APSG class A common stock and (ii) a Z ordinary share of GBT, and after considering payment of certain transaction expenses and redemption of preferred shares of $168 million (including accrued dividends until the date of closing), GBT received net proceeds of $128 million upon closing of the Business Combination.

 

GBTG/APSG issued and sold to GBT, and GBT subscribed for and purchased from GBTG/APSG, 394,448,481 shares of GBTG/APSG’s class B common stock equal to the total number of B ordinary shares of GBT issued in connection with the Business Combination Agreement, and GBT paid to GBTG/APSG the par value amount per share for such share subscription.

 

Juweel, Expedia and Amex Coop (together the “Continuing JerseyCo Owners”) and GBT entered into a class B common stock distribution agreement pursuant to which GBT distributed to the Continuing JerseyCo Owners, and each Continuing JerseyCo Owner accepted from GBT, the shares of class B common stock that GBT acquired in connection with the GBTG/APSG subscription of such shares as discussed above, in partial consideration for the redemption and cancellation of the existing GBT ordinary shares held by the Continuing JerseyCo Owners. Upon such distribution and exchange, GBT’s existing voting, non-voting and profit shares were cancelled.

 

Holders of GBT ordinary shares, profit shares, MIP shares and GBT MIP Options were granted an aggregate of 15,000,000 C ordinary shares, that were allocated among such holders on a pro rata basis. C ordinary shares are “earnout” shares and vest as follows:

 

oOne-half, if the volume-weighted average price (“VWAP”) of class A common stock of GBTG is greater than or equal to $12.50 per share for any 20 trading days within a period of 30 consecutive trading days

 

oOne-half, if the VWAP of class A common stock of GBTG is greater than or equal to $15.00 for any 20 trading days within a period of 30 consecutive trading days

 

To the extent that either of the aforementioned triggering events do not occur within the five year vesting period, such shares will be forfeited and terminated.

 

As a result, after the closing of the Business Combination transaction, GBT had 56,945,033 A ordinary shares, 394,448,481 B ordinary shares and one Z ordinary share issued and outstanding.

 

 24 

 

Exhibit 99.2

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements, and the related notes, included as Exhibit 99.1 in the Current Report on Form 8-K filed with the SEC on June 3, 2022 (the “Report”) to which this Exhibit 99.2 relates. The discussion and analysis below presents our historical results as of and for the periods ended on, the dates indicated. Some of the information contained in this discussion and analysis or set forth elsewhere in this Report, including information with respect to our plans and strategy for our business and related financing, are forward-looking statements that involve risks and uncertainties. You should read the “Risk Factors” section of the Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Unless the context otherwise requires, all references to the “Company,” “we,” “us”, “our” or “GBT” refer to the business of GBT JerseyCo Limited and its subsidiaries.

 

Overview

 

We are the world’s leading business-to-business (“B2B”) travel platform providing a full suite of differentiated, technology-enabled solutions to business travelers and corporate clients, suppliers of travel content (such as airlines, hotels, ground transportation and aggregators) and third party travel agencies.

 

We are at the center of the global B2B travel ecosystem, managing the end-to-end logistics of corporate travel and providing an important link between businesses, their employees, travel suppliers and other industry participants. We service our clients in the following ways:

 

Our travel management solutions (delivered through the portfolio of GBT’s brands, including American Express Global Business Travel, Ovation, Lawyers Travel and Egencia) provide our clients with extensive access to flights, hotel rooms, car rentals and other travel services, including exclusive negotiated content, supported by a full suite of services that allows them to design and operate an efficient travel program and solve complex travel requirements.

 

GBT Partner Solutions extends our platform to our Network Partners who are Travel Management Companies (“TMCs”) and independent advisors, offering them access to our differentiated content and technology. Through GBT Partner Solutions, we aggregate business travel demand serviced by our Network Partners at low incremental cost, which we believe enhances the economics of our platform, generates increased return on investment and expands our geographic and segment footprint.

 

GBT Supply MarketPlace provides travel suppliers with efficient access to business travel clients serviced by our brands and Network Partners. We believe this access allows travel suppliers to benefit from premium demand (which we generally view as demand that is differentially valuable and profitable to suppliers) without incurring the costs associated with directly marketing to, and servicing, the complex needs of our corporate clients. Our travel supplier relationships generate efficiencies and cost savings that can be passed on to our corporate clients.

 

As of April 30, 2022, we served approximately 19,000 corporate clients and more than 260 Network Partners.

 

In June 2014, American Express established joint venture (“JV”) comprising the GBT operations with a predecessor of Juweel Investors (SPC) Limited (“Juweel”) and a group of institutional investors led by an affiliate of Certares. Following the formation of the JV in 2014, we have evolved from a leading TMC into a complete B2B travel platform, becoming one of the leading marketplaces in travel for corporate clients and travel suppliers. Before June 2014, our operations were owned by American Express and primarily consisted of providing business travel solutions for corporate clients.

 

We have operated our business travel, business consulting and meetings and events businesses under the brands American Express Global Business Travel and American Express Meetings & Events pursuant to an exclusive and worldwide license from American Express.

 

 1 

 

 

We currently have approximately 16,730 employees worldwide (including Egencia (discussed below)) with a proprietary presence or operations in 31 countries. We service clients in the rest of the world through our Travel Partners Network (“TPN”).

 

On December 2, 2021, we entered into a definitive business combination agreement (“Business Combination Agreement”) with Apollo Strategic Growth Capital (“APSG”), a special purpose acquisition company, listed on the New York Stock Exchange (the “Business Combination”). The Business Combination closed on May 27, 2022 upon satisfaction of the closing conditions provided in the Business Combination Agreement, including approval by APSG’s shareholders and certain regulatory approvals. Upon closing of the Business Combination, GBT became a direct subsidiary of APSG, with APSG being renamed “Global Business Travel Group, Inc.” and conducting its business through GBT. We refer you to our Unaudited Pro Forma Condensed Combined Financial Information included as Exhibit 99.4 to this Report to determine the impact of this Business Combination on a pro forma basis.

 

Key Factors Affecting Our Results of Operations

 

As a result of a number of factors, our historical results of operations are not comparable from period to period and may not be comparable to our financial results of operations in future periods. Set forth below is a brief discussion of the key factors impacting the comparability of our results of operations.

 

Industry Trends

 

The travel industry can generally be divided into two sectors: (i) the leisure travel sector, which serves individuals who make reservations for vacation and personal travel, and (ii) the business travel sector, which serves corporate clients that require travel by employees and other travelers for business needs and meetings. We focus primarily on the business travel sector, which is approximately twice as valuable as the leisure travel sector because business travel customers purchase more premium seats, more flexible tickets, more long-haul international trips and more last-minute bookings.

 

Impact of the COVID-19 Pandemic

 

Since March 2020, the outbreak of the novel strain of the coronavirus, COVID-19 (the “COVID-19 pandemic”) severely restricted the level of economic activity around the world and had an unprecedented effect on the global travel industry. Government measures implemented to contain the spread of COVID-19, such as imposing restrictions on travel and business operations and advising or requiring individuals to limit or forgo time outside of their homes, limited business travel significantly below 2019 levels.

 

While many countries have vaccinated a reasonable proportion of their population, the rate and pace of vaccination globally, the severity and duration of resurgence, as well as uncertainty over the efficacy of the vaccines against new variants of the virus, may contribute to delays in economic recovery. Overall, the ultimate impact and duration of the COVID-19 pandemic remains uncertain and will depend upon future developments, which are difficult to predict.

 

However, with the spread of the virus now being contained to varying degrees in certain countries during different times, travel restrictions have been lifted and clients have become more comfortable traveling, particularly to domestic locations. This has led to a moderation of the more severe declines in business travel bookings experienced at certain points since the pandemic began. Starting in the second half of 2021 and continuing into first quarter of 2022, global travel activity has since shown a recovery trend, but remained below 2019 levels as of April 2022. We continue to see momentum in the business travel recovery, with transactions reaching 72% of 2019 levels in the last two weeks of April 2022.

 

Impact of Business Combination

 

We have been an acquisitive company since formation and have realized substantial growth through our acquisition strategy. In January 2021, we completed the acquisition of Ovation Travel, LLC, (along with its subsidiaries, “Ovation”). Ovation is a leading specialist in providing high-touch service. The Ovation acquisition was an important step in expanding our high value capabilities and building our leadership in the large and attractive U.S. small and medium enterprise (“SME”) customer base and the professional services industry. Further, On November 1, 2021, we completed acquisition of Egencia, a business-to-business digital travel management company serving corporate clients, from an affiliate of Expedia, Inc., EG Corporate Travel Holdings LLC (“Expedia”).

 

 2 

 

 

Our condensed consolidated financial statements for the three months ended March 31, 2022 include the results of above acquisitions from the date of their acquisitions.

 

These acquisitions have been a significant driver of our revenue, cost of revenue and other operating expenses (including integration, restructuring and depreciation and amortization). Further, purchase accounting under GAAP requires that all assets acquired and liabilities assumed be recorded at fair value on the acquisition date. As a result, our acquisition strategy has resulted in past and could result in future significant amount of amortization of acquired intangibles (or impairments, if any) recorded in our results of operations following our acquisition, which may significantly impact our results of operations.

 

Key Operating and Financial Metrics

 

We monitor the following key operating and financial metrics to help us evaluate our business, measure our performance, identify trends affecting our business, prepare financial projections and make strategic decisions. The following key operating and financial metrics, which we believe are useful in evaluating our business, are used by management to monitor and analyze the operational and financial performance of our business:

 

  

Three Months Ended

March 31,

 
($ in millions except percentages)  2022   2021 
Key Operating Metrics          
Total Transaction Value (“TTV”)   4,155    749 
Transaction Growth (Decline)   382%   (82)%
Key Financial Metrics          
Revenue   350    126 
Total operating expense   446    255 
Net loss   (91)   (114)
Net cash used in operating activities   (154)   (114)
EBITDA   (53)   (91)
Adjusted EBITDA   (28)   (90)
Adjusted Operating Expenses   377    215 
Free Cash Flow   (175)   (123)

 

   As of
March 31
   As of
December 31,
 
   2022   2021 
Net Debt   694    507 

 

Key Operating Metrics

 

We consider TTV, followed by Transaction Growth (Decline), to be two significant non-financial metrics that are broadly used in the travel industry and help understand revenue and expense trends. These metrics are used by our management to (1) manage the financial planning and performance of our business, (2) evaluate the effectiveness of our business strategies, (3) make budgeting decisions, and (4) compare our performance to the performance of our peer companies. We also believe that TTV, followed by Transaction Growth (Decline), may assist potential investors and financial analysts in understanding the drivers of growth in our revenues and changes in our operating expenses across reporting periods.

 

TTV

 

TTV refers to the sum of the total price paid by travelers for air, hotel, rail, car rental and cruise bookings, including taxes and other charges applied by suppliers at point of sale, less cancellations and refunds.

 

 3 

 

 

TTV of $ 4,155 million for the three months ended March 31, 2022 increased by 454% compared to the three months ended March 31, 2021 primarily due to (i) full quarterly inclusion of Egencia’s TTV in the metric which added 143 % to the TTV increase and (ii) the business recovering from the period of significant Covid-19 travel restrictions, that were introduced by governments in response to the COVID-19 pandemic. The increase in TTV, in part, indicates companies returning to travel and reductions in international travel restrictions.

 

Transaction Growth (Decline)

 

Transaction Growth (Decline) represents year-over-year decline or growth as a percentage of the total number of transactions, including air, hotel, car rental, rail or other travel-related transactions, recorded at the time of booking, is calculated on a gross basis to include cancellations, refunds and exchanges. To calculate year-over-year decline or growth, GBT compares the total number of transactions in the comparative previous period/year to the total number of transactions in the current period/year in percentage terms.

 

During the three months ended March 31, 2022, Transaction Growth was 382% compared to three months ended March 31, 2021 primarily due to (i) full quarterly inclusion of Egencia’s transaction volume in the metric which added 171 % to Transaction Growth and (ii) the increase in transactions due to continued easing of travel restrictions, that were introduced by governments in response to the COVID-19 pandemic.

 

Non-GAAP Financial Measures

 

We report our financial results in accordance with GAAP. Our non-GAAP financial measures are provided in addition to, and should not be considered as an alternative to, other performance or liquidity measure derived in accordance with GAAP. Non-GAAP financial measures have limitations as analytical tools, and you should not consider them either in isolation or as a substitute for analyzing our results as reported under GAAP. In addition, because not all companies use identical calculations, the presentations of our non-GAAP financial measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.

 

Management believes that these non-GAAP financial measures provide users of our financial information with useful supplemental information that enables a better comparison of our performance or liquidity across periods. In addition, we use certain of these non-GAAP financial measures as performance measures as they are important metrics used by management to evaluate and understand the underlying operations and business trends, forecast future results and determine future capital investment allocations. We use two of our non-GAAP financial measures as indicators of our ability to generate cash to meet our liquidity needs and to assist our management in evaluating our financial flexibility, capital structure and leverage. These non-GAAP financial measures supplement comparable GAAP measures in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and/or to compare our performance and liquidity against that of other peer companies using similar measures.

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses

 

We define EBITDA as net (loss) income before interest income, interest expense, loss on early extinguishment of debt, benefit from (provision for) income taxes and depreciation and amortization.

 

We define Adjusted EBITDA as EBITDA excluding costs that management believes are non-core to the underlying business of the Company, consisting of restructuring costs, integration costs, costs related to mergers and acquisitions, separation costs, non-cash equity-based compensation, long-term incentive plan costs, certain corporate costs, foreign currency gains (losses), non-service components of net periodic pension benefit (costs) and gains (losses) on disposal of businesses.

 

We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue.

 

We define Adjusted Operating Expenses as total operating expenses excluding depreciation and amortization and costs that management believes are non-core to the underlying business of the Company, consisting of restructuring costs, integration costs, costs related to mergers and acquisitions, separation costs, non-cash equity-based compensation and certain corporate costs.

 

 4 

 

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are supplemental non-GAAP financial measures of operating performance that do not represent and should not be considered as alternatives to net (loss) income or total operating expenses, as determined under GAAP. In addition, these measures may not be comparable to similarly titled measures used by other companies. These non-GAAP measures have limitations as analytical tools, and these measures should not be considered in isolation or as a substitute for analysis of the Company’s results or expenses as reported under GAAP. Some of these limitations are that these measures do not reflect:

 

changes in, or cash requirements for, our working capital needs or contractual commitments;

 

our interest expense, or the cash requirements to service interest or principal payments on our indebtedness;

 

our tax expense, or the cash requirements to pay our taxes;

 

recurring, non-cash expenses of depreciation and amortization of property and equipment and definite-lived intangible assets and, although these are non-cash expenses, the assets being depreciated and amortized may have to be replaced in the future;

 

the non-cash expense of stock-based compensation, which has been, and will continue to be for the foreseeable future, an important part of how we attract and retain our employees and a significant recurring expense in our business;

 

restructuring, mergers and acquisition and integration costs, all of which are intrinsic of our acquisitive business model; and

 

impact on earnings or changes resulting from matters that we consider not to be indicative of our future operations.

 

EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses should not be considered as a measure of liquidity or as a measure determining discretionary cash available to us to reinvest in the growth of our business or as measures of cash that will be available to us to meet our obligations.

 

We believe that the adjustments applied in presenting EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are appropriate to provide additional information to investors about certain material non-cash and other items that management believes are non-core to the underlying business of the Company.

 

We use these measures as performance measures as they are important metrics used by management to evaluate and understand the underlying operations and business trends, forecast future results and determine future capital investment allocations. These non-GAAP measures supplement comparable GAAP measures in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. We also believe that EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are helpful supplemental measures to assist potential investors and analysts in evaluating our operating results across reporting periods on a consistent basis.

 

Set forth below is a reconciliation of net loss to EBITDA and Adjusted EBITDA for the three months ended March 31, 2022 and 2021.

 

  

Three Months Ended

March 31,

 
($ in millions except percentages)  2022   2021 
Net loss   (91)   (114)
Interest expense   19    11 
Benefit from income taxes   (25)   (22)
Depreciation and amortization   44    34 
EBITDA   (53)   (91)
Restructuring charges(a)   2     
Integration costs(b)   9    1 
Mergers and acquisitions(c)   1    3 
Equity-based compensation(d)   3     
Other adjustments, net(e)   10    (3)
Adjusted EBITDA   (28)   (90)
           
Net loss margin   (26)%   (90)%
Adjusted EBITDA Margin   (8)%   (71)%

 

 5 

 

 

Set forth below is a reconciliation of total operating expenses to Adjusted Operating Expenses for the three months ended March 31, 2022 and 2021:

 

  

Three Months Ended

March 31,

 
($ in millions)  2022   2021 
Total operating expenses   446    255 
Adjustments:          
Depreciation and amortization   (44)   (34)
Restructuring charges(a)   (2)    
Integration costs(b)   (9)   (1)
Mergers and acquisition(c)   (1)   (3)
Equity-based compensation(d)   (3)    
Other adjustments, net(e)   (10)   (2)
Adjusted Operating Expenses   377    215 

 

 

(a)Represents severance and related expenses due to restructuring activities.

(b)Represents expenses related to the integration of businesses acquired.

(c)Represents expenses related to business acquisitions, including potential business acquisitions, and includes pre-acquisition due diligence and related activities costs.

(d)Represents non-cash equity-based compensation expense related to the GBT MIP.

(e)Adjusted Operating Expenses excludes (i) long-term incentive plan expense of $9 million and $1 million for the three months ended March 31, 2022 and 2021, respectively and.(ii) litigation and professional services costs of $1 million for each of the three months ended March 31, 2022 and 2021. Adjusted EBITDA additionally excludes (i) unrealized foreign exchange (losses) gains of $(2) million and $3 million for the three months ended March 31, 2022 and 2021, respectively, and (ii) non-service component of our net periodic pension benefit related to our defined benefit pension plans of $2 million for each of the three months ended March 31, 2022 and 2021.

 

For a discussion of Free Cash Flow and Net Debt, see “Liquidity and Capital Resources— Free Cash Flow” and “Liquidity and Capital Resources— Net Debt.”

 

 6 

 

 

Results of Operations

 

Three Months Ended March 31, 2022 Compared to Three Months Ended March 31, 2021

 

The following table summarizes our historical condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Revenue  $350   $126   $224    179%
Costs and Expenses:                    
Cost of revenues (excluding depreciation and amortization shown separately below)   173    82    (91)   (110)%
Sales and marketing   72    43    (29)   (70)%
Technology and content   90    57    (33)   (59)%
General and administrative   65    39    (26)   (69)%
Restructuring charges   2        (2)   n/m 
Depreciation and amortization   44    34    (10)   (28)%
Total operating expense   446    255    (191)   (75)%
Operating loss   (96)   (129)   33    26%
Interest expense   (19)   (11)   (8)   (75)%

 

 7 

 

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Other income, net       5    (5)   (93)%
Loss before income taxes and share of losses from equity method investments   (115)   (135)   20    15%
Benefit from income taxes   25    22    3    17%
Share of losses in equity method investments   (1)   (1)        
Net loss   (91)   (114)   23    20%

 

 

n/m — not meaningful

 

Revenue

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Travel Revenue  $256   $62   $194    318%
Products & Professional Services Revenue   94    64    30    45%
Total Revenue  $350   $126   $224    179%

 

For the three months ended March 31, 2022, our total revenue increased by $224 million, or 179%, due to incremental revenue resulting from the Egencia acquisition and recovery in both Travel Revenue and Products & Professional Services revenue.

 

Travel Revenue increased by $194 million, or 318%, primarily due to (i) increment revenue of $64 million resulting from the Egencia acquisition and (ii) Transaction Growth of 211% driven by the recovery in travel from the COVID-19 pandemic, with transaction yield remaining stable. Transaction yield is calculated by dividing our Travel Revenue by total gross transactions.

 

Product and Professional Services Revenue increased $30 million, or 45%, primarily due to (i) $28 million of increased management fees and meetings and events revenue as relaxed COVID-19 restrictions drove increased business meetings and (ii) $ 2 million resulting from the Egencia acquisition.

 

Cost of Revenue

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Cost of revenue (excluding depreciation and amortization)  $173   $82   $(91)   (110)%

 

For the three months ended March 31, 2022, cost of revenue increased by $91 million, or 110%, due to additional cost of revenue resulting from Egencia consolidation and increase in both, salaries and benefits expenses and other cost of revenue.

 

Salaries and benefits expenses related to cost of revenue increased by $70 million, or 103%, primarily due to increase in (i) number of travel care employees employed to meet the increased travel demand as the recovery in business travel from the Covid-19 pandemic continues, (ii) $18 million incremental salaries and benefits resulting from Egencia consolidation and (iii) a decrease in funds received from governments of $12 million in connection with programs designed to minimize employment losses related to the COVID-19 pandemic which were netted against salaries and benefits expenses.

 

Other cost of revenue increased by $21 million, or 142%, primarily due to (i) inclusion of $13 million of other cost of revenue resulting from Egencia consolidation and (ii) increase in vendor costs to meet the increase in transaction volume driven by the recovery from the Covid-19 pandemic.

 

 8 

 

 

Sales and Marketing

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Sales and marketing  $72   $43   $(29)   (70)%

 

For the three months ended March 31, 2022, sales and marketing expenses increased by $29 million, or 70%, due to additional sales and marketing cost resulting from Egencia consolidation and increase in both, salaries and benefits expenses and other sales and marketing costs.

 

Salaries and benefits expenses related to sales and marketing increased by $26 million, or 74%, due to (i) $17 million of incremental salaries and benefits resulting from Egencia consolidation and (ii) $9 million increase primarily due to the restoration of full salaries and benefits during the three months ended March 31, 2022 compared to reduced salaries and benefits resulting from mandatory salary reductions that were in place during the three months ended March 31, 2021.

 

Other sales and marketing expenses increased by $3 million, or 47%, primarily due to Egencia consolidation.

 

Technology and Content

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
Technology and content  $90   $57   $(33)   (59)%

 

For the three months ended March 31, 2022, technology and content costs increased by $33 million, or 59%, due to additional technology and content costs resulting from Egencia consolidation and increases in both, salaries and benefits expenses and other technology and content costs.

 

Salaries and benefits expenses related to technology and content increased by $16 million, or 58%, primarily due to (i) $10 million of incremental salaries and benefits resulting from Egencia consolidation and (ii) $5 million increase due to the restoration of full salaries and benefits during the three months ended March 31, 2022 compared to reduced salaries and benefits resulting from the mandatory salary reductions that were in place during the three months ended March 31, 2021.

 

Other technology and content costs increased by $17 million, or 61%, due to (i) $10 million increase resulting from Egencia consolidation and (ii) $7 million increase driven by higher volumes on voice related costs and an increase in data processing parallel costs from cloud migration as we complete the transition from proprietary data centers to cloud hosting.

 

General and Administrative

 

   Three Months Ended
March 31,
   Change
favorable/(unfavorable)
 
($ in millions except percentages)  2022   2021   $   % 
General and administrative  $65   $39   $(26)   (69)%

 

For the three months ended March 31, 2022, general and administrative expenses increased by $26 million, or 69%, due to additional general and administrative costs resulting from Egencia consolidation and increase in both, salaries and benefits expenses and other general and administrative costs.

 

Salaries and benefits expenses related to general and administrative increased by $10 million, or 41%, primarily due to incremental salaries and benefits of $11 million resulting from the Egencia consolidation

 

Other general and administrative expenses increased by $16 million, or 107%, due to (i) $4 million resulting from the Egencia consolidation and (ii) $12 million increase in head office costs including $6 million of integration costs with the remainder driven by increased outsourced vendor costs and an increase in travel spend as a result of return to travel.

 

 9 

 

 

Depreciation and Amortization

 

For the three months ended March 31, 2022, depreciation and amortization increased by $10 million, or 28%, primarily due to additional depreciation and amortization resulting from the fair value of property and equipment and other intangible assets, recognized from the Ovation and Egencia acquisitions.

 

Interest Expense

 

For the three months ended March 31, 2022, interest expense increased by $8 million, or 75%. The increase was primarily due to additional borrowings of term loans in December 2021 at a higher rate of interest.

 

Other Income, net

 

For the three months ended March 31, 2022, other income, net, decreased by $5 million, or 100%, due to adverse changes in foreign exchange.

 

Benefit from Income Taxes

 

During the three months ended March 31, 2022, the effective income tax rate was 22% compared to 16% during the three months ended March 31, 2021. The change in effective tax rate is primarily driven by the change in the United Kingdom (U.K.) statutory corporation tax rate which was enacted in the second quarter of 2021 and which changed the U.K. corporation income tax rate from 19% to 25% effective from April 2023. The effective tax rate for the three months ended March 31, 2022 is higher than the U.K. statutory rate of 19% due to overseas tax rate differentials and U.K. operating losses being recognized at the rate at which they are expected to reverse of 25%. This is partially negated by changes in valuation allowances.

 

Liquidity and Capital Resources

 

Our principal sources of liquidity are typically cash flows generated from operations, cash available under the credit facilities under the senior secured credit agreement as well as cash and cash equivalents. As of March 31, 2022 and December 31, 2021, our cash and cash equivalent balances were $329 million and $516 million, respectively.

 

On May 27, 2022, we completed our Business Combination transaction. After considering payments of certain transaction expenses and redemption of preferred shares of $168 million (including accrued dividends until the date of closing), we received net proceeds of $128 million upon closing of the Business Combination.

 

On May 19, 2022, we borrowed a principal amount of $100 million of senior secured tranche B-3 term loans under the $200 million of delayed draw commitments that were established under the senior secured credit agreement in December 2021.

 

As of March 31, 2022, our pro forma liquidity was over $700 million and primarily consisted of:

 

$557 million of pro forma cash and cash equivalents (comprised of (i) $329 million of cash and cash equivalents as of March 31, 2022, (ii) $128 million net proceeds received upon closing of the Business Combination and (iii) $100 million of principal amount of senior secured tranche B-3 term loans borrowed in May 2022),

$100 million of currently undrawn commitments remaining under the senior secured tranche B-3 term loan facilities, which are available on a delayed-draw basis until mid-June 2022 (subject to certain customary borrowing conditions), and

$50 million of undrawn commitments under the senior secured revolving credit facility (subject to the satisfaction of applicable borrowing conditions and compliance with applicable covenants related to borrowings thereunder).

 

On May 25, 2022, we issued a notice to the administrative agent under the senior secured credit agreement requesting an additional borrowing of the last remaining $100 million of delayed draw commitments under the senior secured tranche B-3 term loan facilities. It is expected that the funding of such requested borrowing will be completed on June 9, 2022, subject to certain customary borrowing conditions.

 

 10 

 

 

We believe, based on our current operating plan, that our existing cash and cash equivalents, together with the senior secured revolving credit facility, the senior secured tranche B-3 delayed draw term loan facility and cash flows from operating activities, will be sufficient to meet our anticipated cash needs for working capital, financial liabilities, capital expenditures and business expansion for at least the next 12 months. Although we believe that we will have a sufficient level of cash and cash equivalents to cover our working capital needs in the ordinary course of business and to continue to expand our business, we may, from time to time, explore additional financing sources to lower our cost of capital, which could include equity, equity-linked and debt financing. In addition, from time to time, we may evaluate acquisitions and other strategic opportunities. If we elect to pursue any such investments, we may fund them with internally generated funds, bank financing, the issuance of other debt or equity or a combination thereof. There is no assurance that such funding would be available to us on acceptable terms or at all. Furthermore, we cannot assure you that we would be able to satisfy or obtain a waiver of applicable borrowing conditions for borrowing additional amounts under the unused commitments under the senior secured credit agreement in the future. In addition, utilization of the senior secured revolving credit facility may be effectively limited in future periods if we are unable to comply with the leverage-based financial covenant for such facility contained in the senior secured credit agreement when required.

 

Cash Flows

 

The following table summarizes our cash flows for the three months ended March 31, 2022 and 2021:

 

  

Three Months Ended

March 31,

 
($ in millions)  2022   2021 
Net cash used in operating activities   (154)   (114)
Net cash used in investing activities   (21)   (62)
Net cash (used in) from financing activities   (7)   89 
Effect of exchange rate changes on cash, cash equivalents and restricted cash   (3)   (3)
Net decrease in cash, cash equivalents and restricted cash   (185)   (90)

 

Cash Flows for the Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021

 

As of March 31, 2022, we had $340 million of cash, cash equivalents and restricted cash, a decrease of $185 million compared to December 31, 2021. The following discussion summarizes changes to our cash flows from operating, investing and financing activities for the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

 

Operating Activities

 

For the three months ended March 31, 2022, net cash used in operating activities was $154 million compared to $114 million for the three months ended March 31, 2021. The increase in cash used in operating activities of $40 million was primarily due to increased cash usage for working capital as business recovery from COVID-19 pandemic continued, partially offset by decrease in operating loss.

 

Investing Activities

 

During the three months ended March 31, 2022 net cash used in investing activities of $21 million was related to purchase of property and equipment. Cash used in investing activities for the three months ended March 31, 2021 of $62 million comprised of cash consideration of $53 million paid for the acquisition of the Ovation travel business and $9 million used for the purchase of property and equipment.

 

Financing Activities

 

During the three months ended March 31, 2022, net cash used in financing activities of $7 million was due to $4 million of costs related to a potential equity offering transaction and $3 million of repayment of finance lease obligation and principal amount of quarterly term loan installment. During the three months ended March 31, 2021, net cash from financing activities of $89 million primarily comprised of: (i) $50 million of gross cash proceeds received from term loans borrowed pursuant to senior secured prior tranche B-2 term loan facility, (ii) $50 million of proceeds received from the issuance of preferred shares, partially, offset by: (iii) $ 6 million of payment of lender fees and issuance costs for senior secured term loans facilities and (iv) $ 4 million of repayment of finance lease obligation and principal amount of quarterly term loan installment.

 

 11 

 

 

Free Cash Flow

 

We define Free Cash Flow as net cash (used in) from operating activities, less cash used for additions to property and equipment.

 

We believe Free Cash Flow is an important measure of our liquidity. This measure is a useful indicator of our ability to generate cash to meet our liquidity demands. We use this measure to conduct and evaluate our operating liquidity. We believe it typically presents an alternate measure of cash flows since purchases of property and equipment are a necessary component of our ongoing operations and it provides useful information regarding how cash provided by operating activities compares to the property and equipment investments required to maintain and grow our platform. We believe Free Cash Flow provides investors with an understanding of how assets are performing and measures management’s effectiveness in managing cash.

 

Free Cash Flow is a non-GAAP measure and may not be comparable to similarly named measures used by other companies. This measure has limitations in that it does not represent the total increase or decrease in the cash balance for the period, nor does it represent cash flow for discretionary expenditures. This measure should not be considered as a measure of liquidity or cash flows from operations as determined under GAAP. This measure is not measurement of our financial performance under GAAP and should not be considered in isolation or as alternative to net (loss) income or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of liquidity.

 

Set forth below is a reconciliation of net cash used in operating activities to Free Cash Flow.

 

  

Three Months Ended

March 31,

 
($ in millions)  2022   2021 
Net cash used in operating activities  $(154)  $(114)
Less: Purchase of property and equipment   (21)   (9)
Free Cash Flow  $(175)  $(123)

 

Free Cash Flow of $(175) million for the three months ended March 31, 2022, declined by $(52) million compared to Free Cash Flow of $(123) million for the three months ended March 31, 2021, due to a $40 million increase in net cash used in operating activities as discussed above and an increase of $12 million of cash outflows related to purchases of property and equipment.

 

Net Debt

 

The following table summarizes our Net Debt position as of March 31, 2022 and December 31, 2021:

 

   As of 
(in $ millions)  March 31,
2022
   December 31,
2021
 
Senior Secured Credit Agreement          
Principal amount of senior secured initial term loans (Maturity – August 2025) (1)  $241   $242 
Principal amount of senior secured tranche B-3 term loans (Maturity – December 2026) (2)   800    800 
Principal amount of senior secured revolving credit facility (Maturity – August 2023) (3)        
    1,041    1,042 
Less: Unamortized debt discount and debt issuance costs   (18)   (19)
Total debt, net of unamortized debt discount and debt issuance costs   1,023    1,023 
Less: Cash and cash equivalents   (329)   (516)
Net Debt  $694   $507 

 

 

(1)Stated interest rate of LIBOR + 2.50% as of March 31, 2022 and December 31, 2021.

(2)Stated interest rate of LIBOR + 6.50% (with a LIBOR floor of 1.00%) as of March 31, 2022 and December 31, 2021.

(3)Stated interest rate of LIBOR + 2.25% as of March 31, 2022 and December 31, 2021.

 

 12 

 

 

We define Net Debt as total debt outstanding consisting of current and non-current portion of long-term debt (defined as debt (excluding lease liabilities) with original contractual maturity dates of one year or greater), net of unamortized debt discount and unamortized debt issuance costs, minus cash and cash equivalents. Net Debt is a non-GAAP measure and may not be comparable to similarly named measures used by other companies. This measure is not a measurement of our indebtedness as determined under GAAP and should not be considered in isolation or as alternative to assess our total debt or any other measures derived in accordance with GAAP or as an alternative to total debt. Management uses Net Debt to review our overall liquidity, financial flexibility, capital structure and leverage. Further, we believe that certain debt rating agencies, creditors and credit analysts monitor our Net Debt as part of their assessment of our business.

 

Total debt was $1,023 million as of March 31, 2022 and December 31, 2021. As of March 31, 2022, Net Debt was $694 million compared to Net Debt of $507 million as of December 31, 2021. The increase in Net Debt was driven by $187 million decreased cash and cash equivalent balance as of March 31, 2022 compared to December 31, 2021.

 

As of March 31, 2022, we were in compliance with all applicable covenants under the senior secured credit agreement.

 

On May 19, 2022, we borrowed a principal amount of $100 million of senior secured tranche B-3 term loans under the $200 million of delayed draw commitments that were established under the senior secured credit agreement in December 2021. On May 25, 2022, we issued a notice to the administrative agent under the senior secured credit agreement requesting an additional borrowing of the last remaining $100 million of delayed draw commitments under the senior secured tranche B-3 term loan facilities. It is expected that the funding of such requested borrowing will be completed on June 9, 2022, subject to certain customary borrowing conditions.

 

Contractual Obligations and Commitments

 

The following table summarizes our contractual obligations and commitments as of March 31, 2022:

 

   Payments Due by Year ($ in millions) 
   Total   Less than 1
Year
   1 – 3 Years   3 – 5 Years   More than 5
Years
 
Long-term debt obligations(1)  $1,023   $3   $5   $1,015   $ 
Operating lease liabilities(2)   95    25    35    14    21 
Finance lease liabilities   2    2             
Interest payments(3)   311    68    136    107     
Purchase commitments(4)   206    71    116    19     
Total contractual obligations  $1,637   $169   $292   $1,155   $21 

 

 13 

 

 

 

(1)Long-term debt obligations exclude lease liabilities. On May 19, 2022, we borrowed an additional $100 million of senior secured tranche B-3 term loans under our senior secured credit agreement. On May 25, 2022, we issued a notice to the administrative agent under the senior secured credit agreement requesting additional borrowing of the last remaining $100 million of delayed draw commitments under the senior secured tranche B-3 term loan facilities. These amounts are not reflected in the amounts above. Under certain circumstances, each year, a portion of the senior secured term loans outstanding under the senior secured credit agreement are required to be prepaid with a percentage of annual excess cash flow, if any, calculated in a manner set forth in the senior secured credit agreement. Under certain circumstances, we will also be required to prepay, or make an offer to prepay, the senior secured term loans outstanding under the senior secured credit agreement with the proceeds received from certain other events, subject to certain exceptions and limitations set forth in the senior secured credit agreement. None of these mandatory prepayment obligations are reflected in the table above. Long-term debt obligations reflected in this table does not include the related unamortized debt discount and unamortized debt issuance costs. As of March 31, 2022, we have unamortized debt discount and unamortized debt issuance costs of $18 million related to the senior secured term loans outstanding as of such date under the senior secured credit agreement that will be amortized over their contractual period.

 

(2)The operating lease liability amounts in the table above are primarily related to corporate office facility leases, as well as other offices for our local operations. Our operating leases expire on various dates through December 31, 2035. In addition to minimum lease payments, we are responsible for our ratable share of taxes and operating costs for leased premises.

 

(3)Includes interest on the senior secured term loans outstanding under the senior secured credit agreement and our finance leases. Interest payments reflected in the table above for the senior secured term loans outstanding under the senior secured credit agreement are based on the applicable interest rate in effect as of March 31, 2022, which was 2.96% per annum for the senior secured initial term loans (calculated as LIBOR plus 2.5%) and 7.5% per annum for loans under the senior secured tranche B-3 term loan facilities (calculated as LIBOR plus 6.5%, with a 1.00% LIBOR floor). Interest payments exclude any impact of expected cash flows resulting from interest rate swap contract entered into in February 2022. As of March 31, 2022, our condensed consolidated balance sheet reflected accrued and unpaid interest of $3 million and we had derivative asset related to interest rate swaps of $9 million.

 

(4)Primarily reflects our noncancelable contractual obligations in the ordinary course of business for which we have not received the goods or services as of March 31, 2022. The obligations are primarily related to service, hosting and licensing contracts for information technology arrangements.

 

Our obligations related to defined benefit and post-retirement plans are actuarially determined on an annual basis at our financial year end. As of December 31, 2021, plan contributions of $25 million were expected to be made in 2022 and for the three months ended March 31, 2022, we have made plan contributions of $6 million. Funding projections beyond 2022 are not practical to estimate based on currently available information. Income tax liabilities for uncertain tax positions are excluded as we are unable to make a reasonably reliable estimate of the amount and period of related future payments.

 

Qualitative and Quantitative Disclosures about Market Risk

 

We are exposed to market risks in the ordinary course of our business, which primarily relate to fluctuations in interest rates. Such fluctuations to date have not been significant.

 

Interest Rate Risk

 

As of March 31, 2022, we had unrestricted cash and cash equivalents of $329 million and restricted cash of approximately $11 million.

 

Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political considerations, as well as other factors beyond our control. Interest rate risk is the exposure to loss resulting from changes in the level of interest rates and the spread between different interest rates. We are exposed to market risk from changes in interest rates on debt, which bears interest at variable rates. Interest rate risk is highly sensitive due to many factors, including U.S. monetary and tax policies, U.S. and international economic factors and other factors beyond our control. Our debt has floating interest rates. We are exposed to changes in the level of interest rates and to changes in the relationship or spread between interest rates for our floating rate debt. We have interest rate risk primarily related to borrowings under the senior secured credit agreement, which bear interest at a variable rate tied to LIBOR or the applicable base rate plus a margin (subject to certain benchmark replacement provisions and certain interest rate floors, as applicable), and, during certain periods, the margin applicable to certain term loan facilities thereunder will be based on a pricing grid that varies with the total leverage ratio (calculated in a manner set forth in the senior secured credit agreement). Therefore, increases in interest rates may reduce our net income or increase our net loss by increasing the cost of debt. As of March 31, 2022, $1,023 million of senior secured term loans were outstanding under the senior secured credit agreement, net of unamortized debt discount and unamortized debt issuance costs, and no borrowings or letters of credit were outstanding under the senior secured revolving credit facility as of such date.

 

 14 

 

 

Based on the outstanding debt under the senior secured credit agreement as of March 31, 2022, and assuming that our mix of debt instruments and other variables remain unchanged, and excluding any impact of expected cash flows resulting from interest rate swap contract entered into in February 2022: (i) a hypothetical 100 basis points increase in LIBOR would have increased our interest expense by $6 million on an annualized basis and (ii) a hypothetical 100 basis points decrease in LIBOR would have decreased our interest expense by $1 million on an annualized basis due to the LIBOR component thereof being tied to a LIBOR floor in respect of loans that were outstanding as of such date under the senior secured tranche B-3 term loan facilities. In February 2022, we entered into an interest rate swap for a notional amount of $600 million of debt for a period covering from March 2022 to March 2025 to hedge against any future increases in the benchmark rate for the senior secured tranche B-3 term loan facilities. The terms of such swap are initially linked to LIBOR as the benchmark rate, with an adjusted SOFR-based rate replacing LIBOR as the benchmark rate for such swap commencing in June 2023. The interest rate swaps is considered as an accounting hedge and as of March 31, 2022, we had recognized $9 million of derivative asset in our condensed consolidated financial statements.

 

Foreign Currency Exchange Risk

 

Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates relative to U.S. dollars, our functional and reporting currency. Our revenue is generated primarily in U.S. dollars, British pounds sterling, and Euros. Our expenses are generally denominated in the currency of the country in which our operations are located, which are primarily the U.S., Europe and Asia. Our functional currency is denominated in U.S. dollars. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates in ways that are unrelated to our operating performance. As exchange rates may fluctuate significantly between periods, revenue and operating expenses, when converted into U.S. dollars, may also experience significant fluctuations between periods. As our revenues earned and expenses incurred in currencies other than U.S. dollars largely offset each other, fluctuations in the foreign currency exchange rates have not had a material impact on our financial results.

 

We do not engage in any foreign currency related hedging activities. We will continue to reassess our approach to managing risks relating to fluctuations in currency rates.

 

Inflation Risk

 

We do not believe that inflation has had a material effect on our business, results of operations or financial condition. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. Our inability or failure to do so could harm our business, results of operations or financial condition.

 

Critical Accounting Policies and Estimates

 

Our condensed consolidated financial statements and the related notes thereto included as Exhibit 99.1 to this Report are prepared in accordance with accounting policies generally accepted in the United States (“GAAP”). The preparation of condensed consolidated financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. There are certain critical estimates that we believe require significant judgment in the preparation of our condensed consolidated financial statements. We consider an accounting estimate to be critical if: (i) it requires us to make an assumption because information was not available at the time or it included matters that were highly uncertain at the time we were making the estimate; and (ii) changes in the estimate or different estimates that we could have selected may have had a material impact on our financial condition or results of operations.  Actual results could differ significantly from our estimates. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.

 

As discussed earlier in “Key Factors Affecting Our Results of Operations - Impact of the COVID-19 Pandemic,” the COVID-19 pandemic has created and may continue to create significant uncertainty in macroeconomic conditions, which may cause further business disruptions and adversely impact our results of operations. As a result, many of our estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, our estimates may change materially in future periods. For additional information about our other critical accounting policies and estimates, see the disclosure included in the Proxy Statement/Prospectus.

 

Recent Accounting Pronouncements

 

For information on recently issued accounting pronouncements, adopted and not yet adopted by us, see note 2 to our condensed consolidated financial statements included as Exhibit 99.1 to the Report.

 

 15 

 

Exhibit 99.4

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

Defined terms included below have the same meaning as terms defined and included elsewhere in this Form 8-K and, if not defined in the Form 8-K, the Proxy Statement/Prospectus.

 

Introduction

 

We are providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Business Combination. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses.”

 

The unaudited pro forma condensed combined balance sheet as of March 31, 2022 combines the historical balance sheet of APSG and Legacy GBT on a pro forma basis as if the Business Combination and related transactions, summarized below, had been consummated on March 31, 2022. The Egencia Acquisition closed on November 1, 2021 and, therefore, the consolidated balance sheet of Legacy GBT as of March 31, 2022 includes the impact of the Egencia Acquisition. The unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2022 combines the historical statements of operations of APSG, Legacy GBT, and Egencia on a pro forma basis as if the Business Combination, the Egencia Acquisition and related transactions, summarized below, had been consummated on January 1, 2021.

 

A summary of the Business Combination, the Egencia Acquisition and related transactions is as follows:

 

On December 2, 2021, APSG entered into a Business Combination Agreement, by and between APSG and Legacy GBT, pursuant to which, among other things and subject to the terms and conditions contained in the Business Combination Agreement, the Continuing JerseyCo Owners, in the aggregate, own a majority voting interest in PubCo and a majority economic interest in GBT, and the existing shareholders of APSG own a minority voting interest in PubCo and an indirect minority economic interest in the GBT business. Upon Closing, GBT serves as PubCo’s operating company in an Up-C structure.

 

The Egencia Acquisition was consummated on November 1, 2021, and Expedia became an indirect holder of approximately 19% of the equity interests of GBT, excluding GBT Preferred Shares, GBT Profit Shares, GBT MIP Options and GBT MIP Shares as of such date. On Closing, and as contemplated by the Egencia Acquisition, Expedia has become a direct equityholder in GBT.

 

Immediately prior to the Closing, the investors of the Common Stock PIPE Investment (the “PIPE Investors”) purchased 32,350,000 shares of APSG Class A common stock for an aggregate purchase price equal to $323.5 million, which, upon the Closing, converted on a one-for-one basis to shares of PubCo’s Class A Common Stock;

 

The unaudited pro forma condensed combined financial information does not purport to represent, and is not necessarily indicative of, what the actual financial condition of the combined company would have been had the Business Combination, the Egencia Acquisition and related transactions taken place on the dates indicated, nor is it indicative of the financial condition of the combined company as of any future date. The unaudited pro forma condensed combined financial information is based on and should be read in conjunction with the historical financial statements of APSG, Legacy GBT and Egencia, and the related notes thereto, as well as the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of APSG” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations of GBT” included in Proxy Statement/Prospectus

 

1 

 

 

The unaudited pro forma condensed combined balance sheet has been prepared to illustrate the effect of the Business Combination and related transactions and the unaudited pro forma condensed combined statements of operations has been prepared to illustrate the effect of the Business Combination, the Egencia Acquisition and related transactions. It has been prepared in accordance with Article 11 of Regulation S-X and is for informational purposes only and is subject to a number of uncertainties and assumptions as described in the accompanying notes. The unaudited pro forma condensed combined financial information reflects transaction-related adjustments management believes are necessary to present fairly (i) the combined company pro forma financial position following the closing of the Business Combination and related transactions and (ii) the combined company pro forma results of operations following the closing of the Business Combination and Egencia Acquisition and related transactions as of and for the periods indicated. The related transaction accounting adjustments are based on currently available information and assumptions management believes are, under the circumstances and given the information available at this time, reasonable, and reflective of adjustments necessary to report PubCo’s (i) financial condition as if the Business Combination and related transactions were completed as of the period indicated and (ii) results of operations as if the Business Combination, the Egencia Acquisition and related transactions were completed as of and for the periods indicated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may be material. We believe that our assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination, the Egencia Acquisition and related transactions contemplated based on information available to management at the time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma combined financial information.

 

Accounting for the Business Combination

 

The Business Combination has `been accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in accordance with accounting principles generally accepted in the United States of America. Under this method of accounting, APSG has been treated as the acquired company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of GBT issuing shares for the net assets of APSG, accompanied by a recapitalization. The net assets of APSG are recognized at fair value (which is expected to be consistent with carrying value as APSG’s net assets primarily comprise of Investments held in Trust Account), with no goodwill or other intangible assets recorded.

 

Legacy GBT has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:

 

Legacy GBT has been determined to be a corporate like entity due to its governance structure;
   
Legacy GBT’s stockholders have the majority of the voting power in the post-Business Combination company i.e. PubCo;
   
Legacy GBT’s stockholders appointed a majority of the PubCo Board;
   
Legacy GBT’s management team constitutes management team of the post-Business Combination company;
   
Legacy GBT’s prior operations comprise the ongoing operations of the post-Business Combination company;
   
Legacy GBT is the larger entity based on historical revenues and business operations; and
   
The post-Business Combination company assumed Legacy GBT’s operating name and its headquarters.

 

Accounting for Egencia Acquisition

 

The Egencia Acquisition closed on November 1, 2021 and, therefore, the consolidated balance sheet of Legacy GBT as of March 31, 2022 includes the impact of Egencia Acquisition. The pro forma adjustments related to the Egencia Acquisition primarily reflect the impact of the following in the unaudited pro forma combined statements of operations:

 

the amortization of acquired intangibles; and
   
the impact of revenue sharing arrangement with Expedia.

 

2 

 

 

Basis of Pro Forma Presentation

 

The following summarizes the pro forma shares of Domesticated Acquiror Common Stock issued and outstanding immediately after the Business Combination and related transactions, taking into consideration actual redemptions:

 

   Number of Shares 
Juweel   162,388,084 
Amex HoldCo.   157,786,199 
Expedia   74,274,198 
Continuing JerseyCo Owners   394,448,481 
Public Shareholders   

4,174,783

 
PIPE Investors   32,350,000 
Sponsor and Insiders   20,420,250 
Total Shares   

451,393,514

 

 

The accompanying notes are an integral part of these pro forma financial statements.

 

3 

 

 

UNAUDITED PRO FORMA

CONDENSED COMBINED BALANCE SHEET

AS OF MARCH 31, 2022

 

($ in millions, except share and per share data)  GBT JerseyCo Limited   Apollo Strategic Growth Capital   Transaction Accounting Adjustments       Pro Forma Combined 
Assets                    
Current assets:                         
Cash and cash equivalents  $329   $-   $132     (a)    $461 
Accounts receivable, net   562    -              562 
Due from affiliates   9    -              9 
Prepaid expenses and other current assets   143    -    (26)    (b)     117 
Total current assets   1,043    -    106         1,149 
Investments held in Trust Account   -    818    (818)   (c)    - 
Property and equipment, net   213    -              213 
Equity method investments   16    -              16 
Goodwill   1,346    -              1,346 
Other intangible assets, net   718    -              718 
Operating lease right-of-use assets   54    -              54 
Deferred tax assets   300    -    166     (n)     466 
Other non-current assets   46    -              46 
Total assets  $3,736   $818   $(546)       $4,008 
                          
Liabilities and shareholders' equity                         
Current liabilities:                         
Accounts payable  $289   $5   $(5)    (d)    $289 
Due to affiliates   41    4    (4)    (e)     41 
Accrued expenses and other current liabilities   448    -    12     (f)     460 
Notes payable   -    6    (6)    (d)     - 
Current portion of operating lease liabilities   20    -              20 
Current portion of long-term debt   3    -              3 
Total current liabilities   801    15    (3)        813 
Long-term non-current debt, net of unamortized debt discount and debt issuance costs   1,020    -              1,020 
Deferred tax liabilities   119    -              119 
Pension liabilities   316    -              316 
Long-term operating lease liabilities   55    -              55 
Derivative warrant liabilities   -    60              60 
Earnout liability   -    -    175     (k)     175 
Deferred underwriting compensation   -    29    (29)    (d)     - 
Other non-current liabilities   26    -              26 
Total liabilities  $2,337   $104   $143        $2,584 
                          
Commitments and contingencies                         
                          
Temporary Equity                         
APSG Class A ordinary shares subject to possible redemption        817    (817)    (l)     - 
GBT Preferred shares   165         (165)    (h)     - 
                          
Shareholders Equity                         
GBT Voting ordinary shares   -                   - 
GBT Non-Voting ordinary shares   -                   - 
GBT Profit shares   -                   - 
GBT Management incentive plan shares   -                   - 
APSG Preferred shares        -              - 
APSG Class A ordinary shares        -              - 
APSG Class B ordinary shares        -              - 
Class A-1 Preferred Stock                       - 
Class B-1 Preferred Stock                       - 
Class A Common Stock                       - 
Class B Common Stock                       - 
Class X Common Stock                       - 
Additional paid-in capital   2,558    -    (103)    (j)     1,761 
              (175)    (k)       
              324     (g)       
              (29)    (d)       
              (776)    (i)       
              817     (l)       
              (988)    (m)       
              (12)    (f)       
              4     (e)        
              (26)    (b)       
              166     (n)       
Accumulated deficit   (1,156)   (103)   103     (j)     (1,156)
Accumulated other comprehensive loss   (169)   -              (169)
Total equity of Company's shareholders  $1,233   $(103)  $(695)       $436 
Equity attributable to non-controlling interest in subsidiaries   1        $988     (m)     989 
Total shareholders' equity  $1,234   $(103)  $293        $1,424 
Equity attributable to non-controlling interest in subsidiaries                         
Total liabilities, preferred shares and shareholders' equity  $3,736   $818   $(546)       $4,008 
                          
The accompanying notes are an integral part of these pro forma financial statements.

 

4 

 

 

UNAUDITED PRO FORMA
CONDENSED COMBINED STATEMENT OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2022
                     
($ in millions, except share and per share data)  GBT JerseyCo Limited
(Historical)
   Apollo Strategic Growth Capital
(Historical)
   Transaction Accounting Adjustments       Pro Forma Combined 
Revenue  $350   $-   $-        $350 
Costs and expenses:                         
Cost of revenue (excluding depreciation and amortization shown separately below)   173    -              173 
Sales and marketing   72    -              72 
Technology and content   90    -              90 
Administration fee - related party        -              - 
General and administrative   65    1              66 
Restructuring charges   2    -              2 
Depreciation and amortization   44    -              44 
Total operating expenses   446    1    -         447 
Operating loss   (96)   (1)   -         (97)
Interest expense   (19)   -              (19)
Other expense, net   -    -    (7)   (aa)    (7)
Change in fair value of derivative warrants        (4)             (4)
Loss before income taxes and share of loss from equity method investments   (115)   (5)   (7)        (127)
                          
Benefit from income taxes   25    -    1   (bb)    26 
Share of losses from equity method investments   (1)   -    -         (1)
Net loss  $(91)  $(5)  $(6)       $(102)
                          
Net (loss) attributable to noncontrolling interests in subsidiaries   -    -    (89)   (cc)    (89)
Net (loss) income attributable to the Company   (91)   (5)   83        (13)
Preferred shares dividend   (5)   -    5    (dd)    - 
Net (loss) income attributable to the Company's ordinary shareholders   (96)   (5)   88        (13)
                          
Earnings per share attributable to the shareholders of the Company’s ordinary shares - Basic and Diluted:                         
Weighted average number of ordinary shares outstanding   44,413,972                     
Loss per share  $(2.15)                    
Weighted average shares outstanding of Class A ordinary shares        81,681,000    369,712,514         

451,393,514

 
Basic and diluted net income per share, Class A       $(0.05)            $(0.03)
Weighted average shares outstanding of Class B ordinary share        20,420,250                
Basic and diluted net loss per share, Class B       $(0.05)               
                          
The accompanying notes are an integral part of these pro forma financial statements.

 

5 

 

 

UNAUDITED PRO FORMA

CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2021

 

($ in millions, except share and per share data) GBT
JerseyCo
Limited
(Historical)
  Egencia
(Unaudited
Historical)
  Egencia
Aqcuisition
Adjustments
     GBT
JerseyCo
Limited
Combined
(Historical)
  Apollo
Strategic
Growth
Capital
(Historical)
  Transaction
Accounting
Adjustments
     Pro Forma
Combined
 
Revenue $763  $148  $(22)   (i)   $889  $-  $-      $889 
Costs and expenses:                                    
Cost of revenue (excluding depreciation and amortization shown separately below)  477   131   -       608   -           608 
Sales and marketing  201   93   -       294   -           294 
Technology and content  264   57   -       321   -           321 
General and administrative  213   35   (6)   (ii)    242   13           255 
Restructuring charges  14   9   -       23   -           23 
Depreciation and amortization  154   40   2    (iii)    196   -           196 
Total operating expenses  1,323   365   (4)      1,684   13   -       1,697 
Operating loss  (560)  (217)  (18)      (795)  (13)  -       (808)
Interest income  1   -   -       1   -           1 
Interest expense  (53)  -   -       (53)  -           (53)
Loss on early extinguishment of debt  (49)  -   -       (49)              (49)
Other income (expense), net  8   2   -       10   -   (11)  (aa)   (1)
Change in fair value of derivative warrants  -   -   -       -   19           19 
Loss before income taxes and share of loss from equity method investments  (653)  (215)  (18)      (886)  6   (11)      (891)
                                     
Benefit from income taxes  186   2   5    (iv)    193   -   2   (bb)   195 
Share of losses from equity method investments  (8)  -   -       (8)  -   -       (8)
Net loss $(475) $(213) $(13)     $(701) $6  $(9)     $(704)
                                     
Net (loss) attributable to noncontrolling interests in subsidiaries  (2)  -   -       (2)  -   (615)  (cc)   (617)
Net (loss) income attributable to the Company  (473)  (213)  (13)      (699)  6   606       (87)
Preferred shares dividend  (10)              (10)  -   10   (dd)   - 
Net (loss) income attributable to the Company's ordinary shareholders  (483)  (213)  (13)      (709)  6   616       (87)
                                     
Earnings per share attributable to the shareholders of the Company’s ordinary shares - Basic and Diluted:                                    
Weighted average number of ordinary shares outstanding  37,406,171                                 
Loss per share $(12.91)                                
Weighted average shares outstanding of Class A ordinary shares                      81,681,000   369,712,514       451,393,514 
Basic and diluted net income per share, Class A                     $0.06          $(0.19)
Weighted average shares outstanding of Class B ordinary share                      20,420,250             
Basic and diluted net loss per share, Class B                     $0.06             
                                     

 

The accompanying notes are an integral part of these pro forma financial statements.

 

6

 

 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

Note 1 — Basis of Presentation

 

The Business Combination is accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in accordance with GAAP. Under this method of accounting, APSG is treated as the “acquired” company for financial reporting purposes. This determination was primarily based on evaluation of the following facts and circumstances: (i) Legacy GBT’s anticipated governance structure is more akin to a corporation; (ii) Legacy GBT’s stockholders have the majority of the voting power in the post- Business Combination company; (iii) Legacy GBT’s stockholders are able to appoint a majority of the PubCo Board; (iv) Legacy GBT’s management team is the management team of the post-Business Combination company; (v) Legacy GBT’s prior operations comprise the ongoing operations of the post-Business Combination company; (vi) Legacy GBT is the larger entity based on historical revenues and business operations; and (vii) the post- Business Combination Company is assuming Legacy GBT’s operating name and its headquarters. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of Legacy GBT issuing shares for the net assets of APSG, accompanied by a recapitalization. The net assets of APSG are stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of Legacy GBT.

 

The unaudited pro forma condensed combined balance sheet as of March 31, 2022 presents the pro forma effect of the Business Combination and related transactions as if they had occurred on March 31, 2022. The unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2022 and for the year ended December 31, 2021 presents the pro forma effect of the Business Combination and the Egencia Acquisition and related transactions as if they had been completed on January 1, 2021. These periods are presented on the basis of Legacy GBT as the accounting acquirer.

 

The unaudited pro forma condensed combined financial information should be read in conjunction with the following materials, each of which is incorporated into this Current Report on Form 8-K by reference:

 

the accompanying notes to the unaudited pro forma condensed combined financial statements;

 

the historical unaudited financial statements of APSG as of, and for the three months ended, March 31, 2022, included as Exhibit 99.3 to this Current Report on Form 8-K;

 

the historical unaudited financial statements of GBT as of, and for the three months ended, March 31, 2022, included as Exhibit 99.1 to this Current Report on Form 8-K;

 

the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of APSG,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations of GBT,” “The Business Combination Proposal” and other financial information included in the Proxy Statement/Prospectus.

 

Management has made significant estimates and assumptions in its determination of the pro forma adjustments (“Transaction Accounting Adjustments”). As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.

 

The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses.” The unaudited pro forma combined financial information reflects transaction related adjustments management believes are necessary to present fairly GBT’s pro forma results of operations and financial position following the closing of the Business Combination and related transactions as of and for the periods indicated. The related transaction accounting adjustments are based on currently available information and assumptions management believes are, under the circumstances and given the information available at this time, reasonable, and reflective of adjustments necessary to report GBT’s financial condition and results of operations as if the Business Combination was completed. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may be material. APSG believes that its assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination and related transactions contemplated based on information available to management at the time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma condensed combined financial information.

 

7

 

 

The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings, or cost savings that may be associated with the Business Combination and Egencia Acquisition.

 

The unaudited condensed pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated.

 

The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination and Egencia Acquisition taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of PubCo. They should be read in conjunction with the audited financial statements of each of APSG, Legacy GBT and Egencia and related notes thereto included in Proxy Statement/Prospectus.

 

Note 2 — Unaudited pro forma adjustments related to Egencia Acquisition

 

The historical consolidated financial information of GBT JerseyCo Limited and subsidiaries is derived from its consolidated financial statements included as Exhibit 99.1 in this Current report on Form 8-K and/or in the Proxy Statement/Prospectus] and includes results of Egencia since the date of its acquisition on November 1, 2021. The historical balance sheet of GBT JerseyCo Limited as of March 31, 2022 includes provisional purchase accounting adjustments related to the Egencia Acquisition. On November 1, 2021, GBT acquired Egencia from Expedia. As part of the Egencia Acquisition’s purchase consideration, Expedia became an indirect holder of non-voting ordinary shares of GBT, which represents approximately 19% of the equity interests of GBT, excluding GBT Preferred Shares, GBT Profit Shares, GBT MIP Options and GBT MIP Shares. On Closing, and as contemplated by the Egencia Acquisition, Expedia became a direct equity holder in GBT. Such equity interest is subject to changes based on final debt/cash and working capital adjustments and we have estimated that the extent of such adjustments is not expected to be material. The pro forma adjustments presented above assume that no additional consideration would be required to be paid to Expedia.

 

Under the acquisition method of accounting, the identifiable assets acquired, and liabilities assumed are recorded at the acquisition date fair values. The pro forma acquisition adjustments are provisional and based on (i) initial fair valuations of purchase consideration, assets acquired and liabilities assumed, and (ii) estimated useful lives of the assets. These pro forma acquisition adjustments illustrate the estimated effect of the Egencia Acquisition on the pro forma consolidated statements of operations. For all assets acquired and liabilities assumed other than acquired technology, identified intangible assets and goodwill, the fair value is determined to be the same as its carrying value. Management continues to evaluate the provisional valuations and the final determination of the fair values will be completed within the one-year measurement period from the date of completion of the acquisition, as required by Accounting Standard Codification Topic 805 — Business Combinations. The significance of the Egencia Acquisition may necessitate the use of this measurement period to adequately analyze and assess a number of the factors used in establishing the asset and liability fair values as of the acquisition date, including customer relationships, tradenames and technology and the assumptions underpinning the related tax impacts. Any potential adjustments made could be material in relation to the provisional values presented in the consolidated balance sheet and pro forma consolidated statements of operations. Accordingly, the purchase price allocation may be subject to further adjustment as additional information becomes available and as additional analyses are completed. There can be no assurances that these additional analyses will not result in significant changes to the estimates of fair value set forth below.

 

8

 

 

 

(i)In connection with the Egencia Equity Contribution Agreement, the Company has entered into a long-term hotel supply agreement whereby the GBT will receive hotel commission revenue from Expedia for the hotel bookings made by Egencia on Expedia’s platform. Historically Egencia has recorded the entire hotel commission in its financial statements. The adjustment represents reversal of Expedia’s share of hotel commission revenue from the combined results pursuant to this agreement, and for the ten months ended October 31, 2021, GBT has estimated that a total of $22 million would have been share of Expedia’s hotel commission revenue under such agreement if the agreement had been in effect as of January 1, 2021.
(ii)Represents:
(1)Reversal of the acquisition transaction costs of $13 million included in the historical statements of operations of GBT for the year ended December 31, 2021 and
(2)Amortization of deferred compensation asset recognized on the Egencia Acquisition of $7 million for the ten months ended October 31, 2021.
(iii)Represents additional amortization expense resulting from the fair value of Egencia’s acquired intangible assets. The table below indicates the fair values, estimated useful lives and the annual amortization of each of the identifiable acquired intangible asset.

 

    Fair     Annual 
($ in millions, except as stated otherwise)   value  Useful lives (years)  Amortization 
Acquired technology   $50   5  $10 
Customer and Supplier relationships    390   15   26 
Tradenames    50   10   5 
Annual estimated additional amortization            41 

 

The pro forma adjustment represents the net additional amount recorded for the ten months ended October 31, 2021 to include the impact of amortization of intangibles assets acquired on business combination, after considering reversal of related depreciation and amortization recorded in historical accounts.

 

(iv)Represents the tax adjustment for the pro forma adjustments of Egencia Acquisition calculated at 28%.

 

Note 3 — Unaudited pro forma adjustments related to Business Combination

 

The adjustments included in the unaudited pro forma condensed combined balance sheet as of March 31, 2022 are as follows:

 

(a)Represents the aggregate impact of the following pro forma adjustments to cash to give effect to the Business Combination:

 

(Signs represent debits/(credits))   
Cash inflow from APSG Trust Account $818(c)
Cash inflow from the PIPE Investment  324(g)
Payment of estimated transaction fees  (69)(d)
Payment to legacy GBT preferred shareholders  (165)(h)
Release of cash for redemption of shares  (776)(i)
Net Pro Forma Adjustment to Cash $132(a)

 

(b)Represents deferred offering costs being written off.
(c)Represents cash equivalents that will be released from the Trust Account and relieved of restrictions regarding use upon consummation of the Business Combination and, accordingly, will be available for general use by PubCo.
(d)Represents the estimated transaction costs incurred in connection with the Business Combination including, but not limited to, advisory fees, legal fees and registration fees that was paid in connection with the consummation of the Business Combination. Of the total amount, (i) $29 million relates to the cash used to pay deferred underwriter compensation that was incurred as part of APSG’s IPO and that was to be paid upon the consummation of a business combination by APSG (ii) $6 million relates to the cash used to pay APSG notes payable and $5 million relates to APSG accounts payable and accrued liabilities for costs incurred in relation to the Business Combination.

 

9

 

 

(e)Represents amounts due to affiliates that were settled as of the acquisition date.
(f)Represents an accrual for unpaid bankers’ fees related to services provided in connection with the Business Combination.
(g)Reflects the gross cash proceeds of $324 million from the issuance and sale of PIPE Securities at $10.00 per share pursuant to the PIPE Subscription Agreements.

 

10

 

 

(h)Represents the payment of $165 million to holders of GBT Preferred Shares.
(i)Represents the cash disbursement for the redemption of 77,514,764 shares of Class A Common Stock at a redemption price of approximately $10.00 per share and any income accrued thereon, totaling approximately $776 million.
(j)Elimination of historical retained earnings of APSG as part of the acquisition accounting.
(k)Reflects the fair value of the Sponsor and legacy shareholders of Legacy GBT Earn-Out Shares contingently issued to the Sponsor and the legacy shareholders as of the Closing. The preliminary fair value was determined utilizing a Monte Carlo simulation analysis in order to capture a wide range of Earn-Out shares vesting scenarios over the five year Earn-Out achievement period. The following assumptions and inputs were used for approximately 20,000 Monte Carlo simulations:

 

Class A common stock price – $9.95

 

Annual volatility – 35.0%

 

Risk-free rate of return – 2.42%

 

(l)Reflects (i) the redemption of 77,514,764 Acquiror Cayman Class A Ordinary Shares and (ii) reclassification of 4,166,236 Acquiror Cayman Class A Ordinary Shares to permanent equity.
(m)Noncontrolling interests represent direct interests held in GBT other than by APSG immediately after the Business Combination. Reflects the noncontrolling interest ownership of 87.4% ownership of PubCo to be held by Continuing JerseyCo Owners.
(n)Represents the net US deferred tax asset to be reflected on PubCo’s books for the outside basis difference on its investment in Legacy GBT of $206 million offset by deferred tax liabilities of $(40) million related to foregone US foreign tax credits on JerseyCo’s foreign deferred tax assets.

 

The pro forma adjustments included in the unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2022 are as follows:

 

(aa)Reflects the change in fair value of the Sponsor and Legacy GBT shareholders Earn-Out shares.

 

(bb)Represents an adjustment to record the income tax impact of APSG’s 2022 income statement activity at a statutory rate of 27% assuming US federal and state income taxes would apply after becoming a US resident corporation (Delaware).

 

(cc)Noncontrolling interests represent direct interests held in GBT other than by APSG immediately after the Business Combination. Reflects the noncontrolling interest ownership of 87.4%.

 

(dd)Represents an adjustment to eliminate the preferred shares dividend associated with the paydown of GBT Preferred Shares upon consummation of the Business Combination.

 

11

 

 

Note 4 — Earnings per Share

 

Represents the net earnings per share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination, assuming the shares were outstanding since January 1, 2021. As the Business Combination is being reflected as if it had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net income (loss) per share assumes that the shares issuable in connection with the Business Combination have been outstanding for the entire period presented. This calculation is retroactively adjusted to eliminate 77,514,764 Acquiror Cayman Class A Ordinary Shares that have been redeemed for the entire period. The Company uses the two-class method to compute basic and diluted earnings per common share. In periods of net loss, no effect was given to the Company’s participating securities as they did not contractually participate in the losses of the Company.

 

The unaudited pro forma condensed combined financial information has been presented under the Actual Redemptions:

 

  For the Three
Months Ended
 
  March 31, 2022  
Pro Forma Basic and Diluted Loss Per Share      
Pro Forma net loss attributable to shareholders (in $ millions) $ (13 )
Weighted average shares outstanding, basic and diluted   451,393,514  
Basic and diluted net loss per share $ (0.03 )
Pro Forma Weighted Average Shares – Basic and Diluted      
Juweel   162,388,084  
Amex HoldCo   157,786,199  
Expedia   74,274,198  
Continuing JerseyCo Owners   394,448,481  
Public Shareholders   4,174,783  
PIPE Investors   32,350,000  
Sponsor and Insiders   20,420,250  
Pro Forma Weighted Average Shares – Basic and Diluted(1)   451,393,514  

 

 

(1)Potentially dilutive securities that are not included in the calculation of diluted net loss per share consist of 36,535,801 shares of Domesticated Acquiror Class A Common Stock that may be issued upon the exercise of 36,535,801 Acquiror Options to purchase Domesticated Acquiror Class A Common Stock, 39,451,134 shares of Domesticated Acquiror Class A Common Stock that may be issued upon exercise of Domesticated Acquiror Warrants and 15,000,000 earnout shares. These securities are not included in the diluted net loss per share calculation because to do so would be anti-dilutive due to the Pro Forma Consolidated net loss results for the three months ended March 31, 2022.

 

Note 5 — Long-term Debt

 

Effective as of December 16, 2021, Legacy GBT amended the senior secured credit agreement to, among other things, establish the $1,000 million senior secured tranche B-3 term loan facilities, $800 million of which was borrowed on such date and $200 million of which is available on a delayed-draw basis for a six-month period after the date of such initial borrowings, subject to certain customary borrowing conditions. On May 19, 2022, Legacy GBT borrowed a principal amount of $100 million of senior secured tranche B-3 term loans under the $200 million of delayed draw commitments that were established under the senior secured credit agreement in December 2021. Legacy GBT expects to draw down the balance of $100 million of principal amount of tranche B-3 term loan in June 2022.

 

12